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Networks of interneurons within the spinal cord coordinate the rhythmic activation of muscles 
during locomotion. These networks are subject to extensive neuromodulation, ensuring 
appropriate behavioural output. Astrocytes are proposed to detect neuronal activity via Gαq-
linked G-protein coupled receptors and to secrete neuromodulators in response. However, 
there is currently a paucity of evidence that astrocytic information processing of this kind is 
important in behaviour. Here, it is shown that protease-activated receptor-1 (PAR1), a Gαq-
linked receptor, is preferentially expressed by glia in the spinal cords of postnatal mice. During 
ongoing locomotor-related network activity in isolated spinal cords, PAR1 activation stimulates 
release of adenosine triphosphate (ATP), which is hydrolysed to adenosine extracellularly. 
Adenosine then activates A1 receptors to reduce the frequency of locomotor-related bursting 
recorded from ventral roots. This entails inhibition of D1 dopamine receptors, activation of 
which enhances burst frequency. The effect of A1 blockade scales with network activity, 
consistent with activity-dependent production of adenosine by glia. Astrocytes also regulate 
activity by controlling the availability of D-serine or glycine, both of which act as co-agonists of 
glutamate at N-methyl-D-aspartate receptors (NMDARs). The importance of NMDAR 
regulation for locomotor-related activity is demonstrated by blockade of NMDARs, which 
reduces burst frequency and amplitude. Bath-applied D-serine increases the frequency of 
locomotor-related bursting but not intense synchronous bursting produced by blockade of 
inhibitory transmission, implying activity-dependent regulation of co-agonist availability. 
Depletion of endogenous D-serine increases the frequency of locomotor-related but not 
synchronous bursting, indicating that D-serine is required at a subset of NMDARs expressed 
by inhibitory interneurons. Blockade of the astrocytic glycine transporter GlyT1 increases the 
frequency of locomotor-related activity, but application of glycine has no effect, indicating that 
GlyT1 regulates glycine at excitatory synapses. These results indicate that glia play an 
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Chapter 1: General introduction 
Spinal locomotor networks in mammals 
Movement is a fundamental behaviour, allowing animals to interact with their environment and 
satisfy the requirements of survival. In vertebrates it arises from the biomechanical properties 
of the skeletomuscular system and activity within dedicated neural circuitry in the central 
nervous system (CNS) (Orlovsky, Deliagina and Grillner, 1999; Dickinson, 2000; Grillner, 2006; 
Kiehn, 2006; Kiehn, 2016). Planning and initiation of movements involves various brain 
regions, including the cortex, basal ganglia, midbrain and hindbrain (Orlovsky, Deliagina and 
Grillner, 1999; Takakusaki et al., 2004), but executive control over the timing and coordination 
of muscle activity resides in networks of interneurons in the ventral horn of the spinal cord. 
These networks selectively excite and inhibit pools of motoneurons with precise timing to 
ensure appropriate contraction and relaxation within antagonistic pairs of muscles, resulting 
in smooth, controlled movement. 
During rhythmic locomotor behaviours such as walking, flying and swimming, spinal networks 
activate muscles in a cyclically repeated sequence (Orlovsky, Deliagina and Grillner, 1999). 
The rhythmic output of spinal networks arises from the passive electrical properties of their 
constituent interneurons and the synaptic connections between those neurons (Grillner, 2003, 
2006; Kiehn, 2016). Although spinal networks receive command signals and modulatory 
inputs from descending and peripheral pathways, they remain capable of generating a basic 
motor pattern when extrinsic influences are removed and are therefore an example of a central 
pattern generator (CPG) (Brown, 1911; Guertin, 2009). Other examples of CPGs include 
brainstem networks for chewing, swallowing and respiration (Jean, 2001; Marder and Bucher, 
2001; Feldman and Del Negro, 2006; Lund and Kolta, 2006). Spinal cord preparations, 
primarily from cats, rats and mice, have been used extensively in conjunction with 
pharmacological and genetic manipulations to determine the organisation of the spinal motor 
circuitry (Orlovsky, Deliagina and Grillner, 1999; Kiehn and Butt, 2003; Whelan, 2010). Rodent 
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spinal cords may be isolated and sustained in artificial cerebrospinal fluid in vitro. Rhythmic 
locomotor-related activity can be evoked in hindlimb motor circuitry in these preparations by 
application of agonists of glutamate and monoamine receptors or by electrical or optogenetic 
stimulation (Kudo and Yamada, 1987; Smith and Feldman, 1987; Kiehn and Kjaerulff, 1996; 
Whelan, Bonnot and O’Donovan, 2000; Hägglund et al., 2013). Isolated networks generate 
activity in hindlimb muscles, if present (Hayes, Chang and Hochman, 2009), or in transected 
ventral roots containing the motoneurons that innervate muscles in intact animals (Kudo and 
Yamada, 1987; Smith and Feldman, 1987). In preparations where the ventral roots are 
transected, field-potential recordings reveal a pattern of activity in the lumbar ventral roots 
corresponding to activity observed during treadmill locomotion in adult animals (Cowley and 
Schmidt, 1994; Kiehn and Kjaerulff, 1996; Whelan, Bonnot and O’Donovan, 2000). Bursts 
recorded from lumbar ventral roots L1-L4 are in phase with hip flexors and alternate with bursts 
in phase with hip extensors in roots L5-L6. Activity also alternates between left-right pairs of 
roots in all segments. 
Many features of locomotor networks are conserved between non-limbed and limbed 
vertebrates (Orlovsky, Deliagina and Grillner, 1999; Marder and Bucher, 2001; Goulding, 2009; 
Kiehn, 2016); however, the architecture of locomotor circuits in the latter are considerably 
more complicated. In non-limbed vertebrates such as lampreys and frog tadpoles, muscle 
activation alternates between bilaterally paired axial muscles along the rostral-caudal axis, 
producing bends in the body in a metachronal wave that propels the animal during swimming. 
In limbed vertebrates including mammals, locomotion requires strict alternation of antagonistic 
groups of flexor and extensor muscles around the limb joints in addition to bilateral 
coordination of homologous muscles in the limbs and trunk. 
Locomotor networks express rhythm, resulting in phasic activity within pools of motoneurons, 
and pattern, resulting in coordination of activity between pools of motoneurons (Kiehn, 2006; 
Kiehn, 2016). Changes in rhythm generation result in changes in cycle period. Changes in 
pattern generation result in differences in phase relationships between muscle groups. In 
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mammals, rhythm and pattern generation covary to produce different gaits at non-overlapping 
ranges of speed, allowing energetically efficient movement (Bellardita and Kiehn, 2015; Kiehn, 
2016).  
In non-limbed vertebrates, rhythm and pattern are proposed to be generated by common 
circuit elements with a single-layer organisation. This likely incorporates half-centre networks 
coupled across the midline by reciprocal inhibition in antiphase, such that when muscles are 
activated on one half of the body, those on the opposite side are rendered inactive (Roberts 
et al., 1998; Grillner, 2003; Moult, Cottrell and Li, 2013). In limbed vertebrates, rhythm- and 
pattern-generating components are proposed to be segregated into two or more layers 
(Kriellaars et al., 1994; Burke, Degtyarenko and Simon, 2001; Lafreniere-Roula and McCrea, 
2005; Kiehn, 2006; McCrea and Rybak, 2008). Evidence supporting this model includes the 
observations that rhythm generation occurs in the absence of left-right alternation, for instance 
following hemisection of the spinal cord (Kato, 1987; Noga et al., 1987; Kremer and Lev-Tov, 
1997; Bonnot et al., 2002), and that it is independent of flexor-extensor alternation (Machado 
et al., 2015). 
In mammals, the locomotor circuitry is distributed within the ventral horn of the spinal cord, 
with the upper limbs governed by networks located in cervical segments and the hindlimbs by 
networks in lumbar and sacral segments (Orlovsky, Deliagina and Grillner, 1999; Kiehn et al., 
2008; Goulding, 2009). Ventral horn interneurons have been described according to 
transcription-factor expression, axonal branching, neurotransmitter phenotype, passive 
membrane properties, sensory inputs and physiological function (Jankowska, 2001; Kiehn and 
Butt, 2003; Goulding, 2009). Four cardinal classes of postmitotic interneuron are generated 
within the ventral horn during embryonic development (these are V0, V1, V2 and V3 
interneurons), as are motoneurons (Goulding, 2009). In addition, dorsally derived dI6 
interneurons are integrated into the ventral circuitry. Each of these cell types is proposed to 
give rise to multiple subtypes in mature networks, generating considerable complexity (Bikoff 
et al., 2016). The mechanisms by which this diverse population of interneurons generates 
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rhythm and pattern in mammals have been partially determined, and will be briefly described 
here. 
A set of ipsilaterally projecting glutamatergic interneurons are proposed to form a rhythm 
generating core in both non-limbed and limbed vertebrates (Kiehn et al., 2008; Kiehn, 2016). 
These neurons are proposed to be essential for both the initiation of rhythmic network activity 
and speed control. In mammals, rhythm generation is supressed during inhibition of 
glutamatergic transmission (see below) but can occur in hemisected cords in which 
commissural axons are severed (Kato, 1987; Noga et al., 1987; Kremer and Lev-Tov, 1997; 
Bonnot et al., 2002). Selective activation of glutamatergic neurons within the spinal cord is 
also sufficient to stimulate rhythmic network activity; whereas activity is suppressed when 
glutamatergic neurons are selectively silenced (Hägglund et al., 2013). In mammals, rhythm-
generating neurons are likely to be molecularly heterogeneous and may include neurons 
expressing the transcription factor short stature homeobox protein 2 (SHOX2) but not ceh-10 
homeodomain containing homologue (CHX10); silencing of these cells results in perturbation 
of rhythmic bursting (Dougherty et al., 2013), and interneurons containing the transcription 
factor basic helix–loop–helix domain containing, class B, 9 (Hb9), which display pacemaker 
properties (Wilson et al., 2005; Brownstone and Wilson, 2008; Brocard, Tazerart and Vinay, 
2010). Glutamatergic excitatory transmission is the subject of Chapter 4 and will be discussed 
at greater length under “Excitatory transmission in mammalian spinal locomotor networks”, 
below. 
Commissural interneurons are proposed to coordinate activity in bilaterally homologous motor 
pools (Kiehn, 2016). At lower speeds of locomotion in quadrupeds, gaits are characterised by 
activity alternating between the left and right forelimbs and hindlimbs (Bellardita and Kiehn, 
2015). This is mediated by inhibitory interneurons, since blockade of inhibitory transmission 
with strychnine, a glycine receptor (GlyR) antagonist, and picrotoxin or bicuculline, antagonists 
of γ-aminobutyric acid (GABA) type A (GABAA) receptors results in synchronous activity on 
the left and right sides of the spinal cord (Cowley and Schmidt, 1995; Bracci, Ballerini and 
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Nistri, 1996). Different subsets of commissural V0 neurons are required for left-right alternation 
during walking, the lowest-frequency alternating gait, and trotting, which occurs at higher 
frequencies (Talpalar et al., 2013; Bellardita and Kiehn, 2015). Walking requires dorsal V0 
(V0D) neurons, which are inhibitory, whereas trotting requires excitatory ventral V0 (V0V) 
neurons, presumably in addition to V0D cells. Ablation of all V0 interneurons, including the 
inhibitory V0D subpopulation, prevents mice from producing gaits in which the left and right 
limbs alternate (Bellardita and Kiehn, 2015). 
Gallop and bound are gaits used at the fastest speeds of quadrupedal locomotion, and are 
characterised by synchronous activation of left-right pairs of limbs (Bellardita and Kiehn, 2015). 
Synchronous activity is proposed to be mediated by excitatory commissural interneurons, the 
identity of which remains to be determined. V3 excitatory commissural interneurons contribute 
to the robustness of rhythmic bilaterally alternating locomotor-related activity, such that their 
removal from the spinal cord results in greater variance in amplitude and cycle period (Zhang 
et al., 2008). However, their role in gaits in which the hindlimbs or forelimbs are synchronously 
active has not been assessed. 
Flexor-extensor alternation is specified by circuit components distinct from those required for 
left-right alternation, and persists under conditions where left-right alternation is abolished, 
such as in hemicords (Cazalets, Borde and Clarac, 1995; Whelan, Bonnot and O'Donovan, 
2000; Zagoraiou et al., 2009). Flexor-extensor alternation is mediated by ipsilaterally derived 
inhibitory Ia interneurons belonging to the V1 and V2b populations (Zhang et al., 2014; Britz 
et al., 2015). Blocking output of Ia interneurons prevents flexor-extensor alternation but not 
left-right alternation, with V1 Ia interneurons dominantly inhibiting flexor activity and V2b Ia 
neurons dominantly inhibiting extensor activity. The premotor circuitry for flexion and 
extension is proposed to be organised into discrete modules since rhythmic activity can be 




Excitatory transmission in mammalian spinal locomotor networks 
Excitatory glutamatergic transmission operates both within the spinal locomotor CPG (Kiehn 
et al., 2008; Zhang et al., 2008; Talpalar and Kiehn, 2010; Bellardita and Kiehn, 2015) and 
between descending pathways and the locomotor CPG (Jordan et al., 2008; Hägglund et al., 
2010). Within spinal networks, excitatory transmission is required for rhythm generation, and 
determines the speed and amplitude of locomotor-related activity (Kiehn et al., 2008; Talpalar 
and Kiehn, 2010). It also contributes to the robustness of activity (Zhang et al., 2008; 
Dougherty et al., 2013) and is implicated in gait selection (Talpalar et al., 2013; Bellardita and 
Kiehn, 2015). Between descending pathways and spinal networks, excitatory transmission 
provides signals for both the initiation (Hägglund et al., 2010) and, paradoxically, the cessation 
(Bouvier et al., 2015) of locomotion. 
Experiments in which selective agonists and antagonists of glutamate receptors were applied 
to isolated rodent spinal cord preparations have revealed roles for all three subtypes of 
ionotropic glutamate receptors, namely N-methyl-D-aspartate (NMDA) receptors (NMDARs), 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs) and 
kainate receptors (Smith, Feldman and Schmidt, 1988; Cazalets, Sqalli-Houssaini and Clarac, 
1992; Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Nishimaru, Takizawa and 
Kudo, 2000; Cowley et al., 2005; Talpalar and Kiehn, 2010). In these studies, glutamatergic 
signalling is shown to determine the frequency and/or the amplitude of locomotor-related 
bursting. Glutamate receptors also mediate locomotor-related activity in intact rabbits and cats 
(Fenaux et al., 1991; Douglas et al., 1993; Giroux et al., 2003) 
It has been proposed that glutamatergic signalling differs between postnatal rats and mice 
(Nishimaru, Takizawa and Kudo, 2000). In rats, application of NMDAR agonists alone induces 
sustained locomotor-related activity (Kudo and Yamada, 1987; Smith, Feldman and Schmidt, 
1988). In addition, NMDAR blockade consistently abolishes or reduces the frequency of 
rhythmic activity in rats, depending on the intensity of the stimulus used to excite the network 
(Smith, Feldman and Schmidt, 1988; Cazalets, Sqalli-Houssaini and Clarac, 1992; Beato, 
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Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Gabbay, 2004; Cowley et al., 2005). 
Where activity is not abolished, left-right rhythmic alternation of bursts is maintained during 
NMDAR blockade (Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Cowley et 
al., 2005). 
In mice, sustained rhythmic activity is reported to require 5-HT in addition to NMDAR agonists 
(Jiang, Carlin and Brownstone, 1999), and NMDAR blockade is reported to enhance burst 
frequency during pharmacologically induced locomotor-related activity in mice (Whelan, 
Bonnot and Donovan, 2000). In addition, NMDARs and non-NMDARs may have distinct roles 
within murine locomotor networks. Non-NMDARs are proposed to be required for the 
generation of high (> 0.4 Hz) but not low (< 0.4 Hz) frequencies of locomotor-related activity, 
whereas NMDARs are required for consistent output at high frequencies, during which 
NMDAR blockade disrupts patterned output by increasing non-resetting deletions (breaks in 
rhythmic bursting lasting an integer of the control period), rather than altering frequency per 
se (Talpalar and Kiehn, 2010). 
Glutamatergic signalling is necessary for the synchronous rhythmic bursting generated when 
inhibitory transmission is blocked by strychnine and picrotoxin (Talpalar et al., 2011). Although 
NMDAR blockade abolishes disinhibited bursting in rat preparations, it is restored when 
AMPAR currents are enhanced, indicating this activity is mediated by both NMDARs and non-
NMDARs (Bracci, Ballerini and Nistri, 1996), as is bilaterally alternating locomotor-related 
activity (Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Nishimaru, Takizawa 
and Kudo, 2000; Whelan, Bonnot and Donovan, 2000; Gabbay, 2004; Cowley et al., 2005; 
Talpalar and Kiehn, 2010). 
Neuromodulation of spinal locomotor networks 
Alterations to motor network output allow animals to adjust their behaviour according to 
developmental stage, physiological state, and to meet the challenges of different 
environmental conditions (Grillner, 2006). For instance, changes in flexor-extensor 
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coordination within locomotor networks underlie transitions from one gait to another, and gait 
changes allow animals to efficiently vary the speed of their locomotion (Orlovsky, Deliagina 
and Grillner, 1999; Bellardita and Kiehn, 2015) – compare the movement of a predator evading 
detection with a predator in chase. Network output may vary in response to either descending 
commands mediated by synaptic transmission or the modification of cellular or synaptic 
properties by neuromodulators, which may originate from descending pathways or sources 
within the spinal cord (Jordan et al., 2008; Hägglund et al., 2010; Miles and Sillar, 2011; 
Bouvier et al., 2015). Changes in the cellular composition of the network are a further source 
of flexibility (Talpalar et al., 2013; Bellardita and Kiehn, 2015), but may be secondary to these 
mechanisms. This section will give an overview of neuromodulation and its complexities in the 
locomotor circuitry. The actions of the specific neuromodulators considered in later chapters, 
namely dopamine, adenosine and the N-methyl-D-aspartate (NMDA) receptor (NMDAR) co-
agonists D-serine and glycine, will then be considered in turn. Many neuromodulatory systems 
operating within mammalian locomotor circuitry are also important in non-mammalian 
vertebrates (Dickinson, 2006; Miles and Sillar, 2011); although the focus of this thesis is the 
mammalian locomotor CPG, reference will be made to other models where appropriate. 
The basic motor pattern of a CPG under a given set of conditions is determined by the passive 
electrical properties of its constituent neurons and by the synaptic connections between them. 
Neuromodulators adjust both of these features to regulate fast synaptic transmission and 
information processing within the network (Katz and Frost, 1996; Katz, 1999; Dickinson, 2006; 
Harris-Warrick, 2011; Miles and Sillar, 2011). In this way, neuromodulation enables a defined 
population of neurons to produce diverse outputs and modes of adaptive behaviour. 
Multifarious neuromodulatory influences acting in concert give rise to a vast repertoire of 
network and behavioural outputs and are thus a source of considerable behavioural flexibility 
(Harris-Warrick, 2011; Miles and Sillar, 2011). 
The actions and interactions of neuromodulators within motor networks are numerous and 
complex. Individual neuromodulators have diverse effects within the locomotor CPG, 
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mediated by different cell types and signalling pathways (Harris-Warrick, 2011; Miles and Sillar, 
2011). In general, neuromodulators that adjust the frequency of locomotor-related activity act 
on the premotor rhythm generating circuitry, whereas those that influence the amplitude of 
network output act directly on motoneurons or last order interneurons; neuromodulators that 
alter both properties typically act on both motoneurons and premotor interneurons (Miles and 
Sillar, 2011). Opposing neuromodulatory effects, mediated either by different neuromodulators 
or by a single substance acting via different signalling pathways or different cell types, may 
stabilise network output, ensuring coherent motor behaviour (Harris-Warrick, 2011). In 
addition, neuromodulators may themselves be subject to modulation. Broadly, 
metamodulation may entail a second-order neuromodulator exerting changes in the 
availability (release or uptake) of a first-order neuromodulator, or modulation of its effect on a 
target neuron (Katz, 1999). Metamodulation may be an efficient mechanism for fine-tuning the 
effects of first-order neuromodulators that have diverse actions within a network. 
Neuromodulators acting within spinal motor networks are chemically diverse (Miles and Sillar, 
2011). They include biogenic amines such as 5-hydroxytryptamine (5-HT), dopamine (DA), 
noradrenaline and the trace amines; amino acids such as GABA where it acts at metabotropic 
GABAB receptors and glutamate where it acts at metabotropic glutamate receptors (mGluRs); 
peptides such as somatostatin; the purines adenosine triphosphate (ATP) and adenosine; and 
the gas nitric oxide. The NMDAR co-agonists D-serine and glycine may be categorised as 
amino acid neuromodulators: unlike other neuromodulators, they act at an ionotropic receptor 
and are obligatory for receptor activation; however, they are regulated on a relatively slow 
timescale compared to glutamate released during synaptic transmission, and their availability 
may be regulated to tune the intensity of glutamatergic signalling (see below).  
Receptor diversity is a further source of complexity within neuromodulatory systems: many 
neuromodulators bind to multiple receptors, which differ in their agonist affinity and signalling 
pathways (Dickinson, 2006; Miles and Sillar, 2011). Receptor expression varies between cell 
types, and activation of a given receptor can have different effects depending on cell type. 
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Typically, though not exclusively, neuromodulators are agonists of metabotropic, G-protein 
coupled receptors (GPCRs) (Miles and Sillar, 2011). GPCR activation triggers the dissociation 
of G-proteins into their Gα and Gβγ components intracellularly (Neves, Ram and Iyengar, 2002). 
Dissociated subunits act as transducers within various isoform-specific signalling pathways 
and modulate neuronal activity by diverse mechanisms. Gα subunit isoforms fall into four 
classes, Gαq, Gαs, Gi, Gα12, which act via different signalling pathways (Liebmann and Böhmer, 
2000). It should also be noted that GPCRs display basal activity independent of agonist 
binding, a consequence of their structural flexibility (Gether et al., 1997; Kobilka and Deupi, 
2007; Neve, 2010). In addition, GPCRs are capable of forming homo- and hetero- oligomers, 
permitting functional interactions (Bouvier, 2001). 
Neuromodulators may derive from cells contained within the spinal cord (intrinsic) or from 
others that have projections to the spinal cord originating in brain or brainstem structures 
(extrinsic). Intrinsic sources of neuromodulators include motoneurons and various interneuron 
populations in the spinal cord that produce acetylcholine, which acts as a neuromodulator 
within the spinal cord via metabotropic muscarinic receptors (Witts, Zagoraiou and Miles, 
2013), and glia, proposed as the principle source of modulatory adenosine in the mammalian 
spinal cord (Witts, Panetta and Miles, 2012). Extrinsic sources include the hypothalamic A11 
region, the principle source of dopamine to the spinal cord, and neurons in the brainstem that 
synthesise 5-HT and noradrenaline (Jordan et al., 2008; Miles and Sillar, 2011). Modulation 
by monoamines originating from descending projections has been studied extensively. 
Dopamine, 5-HT and noradrenaline are secreted within the spinal cord during locomotion and 
may, like glutamate released from descending pathways, be implicated in the initiation of 
locomotion in intact animals (Gerin and Privat, 1998; Jordan et al., 2008; Miles and Sillar, 
2011). In addition, all are potent modulators of ongoing locomotor-related activity, acting via 




Dopamine exerts modulatory control over diverse processes, including working memory, 
learning, motivation, and addiction (Girault and Greengard, 2004). In the spinal cord, 
dopamine modulates locomotor networks to ensure correct expression of motor behaviour 
(Miles and Sillar, 2011). Microdialysis experiments have shown that dopamine is released 
within the ventral horn of the mammalian spinal cord during locomotion (Gerin and Privat, 
1998). All segments of the mammalian spinal cord receive dopaminergic inputs from the brain 
(Hökfelt, Phillipson and Goldstein, 1979; Skagerberg and Lindvall, 1985); these originate 
principally in the hypothalamic A11 region, but other descending pathways are reported 
(Björklund and Skagerberg, 1979; Commissiong, Gentleman and Neff, 1979; Hökfelt, 
Phillipson and Goldstein, 1979; Skagerberg and Lindvall, 1985).  
Dopamine receptors fall into two families: D1-like receptors are the D1 and D5 subtypes and 
D2-like receptors are the D2, D3, and D4 subtypes (Neve, 2010; Pieper, Clerkin and MacFarlane, 
2011). Receptors differ in affinity for dopamine, structure, cellular distribution, and G-protein 
coupling. D1-like receptors bind dopamine with a lower affinity than D2-like receptors (Pieper, 
Clerkin and MacFarlane, 2011). They are encoded by genes that lack introns (Zhou, Li and 
Civelli, 1992; Sunahara et al., 1990), whereas D2-like receptors are encoded by genes that 
contain introns, with alternative splicing of D2 genes generating long and short isoforms (Giros 
et al., 1989; Araki et al., 1992). All five dopamine receptor subtypes are expressed in the 
rodent spinal cord, where they are broadly distributed in both the white and grey matters; 
however, D1-like receptors are most strongly expressed in the ventral horn, whereas D2-like 
receptors are most strongly expressed in the dorsal horn (Dubois et al., 1986; Fleetwood-
Walker, Hope and Mitchell, 1988; Zhu et al., 2007, 2008). 
Whereas D1-like receptors signal through Gαq to stimulate phospholipase C and Gαs to 
stimulate adenylyl cyclase, D2-like receptors signal through Gαi to inhibit adenylyl cyclase 
(Abdel-Majid et al., 1998; Pieper, Clerkin and MacFarlane, 2011). Adenylyl cyclase is a 12-
transmembrane-spanning protein that catalyses the synthesis of the second messenger cyclic 
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adenosine monophosphate (cAMP) and pyrophosphate from adenosine triphosphate (ATP). 
cAMP activates various proteins including exchange protein activated by cyclic AMP (EPAC) 
and protein kinase A (PKA). This latter regulates a number of proteins including sodium-
dependent ion transporters, various ion channels, cAMP responsive element binding protein 
1 (CREB1) and dopamine and cyclic AMP-regulated phosphoprotein of 32 kDa (DARPP-32) 
(Abdel-Majid et al., 1998; Undieh, 2010). 
Studies in which agonists and antagonists of dopamine receptors are applied to in vitro spinal 
cord preparations have demonstrated diverse actions of dopamine within mammalian spinal 
locomotor networks. Bath applied dopamine or a D1-like receptor agonist is able to stimulate 
locomotor-related activity in neonatal rat preparations (Kiehn and Kjaerulff, 1996; Barrière, 
Mellen and Cazalets, 2004) but not in neonatal mouse preparations (Jiang, Carlin and 
Brownstone, 1999; Whelan, Bonnot and Donovan, 2000; Sharples et al., 2015); however, 
dopamine can elicit low-frequency, uncoordinated bursting in ventral root pairs in neonatal 
mouse preparations (Sharples et al., 2015), and the selective D1-like receptor agonist SKF 
81927 is able to stimulate locomotor activity in intact adult mice subject to spinal cord 
transection at lower thoracic levels (segments T9/T10) (Lapointe et al., 2009). Dopamine may 
also be required in addition to 5-HT and NMDA to elicit locomotor-related activity in isolated 
spinal cords from older (> 1 wk) mice (Jiang, Carlin and Brownstone, 1999). 
When bath-applied during locomotor-related activity induced by NMDA and 5-HT, dopamine 
stabilises rhythmic bursting, reducing the frequency and increasing the amplitude of bursts in 
both mouse and rat spinal cord preparations (Jiang, Carlin and Brownstone, 1999; Whelan, 
Bonnot and Donovan, 2000; Barrière, Mellen and Cazalets, 2004; Madriaga et al., 2004; 
Humphreys and Whelan, 2012; Sharples et al., 2015). Dopamine also increases the amplitude 
of flexor activity during ongoing locomotion in the cat (Barbeau and Rossignol, 1991). These 
effects are mediated by both D1-like and D2-like receptors, and selective agonists and 
antagonists have been used to characterise the contributions of both subfamilies (Madriaga 
et al., 2004; Humphreys and Whelan, 2012; Sharples et al., 2015). Although D1-like receptors 
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typically have excitatory effects, they are reported not to increase the frequency of ongoing 
locomotor-related activity in mice (Humphreys and Whelan, 2012; Sharples et al., 2015), but 
may instead enhance the stability of rhythmic bursting (Sharples et al., 2015). By contrast, D2-
like receptors are reported to mediate the reduction in burst frequency produced by bath-
applied dopamine (Humphreys and Whelan, 2012; Sharples et al., 2015). The selective 
agonist quinpirole has been reported both to increase (Sharples et al., 2015) and decrease 
(Humphreys and Whelan, 2012) the stability of bursting. 
The effects of dopamine on network activity likely reflect multiple effects on diverse cell types 
mediated by both D1-like and D2-like receptors; accordingly, dopamine has been shown to 
modulate both synaptic strength and intrinsic properties of motoneurons and interneurons in 
mice. Dopamine depolarises motoneurons and interneurons projecting into the ventrolateral 
funiculus (Han et al., 2007). When applied to spinal motoneurons, dopamine also decreases 
both first-spike latency by modulation of 4-AP-sensitive, low-threshold, fast inactivating K+ 
currents (IA) and the medium-duration afterhyperpolarisation (mAHP) by modulation of 
apamin-sensitive small-conductance Ca2+-activated K+ channel (SKCa) currents. Together 
these mechanisms increase the frequency-current slope, thereby enhancing motoneuronal 
excitability. Dopamine also enhances synaptic inputs onto motoneurons by modulation of α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor currents (Han et al., 
2007). Activation of D1-like but not D2-like receptors increases the open probability and open 
duration of AMPA receptor channels in a PKA-dependent manner, but does not alter insertion 
of receptors (Han and Whelan, 2009). By contrast, D2-like but not D1-like receptors are 
proposed to mediate inhibition of an excitatory recurrent collateral pathway onto the CPG 
(Humphreys and Whelan, 2012). In addition, dopamine modulates excitatory Hb9+ 
interneurons to facilitate rhythmic oscillations in membrane potential, a characteristic that may 
be important in network rhythmogenesis (Han et al., 2007). Information about the effects of 
dopamine on other populations of ventral horn interneurons is currently lacking. Dopamine 
modulates synaptic inputs to motoneurons from sensory afferents (Carp and Anderson, 1982; 
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Clemens, 2004; Barrière et al., 2008) and may modulate synaptic transmission between 
motoneurons and Renshaw cells (Maitra et al., 1993; Seth et al., 1993). 
Thus, dopamine has multiple targets within the spinal cord and acts via diverse mechanisms, 
in some cases inhibiting and in others enhancing neuronal activity. It is likely that the full range 
of modulatory mechanisms mediated by dopamine receptors remains to be elucidated. 
Furthermore, modulation by dopamine may itself be regulated by other modulators. For 
instance, D1-like dopamine receptors are proposed to interact with A1 adenosine receptors in 
mouse locomotor networks (see below) (Acevedo et al., 2016). These considerations must be 
taken into account when the effects of dopamine or selective dopamine-receptor agonists and 
antagonists are evaluated at the network or behavioural level (Sharples et al., 2014).  
Adenosinergic modulation 
The purines ATP and its derivative adenosine are involved in a myriad of biological processes, 
most notably energy transfer. In the nervous system they also function as neuromodulators, 
and are involved in diverse processes in health and disease, including sleep homeostasis, 
memory, and the regulation of mood (Cunha, 2001; Fredholm et al., 2005; Burnstock, 2007). 
There are four adenosine receptor subtypes, designated A1, A2A, A2B and A3, which differ in 
affinity for adenosine, structure, cellular distribution, and G-protein coupling. A1 and A2A 
receptors have the highest affinity for adenosine and are the best characterised (Cunha, 2001). 
Both A1 and A2A receptors are expressed throughout the spinal cord (Reppert et al., 1991; 
Deuchars, Brooke and Deuchars, 2001; Paterniti et al., 2011). A1 receptors are tightly coupled 
to the Gαi pathway, which mediates inhibition of adenylyl cyclase and reduced production of 
cAMP. However, A1 receptors are also coupled to other G proteins and act via adenylyl 
cyclase-independent pathways to inhibit spontaneous and evoked neurotransmitter release. 
Presynaptic inhibition may entail the adenylyl cyclase-independent inhibition of N-type Ca2+ 
channels (Ribeiro, 1995; Cunha, 2001). A2A receptors are primarily coupled to Gαs, but also to 
Gαi and Gα12, and have diverse effects mediated by PKA, PKC, N-type and P-type calcium 
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channels (Cunha, 2001). In many systems the inhibitory actions of A1 receptors are countered 
by the facilitatory actions of A2A receptors in a concentration-dependent manner (Cunha, 2001).  
Extracellular adenosine is largely formed from ATP released from neurons or glia, although 
cells also release adenosine itself (Cunha, 2001; Klyuch, Dale and Wall, 2012; Wall and Dale, 
2013). An array of ectonucleotidases catalyses ATP to adenosine in the extracellular space, 
and the dynamic regulation of the availability of ATP and adenosine by this mechanism is an 
important property of purinergic modulation in many systems (Wall and Dale, 2008).  
Homeostatic, activity-dependent production of adenosine has been detected in several 
systems, including the mammalian brain and brainstem, and in the spinal cord of Xenopus 
tadpoles, and is proposed as a mechanism to avert fatigue and excitotoxicity (Wall and Dale, 
2008). In some cases, this is coupled to the degradation of ATP. Adenosine derived from ATP 
consumed by neurons as a source of energy during activity is proposed to be released directly 
via neuronal equilibrative nucleoside transporters. Autocrine inhibition of activity via A1 
receptors is proposed as a homeostatic mechanism to prevent metabolic exhaustion (Cunha, 
2001; Fredholm et al., 2005). However, this mechanism does not appear to operate in some 
systems, including murine locomotor networks, in which the source of adenosine is ATP 
released into the extracellular space from either neurons or glia (Wall and Dale, 2008; Witts, 
Panetta and Miles, 2012; Carlsen and Perrier, 2014). For instance, ATP released during 
network activity in the spinal cord of Xenopus tadpoles is excitatory and sustains locomotor 
activity; the excitatory effect of ATP is counterbalanced by the inhibitory effect of adenosine, 
which accumulates following ATP release (Dale and Gilday, 1996). In several preparations, 
production of modulatory adenosine follows release of ATP from astrocytes (Panatier et al. 
2011; Pascual et al. 2005; Serrano et al. 2006; Carlsen and Perrier 2014). 
The role of adenosine signalling in the modulation of mammalian locomotor behaviour has 
been addressed by injection of intact animals with receptor antagonists, which typically have 
an excitatory effect. This effect has been proposed to be mediated by either A1 (Snyder et al., 
1981; Goldberg, Prada and Katz, 1985), A2A (Svenningsson, Nomikos and Fredholm, 1995; 
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Ledent et al., 1997; Svenningsson et al., 1997; El Yacoubi et al., 2000; Lindskog et al., 2002) 
or both A1 and A2A receptors (Karcz-Kubicha et al., 2003; Antoniou et al., 2005; Kuzmin et al., 
2006), indicating a role for both receptor subtypes. However, interpretation of studies in which 
antagonists are chronically applied is complicated by the reported acquisition of receptor 
tolerance, to which A1 receptors are particularly susceptible (Karcz-Kubicha et al., 2003). It is 
also difficult to draw conclusions about the locus or loci of adenosinergic modulation – it is 
likely that adenosine regulates locomotion in multiple regions of the nervous system involved 
in motor control, including the basal ganglia (Popoli et al., 1996) and ventral spinal cord (Witts, 
Panetta and Miles, 2012; Acevedo et al., 2016). It is conceivable that the effects of adenosine 
blockade in one network mask its effects in another. 
Experiments in which spinal cord preparations were exposed to adenosine receptor agonists 
and antagonists have addressed the role of adenosine specifically within spinal locomotor 
networks. During locomotor-related activity induced by bath application of DA, NMDA and 5-
HT in neonatal mouse preparations, blockade of A1 receptors results in increased burst 
frequency (Witts, Panetta and Miles, 2012; Acevedo et al., 2016), with no effect on amplitude, 
whereas blockade of A2A receptors has no effect (Witts, Panetta and Miles, 2012; Acevedo 
et al., 2016). Conversely, bath application of adenosine results in reduced burst frequency in 
a dose-dependent manner, again with no effect on amplitude (Witts, Panetta and Miles, 2012; 
Acevedo et al., 2016). The frequency effects are associated with changes in burst and cycle 
duration, implying no change in duty cycle (Acevedo et al., 2016). Bath application of ATP has 
a similar effect to adenosine in reducing burst frequency (Witts, Panetta and Miles, 2012); 
however, both blockade of adenosine receptors and application of ATP have no effect in the 
presence of an ectonucleotidases inhibitor, indicating that endogenous adenosine is derived 
from ATP released into the extracellular space, that ATP itself does not modulate locomotor-
related activity, and that both endogenous and exogenous ATP are efficiently degraded to 
adenosine within the spinal cord (Witts, Panetta and Miles, 2012). This ATP appears to derive 
from glia since adenosine receptor blockade has no effect on locomotor-related activity 
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following pharmacological ablation of glia by treatment with gliotoxins (see below) (Witts, 
Panetta and Miles, 2012). 
Modulation of the frequency but not the amplitude of locomotor-related activity by adenosine 
suggests that it acts on the premotor circuitry rather than on motoneurons (Miles and Sillar, 
2011). Consistent with this hypothesis, adenosine does not modulate disinhibited activity 
mediated by motoneurons and excitatory components of the locomotor circuitry alone (Witts, 
Panetta and Miles, 2012), implying that adenosine exerts its depressive effects via inhibitory 
interneurons, such as the V1 population (Gosgnach et al., 2006). 
It has been proposed that A1-adenosine receptors interact with D1-like DA receptors in the 
spinal locomotor circuitry (Acevedo et al., 2016), as is observed in the basal ganglia (Popoli 
et al., 1996). DA stabilises locomotor-related activity in isolated spinal cord preparations (Jiang, 
Carlin and Brownstone, 1999; Whelan, Bonnot and Donovan, 2000; Barrière, Mellen and 
Cazalets, 2004; Madriaga et al., 2004; Humphreys and Whelan, 2012; Sharples et al., 2015), 
but is presumed to be absent unless exogenously applied, as descending inputs that release 
DA onto the spinal cord are severed in in vitro preparations (Gerin, Becquet and Privat, 1995; 
Gerin and Privat, 1998). When dopamine is absent or when D1-like receptors are selectively 
blocked, A1 blockade no longer alters the frequency of locomotor-related bursting (Acevedo 
et al., 2016). A1 blockade is similarly ineffective when the Gαs signalling pathway through which 
D1-like receptor signal is inhibited at the level of PKA. However, when forskolin is applied to 
activate adenylyl cyclase in a receptor-independent manner, the effect of A1 blockade on the 
frequency of locomotor-related bursting is restored. Together, these data indicate that 
adenosine acting through A1 receptors may function as a metamodulator to regulate the 
activity of locomotor networks by inhibition of D1-like receptor signalling. This may occur 
through direct inhibition of adenylyl cyclase mediated by the Gαi pathway to which A1 receptors 
are coupled.  
The effects of bath-applied adenosine on neurons in acute slices from postnatal mice have 
also been assessed. In the absence of dopamine, adenosine induces a hyperpolarising 
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current in ventral horn interneurons, likely by facilitating leak K+ currents, and acts at A1 
receptors to reduce both inhibitory and excitatory spontaneous postsynaptic currents (IPSCs; 
EPSCs) by both pre- and post-synaptic mechanisms (Witts, Nascimento and Miles, 2015). In 
addition, adenosine reduces the amplitude of evoked EPSCs onto interneurons by a 
presynaptic mechanism (Carlsen and Perrier, 2014). ATP has a similar effect, but only after a 
delay, consistent with its hydrolysis to adenosine by ectonucleotidases (Carlsen and Perrier, 
2014). In motoneurons, by contrast, adenosine induces a depolarising current and reduces 
spontaneous postsynaptic currents by a presynaptic mechanism (Witts, Nascimento and Miles, 
2015). Thus, adenosine has disparate effects on different populations of neurons in the ventral 
horn. A1-receptor blockade alone has no effect on spontaneous postsynaptic currents, either 
because there is insufficient adenosine present in acute slices for the tonic activation of these 
receptors, or because adenosine at the concentrations at which it exists in the spinal cord 
requires concurrent activation of D1-like receptors to exert modulatory effects(Acevedo et al., 
2016). 
Stimulation of Ca2+ signalling in glia by selective activation of protease-activated receptor-1 
(PAR1), an endogenous GPCR preferentially expressed by astrocytes, also reduces the 
amplitude of evoked EPSCs by a presynaptic mechanism in a manner depending on 
extracellular ectonucleotidase activity and A1 receptor activation (Carlsen and Perrier, 2014). 
Conversely, chelation of Ca2+ in astrocytes enhances evoked EPSCs; however, it has not been 
shown directly that this effect is mediated by A1 receptors. These data indicate that ventral 
horn astrocytes in slice preparations release ATP in a Ca2+-dependent manner, and that glial 
cell-derived ATP is degraded to adenosine, which acts at A1 receptors to inhibit excitatory 
transmission by a DA-independent presynaptic mechanism. These results may be consistent 
with inhibition of network activity by adenosine derived from glia in the presence of DA, but it 
will be important to determine whether adenosine modulates evoked EPSCs by the same 
mechanism in the presence and absence of DA. 
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In spinal cord preparations from postnatal rats, adenosine does not modulate the frequency 
of locomotor-related bursting evoked by 5-HT and NMDA in the absence of dopamine, and A1 
blockade has no effect on drug-induced or electrically stimulated locomotor-related activity 
(Taccola et al., 2012). These data may indicate that adenosinergic modulation of the frequency 
of locomotor-related activity requires DA in rats, as in mice; however, the effects of adenosine 
on locomotor-related activity in the presence of DA in rats are not known, preventing direct 
comparison with results from mouse preparations. Furthermore, adenosine is reported to have 
effects in isolated rat spinal cords in the absence of DA that have not been reported in mouse 
preparations. In rats, adenosine enhances burst amplitude during locomotor-related activity 
and depresses the frequency of disinhibited bursting in an A1-dependent manner (Taccola et 
al., 2012), effects not observed in mouse preparations (Witts, Panetta and Miles, 2012; 
Acevedo et al., 2016). In addition, the duration of bouts of locomotor-related activity induced 
by dorsal-root stimulation is reduced by bath-applied adenosine (Taccola et al., 2012), and 
reflex potentials produced by dorsal root stimulation are depressed by adenosine released 
under hypoxic conditions (Otsuguro, Wada and Ito, 2011). Both of these mechanisms are 
mediated by A1 receptors. Although A1 blockade prevents the depression of disinhibited and 
electrically evoked bursting by bath-applied adenosine, it has no effect alone. It is possible 
that high concentrations of adenosine, such as those used in bath applications or produced 
during hypoxia, are able to modulate neural activity independently of DA, as in acute slices 
from mice, whereas low levels of endogenous adenosine require DA to be present. 
Xenopus tadpoles provide an example of purinergic signalling during motor behaviour in a 
non-mammalian vertebrate. ATP released within the spinal cord during episodes of swimming 
serves to excite the locomotor CPG and extend the duration of swimming bouts (Dale and 
Gilday, 1996; Dale, 1998). As swimming progresses, ATP is hydrolysed to adenosine, which 
activates A1 receptors to drive down network activity (Brown and Dale, 2000). This mechanism 
may exist to prevent metabolic exhaustion and excitotoxicity (Wall and Dale, 2008). 
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It may be instructive to compare the effects of adenosine on spinal locomotor networks with 
its effects on rhythmically active respiratory networks in the mammalian brainstem. As in the 
spinal cord of Xenopus tadpoles, adenosinergic inhibition of respiratory networks is reported 
to follow ATP-mediated excitation in in vitro preparations from neonatal mice (Funk et al., 1997) 
and rats (Miles et al., 2002; Lorier et al., 2007), and in anaesthetised adult rats (Funk et al., 
1997). By contrast, ATP does not modulate ongoing locomotor network activity in mice (Witts, 
Panetta and Miles, 2012). It may, however, be relevant that the rat respiratory CPG is reported 
to be less sensitive to adenosinergic modulation than mouse networks because of differences 
in ectonucleotidase expression (Zwicker et al., 2011). Adenosine also exerts a tonic 
depression of network activity in cats (Schmidt, Bellingham and Richter, 1995), rats (Kawai et 
al., 1995; Huxtable et al., 2009) and mice (Mironov, Langohr and Richter, 1999); this declines 
during development in rats (Huxtable et al., 2009).  
Modulation of NMDARs via the co-agonist binding site 
Unlike non-NMDARs, canonical GluN1/GluN2 subunit-containing NMDARs require the 
binding of a co-agonist in addition to the binding of glutamate for their activation (Johnson and 
Ascher, 1987; Kleckner and Dingledine, 1988; Clements and Westbrook, 1991; Paoletti, 
Bellone and Zhou, 2013). In the brain, the endogenous co-agonist may be either glycine or D-
serine, with one or the other dominating at a given synapse, such that its selective depletion 
results in a reduction in NMDAR current (Mothet et al., 2000; Kalbaugh, Zhang and Diamond, 
2009; Li et al., 2009, 2013, Henneberger et al., 2010, 2013; Papouin et al., 2012; Le Bail et 
al., 2015; Meunier et al., 2016). The identity of the dominant co-agonist is proposed to vary 
during development (Le Bail et al., 2015), with receptor subunit composition (Kalbaugh, Zhang 
and Diamond, 2009; Papouin et al., 2012; Le Bail et al., 2015), between synaptic and 
extrasynaptic receptor populations (Papouin et al., 2012), and in an activity-dependent 
manner (Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013). In the spinal cord, co-
agonist identity has hitherto received little attention. 
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Occupancy of the co-agonist binding site is proposed to be regulated in an activity-dependent 
manner, in this way modulating NMDAR activity (Kalbaugh, Zhang and Diamond, 2009; Li et 
al., 2009, 2013). An unsaturated co-agonist binding site could permit the regulation of 
glutamatergic signalling by adjustments to the availability of the co-agonist (Berger, 
Dieudonné and Ascher, 1998; Li et al., 2009, 2013). The co-agonist binding site is reported to 
be unsaturated in some preparations (Berger, Dieudonné and Ascher, 1998; Kalbaugh, Zhang 
and Diamond, 2009; Li et al., 2009, 2013; Le Bail et al., 2015), but saturated in others (Kemp 
et al., 1988; Li et al., 2009; Shigetomi et al., 2013), and activity-dependent changes in 
occupancy of the co-agonist binding site have been reported in the brain (Kalbaugh, Zhang 
and Diamond, 2009; Li et al., 2009, 2013). 
The co-agonist binding site is unsaturated in in vitro forelimb locomotor circuit preparations of 
pre- and postnatal rats (Shimomura et al., 2015), in motoneurons in a hemisected spinal cord 
preparation from postnatal rats (Brugger et al., 1990), and in the locomotor network of 
Xenopus tadpoles during swimming; in this latter preparation episodes of swimming are 
prolonged by exogenous application of either of the two NMDAR co-agonists D-serine or 
glycine (Issberner and Sillar, 2007). Thus, either increases or decreases in co-agonist 
availability could modulate excitatory transmission within the spinal cord locomotor circuitry to 
modulate behaviour. 
The availability of both D-serine and glycine at excitatory synapses is determined by metabolic 
processes in both neurons and astrocytes, and entails functional coupling between these two 
cell types (Le Bail et al., 2015). Evidence that co-agonist availability may be regulated in an 
activity-dependent manner (Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013, 
Henneberger et al., 2010, 2013) implies information processing by astrocytes. 
Glycine 
Glycine is released at inhibitory synapses by vesicular exocytosis and may spill over into 
excitatory synapses to bind to NMDARs (Ahmadi et al., 2003; Bowery and Smart, 2006). 
Alternatively, it may be released at excitatory synapses from neurons by Asc-1 (Rosenberg et 
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al., 2013), or from astrocytes by reverse operation of glycine transporter-1 (GlyT1) triggered 
by increase in intracellular Na+, for instance following activation of astrocytic AMPA receptors 
(Attwell, Barbour and Szatkowski, 1993; Roux and Supplisson, 2000; Marcaggi and Attwell, 
2004; Li et al., 2009; Shibasaki et al., 2016). 
Levels of extracellular glycine are regulated by forward operation of GlyT1 and glycine 
transporter-2 (GlyT2), both of which are highly expressed in the spinal cord and brainstem, 
where glycinergic transmission is prevalent (Eulenburg et al., 2005). GlyT2 is exclusively 
expressed on the terminals of glycinergic interneurons (Zafra, Aragón, et al., 1995; Jursky and 
Nelson, 1996), where it removes glycine from inhibitory and possibly also excitatory synapses 
(Danglot et al., 2004). By contrast, GlyT1 regulates glycine concentrations at glutamatergic 
synapses and is strongly expressed by astrocytes in the grey matter of the spinal cord and 
brainstem (Zafra, Gomeza, et al., 1995; Cubelos, Giménez and Zafra, 2005), although 
neuronal expression at lower levels has also been reported (Cubelos, Giménez and Zafra, 
2005).  
GlyT1 is a potent regulator of extracellular glycine capable of maintaining local concentration 
considerably below its concentration in the cerebrospinal fluid or a perfusate (Supplisson and 
Bergman, 1997; Berger, Dieudonné and Ascher, 1998; Bergeron et al., 1998). Previously, 
glycine was found to be ineffective at potentiating NMDAR currents in brainstem preparations 
when bath applied at concentrations under 100 µM, orders of magnitude above its EC50, 
consistent with very tight regulation of glycine in the extracellular space by GlyT1 (Berger, 
Dieudonné and Ascher, 1998).  
In the spinal cord, spillover of synaptically released glycine is reported to facilitate NMDAR 
currents in the dorsal horn of postnatal rats (Ahmadi et al., 2003). In pre- and postnatal rat 
forelimb locomotor circuits, activity is facilitated by blockade of GlyT1 (Shimomura et al., 2015), 
suggesting a role for glycine transport in the regulation of excitatory transmission. Similarly, 
blockade of GlyT1 enhances NMDAR-dependent swimming in Xenopus tadpoles (Issberner 
and Sillar, 2007). However, it is unknown whether GlyT1 regulates glycine concentrations at 
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excitatory synapses in the spinal cord to determine rhythmic locomotor-related activity in 
mammals. 
D-serine 
The D-serine synthesis pathway is distributed between both neurons and astrocytes 
(Wolosker, 2011; Ehmsen et al., 2013). Synthesis of D-serine from L-serine by serine 
racemase occurs in both neurons and astrocytes (Wolosker, 2011). However, the first reaction 
in the biosynthesis of L-serine is catalysed by 3-phosphoglycerate dehydrogenase, which is 
exclusive to astrocytes (Ehmsen et al., 2013). D-serine is degraded by D-amino acid oxidase, 
which may be expressed by both neurons and glia, but is enriched in spinal cord astrocytes 
(Verrall et al., 2007; Sasabe et al., 2014). The availability of D-serine is therefore largely 
determined by the opposing actions of serine racemase, the enzyme that synthesises D-serine 
from L-serine, and D-amino acid oxidase (DAAO), the enzyme that degrades D-serine in vivo 
(Wolosker, Blackshaw and Snyder, 1999; Sasabe et al., 2014); however, see (Crow, Marecki 
and Thompson, 2012) for a review of the complexities of D-serine metabolism. 
D-serine may be released from astrocytes via ASCT2 (Verrall et al., 2010) or by Ca2+-
dependent exocytosis (Yang et al., 2003; Mothet et al., 2005; Henneberger et al., 2010). It is 
secreted from neurons via alanine–serine–cysteine transporter-1 (Asc-1) (Rosenberg et al., 
2013) or ASCT2 (Verrall et al., 2010). Release from neurons may occur upon depolarisation 
by a Ca2+-independent mechanism (Rosenberg et al., 2010).  
Concentrations of D-serine in the mammalian spinal cord are considerably lower than those 
of glycine, and considerably lower than those detected in the brain (Schell et al., 1997; Sasabe 
et al., 2007; Miyoshi et al., 2012; Thompson et al., 2012). Accordingly, glycine was proposed 
as the exclusive co-agonist of NMDARs in the spinal cord (Schell et al., 1997). However, 
selective degradation of D-serine reduces pain symptoms in rats subjected to nerve ligation 
(Lefèvre et al., 2015; Moon et al., 2015), and levels of both D-serine and serine racemase are 
higher in the spinal cord following surgery (Lefèvre et al., 2015; Moon et al., 2015).  
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Aberrant D-serine metabolism in the spinal cord is implicated in the pathogenesis of 
amyotrophic lateral sclerosis (ALS) (Sasabe et al., 2007; Mitchell et al., 2010; Paul and de 
Belleroche, 2014). Amyotrophic lateral sclerosis (ALS) is the most common adult 
neuromuscular disease, with a lifetime risk of 1 in 500. It is characterised by loss of 
motoneurons in the spinal cord, brainstem and cerebral cortex, with substantial dysfunction in 
associated glia (Bruijn, Miller and Cleveland, 2004; Robberecht and Philips, 2013). These 
cellular effects are associated with progressive muscle weakness, paralysis and muscle 
atrophy. Disease progression is rapid and death, usually from respiratory failure, typically 
occurs within 30 months of symptom onset (Gordon, 2013).  
Levels of D-serine were found to be elevated in the spinal cords of both a small sample of ALS 
patients and in the G93A SOD1 mouse model of ALS (Sasabe et al., 2007, 2012). Consistent 
with these reports, a mutation (R199W) in DAAO that abolishes enzyme function has been 
identified in a small subset of familial ALS (FALS) cases (Mitchell et al., 2010) and DAO is 
downregulated in the mouse model (Sasabe et al., 2012). In addition, the number of cells, 
predominantly glia, expressing serine racemase is increased in the SOD1 mouse model, 
possibly as a result of cell stress (Sasabe et al., 2007; Paul and de Belleroche, 2012). By 
contrast, serine racemase knockout in the G93A SOD1 mouse model accelerates disease 
onset, but slows disease progression (Thompson et al., 2012). 
Elevated D-serine in mouse models of ALS is proposed to mediate excitotoxicity in 
motoneurons in an NMDAR-dependent manner, implying the co-agonist binding site is 
unsaturated in healthy animals, although the requirement of NMDARs for D-serine toxicity has 
been tested only in primary cultures (Sasabe et al., 2007, 2012; Paul et al., 2014). Thus, 
further study of the regulation of NMDARs via the co-agonist binding site will provide important 
information required to understand the pathogenesis of ALS. 
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Information processing by astrocytes 
Glia are a class of cell within the central and peripheral nervous systems represented by 
macroglia, which include astrocytes, oligodendrocytes and Schwann cells, and microglia. 
Astrocytes, like the other cell-types, are traditionally considered to have a merely passive, 
supportive function within neural networks, with well-established roles in, inter alia, ion 
homeostasis and the synthesis and clearance of neurotransmitters (Verkhratsky and Butt, 
2013). However, substantial evidence now indicates that astrocytes dynamically regulate 
neuronal excitability and synaptic strength by the release of so-called gliotransmitters, in this 
way acting as the third partner in a tripartite synapse with pre- and postsynaptic neuronal 
elements (Araque et al., 1999, 2014; Haydon and Nedergaard, 2015; Bazargani and Attwell, 
2016). In its original formulation, the tripartite-synapse model entails the binding of a 
neurotransmitter released during synaptic activity to an astrocytic Gαq-linked GPCR; the 
production of inositol trisphosphate (IP3) and the release of Ca2+ from stores within the 
astrocyte mediated by IP3 receptors; Ca2+-dependent release of a gliotransmitter such as 
glutamate (Parpura et al., 1994; Pasti et al., 1997; Bezzi et al., 1998), ATP (Newman, 2001; 
Pryazhnikov and Khiroug, 2008) or D-serine (Mothet et al., 2005) by vesicular exocytosis or 
via ion channels; and finally the activation of metabotropic or ionotropic receptors on either 
the pre- or postsynaptic element of the same or a different synapse (Araque et al., 1999; 
Hamilton and Attwell, 2010). Although signalling in this manner has been denoted 
“gliotransmission”, this is arguably a misnomer: modulation of neuronal activity by substances 
derived from glia occurs on a variable timescale, but owing to its dependency on metabotropic 
receptors, is necessarily slower than acute transmission mediated by ionotropic receptors 
(Agulhon et al., 2012; Araque et al., 2014). “Gliomodulation” has therefore been proposed as 
a more appropriate term to distinguish bidirectional signalling between neurons and glia 
(Agulhon et al., 2012), but is not widely used. 
The steps in the pathway described above have been deduced largely from Ca2+ imaging of 
astrocytes and electrophysiological recordings from neurons, and are supported by numerous 
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studies (Haydon and Nedergaard, 2015). However, the extent to which gliotransmission is 
important for the operation of neural networks and in the production of behaviour in healthy 
animals remains controversial (Hamilton and Attwell, 2010; Agulhon et al., 2012; Nedergaard 
and Verkhratsky, 2012; Sloan et al., 2014; Bazargani and Attwell, 2016). The coding of 
information by astrocytes in the form of Ca2+ fluctuations, which vary in kinetics and subcellular 
localisation, is poorly understood, and the physiological relevance of experimental 
manipulations used to investigate Ca2+ signalling is disputed (Nedergaard and Verkhratsky, 
2012; Rusakov, 2015). Furthermore, several experiments indicate mechanisms of signalling 
between astrocytes and neurons that depart from the model as originally described. 
Importantly, clear evidence is lacking that gliotransmission is important in the generation of 
behaviours is lacking. 
Ca2+ signalling in astrocytes has been extensively studied by imaging cells expressing a 
genetically encoded Ca2+ indicator or loaded with Ca2+-sensitive dyes by means of a patch 
pipette. Astrocytes display intracellular Ca2+ elevations in response to neuronal activity in both 
neonatal and adult rodents in vitro and in vivo (Araque et al., 2014; Bazargani and Attwell, 
2016; Shigetomi, Patel and Khakh, 2016). Ca2+ signalling is observed in response to sensory 
stimulation in the brain and dorsal horn of the spinal cord (Cirillo et al., 2012; Sekiguchi et al., 
2016), and during locomotion in the cortex (Dombeck et al., 2007). Although desirable, Ca2+ 
imaging has not yet been performed in the ventral horn during locomotion in vivo, and is likely 
to be challenging because of the difficulty of accessing ventral horn tissue. However, 
preliminary studies have reported rhythmic Ca2+ fluctuations in putative astrocytes during 
pharmacologically induced locomotor-related activity in in vitro hemicord preparations (Chub, 
Liu and O’Donovan, 2012). Furthermore, Ca2+ fluctuations were selectively blocked during 
inhibition of metabotropic glutamate receptor 1 (mGluR1) during ventral root stimulation in 
disinhibited preparations, implying a role for that receptor in neuron-glia signalling in the spinal 
cord, as reported in the brain (Chub and O’Donovan, 2011). 
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Information about the dynamics of Ca2+ signalling in astrocytes has been provided for the most 
part by studies in the cortex, hippocampus and cerebellum. Astrocytes are acutely sensitive 
to neuronal activity, and respond to basal synaptic activity stimulated by a single action 
potential (Panatier et al., 2011). Ca2+ elevations in astrocytes vary in rise and decay times, 
amplitude, frequency and spatial diffusion (Shigetomi et al., 2008; Rusakov, 2015; Shigetomi, 
Patel and Khakh, 2016). These properties are related to patterns of synaptic activity, 
consistent with astrocytic information processing; however, spontaneous Ca2+ fluctuations 
also occur (Parri, Gould and Crunelli, 2001; Di Castro et al., 2011; Panatier et al., 2011; 
Srinivasan et al., 2015). Although they appear to have a stellate morphology under some 
imaging conditions, such as when stained with antibodies against the intermediate filament 
protein GFAP, astrocytes are in fact spongiform, with intricate folds of membrane, sometimes 
referred to as fine processes, surrounding a soma and larger processes (Rusakov, 2015). The 
conditions for Ca2+ fluxes within and between these astrocytic compartments are yet to be 
elucidated (Rusakov, 2015). In the soma, Ca2+ elevations are in most cases IP3-receptor 
dependent, although Ca2+ release mediated by ryanodine receptors has also been reported 
(Hua et al., 2004; Pankratov and Lalo, 2015; Bazargani and Attwell, 2016). By contrast, Ca2+ 
elevations observable under two-photon excitation microscopy in the fine processes persist in 
mice lacking the type 2 IP3 receptor (IP3R2), which is preferentially expressed by astrocytes 
(Srinivasan et al., 2015; Rungta et al., 2016), and are instead dependent on Ca2+ influx from 
the extracellular medium, mediated by channels that are yet to be identified. These may 
include NMDA and AMPA receptors (Lalo et al., 2006) and transient receptor potential cation 
channel, subfamily A, member 1 (TRPA1), which has been implicated in setting basal Ca2+ 
levels in astrocytes (Shigetomi et al., 2008, 2012), although it does not mediate spontaneous 
Ca2+ elevations in the adult hippocampus (Rungta et al., 2016). Like those in the soma, Ca2+ 
elevations in the fine processes are also enhanced by sensory stimulation and by activation 
of Gαq-linked GPCRs, although these act by an IP3R2-independent pathway (Srinivasan et al., 
2015). Future investigations of Ca2+ signalling in the spinal cord would ideally consider the 
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relationship between astrocytic Ca2+ dynamics and activity in adjacent neurons, as well as 
differences in Ca2+ signalling between astrocytic compartments. 
The role of Ca2+ signalling in astrocytic information processing and release of gliotransmitters 
is supported by experiments in which astrocytic Ca2+ elevations are either induced or blocked, 
or astrocytic function is otherwise impaired. Release of gliotransmitters in these experiments 
is typically inferred from changes in neuronal activity (Haydon and Nedergaard, 2015), 
although in some studies changes in the composition of the extracellular medium are directly 
measured, or behaviour is assessed.  
A range of techniques exists for the experimental induction of astrocytic Ca2+ elevations, 
including ultraviolet (UV) photolysis of caged Ca2+ or IP3 introduced via a patch pipette (Hua 
et al., 2004; Wang et al., 2013; Martin et al., 2015), depolarisation of the astrocyte under 
whole-cell patch-clamp conditions (Kang et al., 1998; Jourdain et al., 2007), mechanical 
stimulation (Hua et al., 2004; Lee et al., 2015), activation of endogenous or transgenically 
expressed GPCRs (Rae and Irving, 2004; Shigetomi et al., 2008; Agulhon, Fiacco and 
McCarthy, 2010; Agulhon et al., 2013), and activation of transgenically expressed 
channelrhodopsins (Gourine et al., 2010; Li et al., 2012; Beppu et al., 2014). The extent to 
which these techniques replicate endogenous Ca2+ signalling is disputed (Nedergaard and 
Verkhratsky, 2012). For instance, although UV photolysis of caged Ca2+ can raise cytosolic 
Ca2+ within the physiological range (Parpura and Haydon, 2000), it may not replicate the 
kinetics or subcellular localisation of Ca2+ release elicited by neural activity. Interestingly, some 
techniques fail to elicit gliotransmitter release in preparations where other techniques are 
effective (Shigetomi et al., 2008; Wang et al., 2013). Activation of either PAR1 or the purinergic 
receptor P2Y1, both endogenous astrocytic Gαq-linked GPCRs, elicits Ca2+ elevations of similar 
amplitude in the somas of astrocytes in the CA1 region of the hippocampus, but only PAR1 
activation stimulates gliotransmitter release. The cause of this discrepancy is unknown, but 
could, for instance, be related to differences in the subcellular localisation of the receptors in 
relation to Ca2+ stores and sites of gliotransmitter release (Bazargani and Attwell, 2016). 
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Caution is therefore necessary when interpreting experiments in which astrocytic Ca2+ 
signalling is experimentally induced, and ideally astrocytes would be stimulated by more than 
one technique. Although stimulation of neuronal activity has been shown to evoke astrocytic 
Ca2+ signalling and concomitant release of gliotransmitters (Navarrete et al., 2012; Martín et 
al., 2015), this is not possible under all experimental conditions. In general, the usefulness of 
the techniques currently available to stimulate astrocytic Ca2+ signalling varies between 
preparations: for instance, dialysis of astrocytes with caged Ca2+ or IP3 via a patch pipette may 
be possible in slices, but not in preparations that do not allow access to astrocytes via a patch 
pipette, such as isolated spinal cord preparations used to study locomotor-related activity in 
vitro.  
In acute spinal cord slices from postnatal mice, experimental activation of Ca2+ signalling in 
ventral horn astrocytes reduces the amplitude of evoked EPSCs in neighbouring interneurons 
by a presynaptic mechanism (Carlsen and Perrier, 2014). This effect is sensitive to inhibitors 
of A1 receptors and ectonucleotidases, suggesting astrocytic release of ATP, hydrolysis of 
ATP to adenosine and activation of presynaptic A1 receptors. The effects of stimulating spinal 
cord astrocytes on IPSCs in neighbouring neurons and on network output during locomotor-
like activity in vitro remain to be determined. The latter may replicate the previously reported 
inhibitory effects of bath applied adenosine; however, it may be expected that astrocytes 
match the multiplicity of genetically and physiologically distinct neuronal cell types in the spinal 
cord (Kiehn and Butt, 2003), and secrete multiple gliotransmitters. 
Astrocytic Ca2+ signalling may be inhibited by various strategies, including loading astrocytes 
with a Ca2+ chelator such as 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid 
(BAPTA) via a patch pipette (Kang et al., 1998; Ge and Duan, 2007; Di Castro et al., 2011; 
Panatier et al., 2011; Morquette et al., 2015), IP3R2 knockout (Petravicz, Fiacco and McCarthy, 
2008; Navarrete et al., 2012; Petravicz, Boyt and McCarthy, 2014; Martin et al., 2015) or 
pharmacological inhibition (Hua et al., 2004; Di Castro et al., 2011; Tang et al., 2015), and 
depletion of intracellular (Carmignoto, Pasti and Pozzan, 1998; Haustein et al., 2014) or 
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extracellular (Lee et al., 2015; Srinivasan et al., 2015) Ca2+. None of the techniques currently 
available is cell-specific, acute and reversible, and it should be noted that disruption of 
astrocytic Ca2+ signalling may influence processes other than gliotransmitter release, such as 
K+ homeostasis via astrocytic Ca2+-dependent K+ channels (Hamilton and Attwell, 2010; 
Nedergaard and Verkhratsky, 2012). Furthermore, those techniques that target IP3 receptors 
may neglect the role of Ca2+ released in IP3 receptor-independent manner (Srinivasan et al., 
2015; Bazargani and Attwell, 2016; Shigetomi, Patel and Khakh, 2016). As with techniques 
for stimulating astrocytes, the usefulness of the techniques available for supressing astrocytic 
Ca2+ signalling varies between preparations.  
In acute spinal cord slices, loading astrocytes with a Ca2+ chelator enhances the amplitude of 
EPSCs in neighbouring neurons (Carlsen and Perrier, 2014). It was proposed that this is 
because Ca2+-dependent release of ATP-adenosine from glia is prevented, but this has not 
been tested directly. The effects of inhibiting Ca2+ signalling in astrocytes during locomotor-
related network activity are also yet to be tested. 
Glial information processing and gliotransmitter release may be disrupted by techniques other 
than those that affect Ca2+ signalling directly. These include inhibition of G-protein signal 
transduction (Di Castro et al., 2011), and disruption of vesicle release mediated by N-
ethylmaleimide–sensitive factor attachment protein receptor (SNARE) proteins, either by 
loading astrocytes with pharmacological agents via a patch pipette (Araque et al., 2000; 
Jourdain et al., 2007; Gourine et al., 2010; Lalo et al., 2014; Sultan et al., 2015) or by 
conditional expression of toxins (Angelova et al., 2015) or a dominant-negative cytosolic 
domain of vesicle-associated membrane protein 2 (VAMP2; aka synaptobrevin 2) (Pascual et 
al., 2005; Fellin et al., 2009; Fujita et al., 2014; Lalo et al., 2014; Sultan et al., 2015). In 
dominant-negative SNARE (dn-SNARE) mice, this protein is expressed under the GFAP 
promotor fragment and interacts with the SNARE complex to prevent exocytosis in astrocytes 
(Pascual et al., 2005) (but see below); channel-mediated release of gliotransmitters is 
presumably unaffected by this manipulation (Hamilton and Attwell, 2010; Oh et al., 2012; Han 
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et al., 2013). Whereas the above manipulations target only one element in putative pathways 
of gliotransmitter release, pharmacological ablation of glia provides a comprehensive 
disruption of astrocytic function (Clarke, 1991; Fonnum, Johnsen and Hassel, 1997; Zhang et 
al., 2003; Huxtable et al., 2010; Witts, Panetta and Miles, 2012; Li et al., 2013; Wall and Dale, 
2013). Substances such as fluoroacetate, fluorocitrate, methionine sulfoximine, L-α-
aminoadipic acid (L-α-AA) selectively disrupt glial metabolism to cause cell death. In 
respiratory and locomotor networks, rhythmic activity is lost following glial ablation (Huxtable 
et al., 2010; Witts, Panetta and Miles, 2012), but can be restored when glutamine is added to 
the preparation, presumably to permit continued synthesis of glutamate and GABA in the 
absence of astrocytes. In spinal locomotor networks, modulation of locomotor-related activity 
by endogenous adenosine is lost following glial ablation by fluoroacetate and methionine 
sulfoximine (Witts, Panetta and Miles, 2012). This is unlikely to be because of receptor 
desensitisation caused by release of purines upon glial cell death (Wall and Dale, 2013), 
because preparations retain sensitivity to adenosine. 
In some studies, gliotransmitter release has been directly demonstrated by the use of high 
performance liquid chromatography (HPLC) (Huxtable et al., 2010); “sniffer cells” expressing 
ligand-gated ATP channels (e.g. P2X2 receptors) (Lalo et al., 2014), which are applied to the 
preparation and recorded from by patch-clamp techniques; the bioluminescent enzyme 
luciferase, which detects ATP (Wang, Haydon and Yeung, 2000); and microelectrode 
biosensors (Wall and Dale, 2013; Lalo et al., 2014), of which several designs exist. These 
techniques vary in their analyte specificity, temporal resolution and the degree to which they 
damage the tissue in which they are applied (Dale, 2013). Direct measurements of 
gliotransmitter release have not been made in spinal cord preparations. Given that ATP-
adenosine is proposed to be released by glia during locomotor-related activity, direct 




Although there is extensive evidence for bidirectional communication between neurons and 
glia in in vitro preparations, there are few clear examples from behavioural studies. Until further 
behavioural evidence for gliotransmission in healthy animals is provided, it will remain 
controversial (Agulhon et al., 2012; Nedergaard and Verkhratsky, 2012; Sloan et al., 2014). 
Importantly, IP3R2 germline knock out (IP3R2KO) mice have been subjected to tests for a 
range of behaviours including locomotion, learning, memory and anxiety, but do not differ from 
wild type littermates on most measures (Agulhon et al., 2013; Petravicz, Boyt and McCarthy, 
2014). Although IP3R2KO are reported to differ from wild type mice in their response to the 
forced swim test, they do not respond to other tests for depressive-like behaviour (Cao et al., 
2013; Petravicz, Boyt and McCarthy, 2014). These findings contradict evidence from many 
studies using slice preparations that support a role for astrocytic IP3 receptors in 
gliotransmission; however, some studies have also not found evidence of gliotransmission in 
slices from IP3R2KO mice (Fiacco et al., 2007; Petravicz, Fiacco and McCarthy, 2008; Agulhon, 
Fiacco and McCarthy, 2010). It may therefore be that IP3 receptor-dependent Ca2+ signalling 
in astrocytic somas, although observable in vitro and in vivo, does not stimulate gliotransmitter 
release in healthy behaving animals. However, it cannot be ruled out that compensatory 
mechanisms during development in IP3R2KO mice mask the effects of deficient astrocytic 
Ca2+ signalling. In addition, it is possible that activity is altered in multiple regions of the CNS 
in IP3R2KO mice, confounding the detection of effects within any given network, though total 
masking of multiple effects may be unlikely. Alternatively, it may be that activity-dependent IP3 
receptor-independent Ca2+ elevations in astrocytic fine processes have a more important in 
role in gliotransmission than currently appreciated. Spontaneous Ca2+ fluctuations in fine 
processes mediated by TRPA1 are proposed to regulate long-term potentiation via constitutive 
D-serine release and inhibitory synapse efficacy via GABA transporter type 3 (GAT-3) 
(Shigetomi et al., 2012, 2013). 
Evidence that behaviours including sleep (Halassa et al., 2009), pain aversion (Foley, McIver 
and Haydon, 2011) and recognition memory (Halassa et al., 2009; Florian et al., 2011) are 
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modulated by substances released from astrocytes in a SNARE- and therefore Ca2+-
dependent manner has been provided by experiments using the dn-SNARE mouse model. 
However, it was recently shown that dn-SNARE is also expressed in cortical neurons (Fujita 
et al., 2014), and it is unclear how this finding affects interpretation of the earlier studies. 
Given the limitations of the techniques currently available for studying gliotransmission in 
behaving animals, in vitro and ex vitro rhythmically active brainstem and spinal cord 
preparations may provide insight into the role of bidirectional neuron-glia signalling in 
behaviour. Iterative, behaviourally relevant patterns of activity can be generated by isolated 
networks in the absence of descending and peripheral inputs, and this has permitted the study 
of diverse neuromodulatory systems and their roles in networks controlling defined behaviours 
(Marder and Bucher, 2001; Dickinson, 2006; Whelan, 2010; Harris-Warrick, 2011; Miles and 
Sillar, 2011). In addition to the examples from spinal locomotor networks given above, studies 
of brainstem networks for respiration and mastication have provided evidence for 
behaviourally-relevant gliotransmission. In the brainstem, astrocytic Ca2+ elevations are 
evoked by reductions in both pH (Gourine et al., 2010; Kasymov et al., 2013) and the partial 
pressure of oxygen (Angelova et al., 2015), in both cases causing release of ATP, which 
stimulates breathing. In intact rats, optogenetic stimulation of astrocytes triggers release of 
ATP, which stimulates breathing (Gourine et al., 2010) whereas expression of tetanus toxin in 
astrocytes to prevent vesicular release prevents increases in respiration normally observed in 
response to reduced oxygen availability (Angelova et al., 2015). In the brainstem circuity for 
mastication, glia release the Ca2+-binding protein S100β in a Ca2+-dependent manner to 
regulate extracellular Ca2+ concentration, conferring rhythmic bursting properties on 
neighbouring neurons (Morquette et al., 2015). 
Several studies have provided evidence for Ca2+-dependent signalling between astrocytes 
and neurons that departs from the established tripartite-synapse model. Signals other than 
neuronal activity are reported to elicit Ca2+ elevations in astrocytes and release of modulators. 
In addition to the examples given above of chemosensitivity in brainstem astrocytes, 
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astrocytes in the nucleus of the solitary tract respond to low glucose availability (McDougal et 
al., 2013), and hippocampal astrocytes display elevations in intracellular Ca2+ in response to 
a reduction in extracellular Ca2+, such as occurs during intense synaptic activity, resulting in 
the release of ATP from astrocytes (Torres et al., 2012). Interestingly, a reduction in 
extracellular Ca2+ is reported in the spinal cord during locomotor-related activity (Brocard et 
al., 2013), but the responsiveness of spinal cord astrocytes to changes in the ionic composition 
of the extracellular medium has not yet been assessed.  
In addition, activity dependent astrocytic Ca2+ elevations are reported to stimulate activities 
that regulate neuronal activity by mechanisms other than the release of receptor agonists. 
These include the release of substances to constrict or dilate the microvasculature according 
to local demand for oxygen and glucose (Stobart and Anderson, 2013), regulation of the Na+- 
and K+-dependent adenosine triphosphatase (Na+/K+-ATPase) to increase K+ uptake and 
hyperpolarise neurons (Wang et al., 2012), and release of the Ca2+-binding protein S100β to 
regulate extracellular Ca2+ concentration, as described above (Morquette et al., 2015). 
Finally, astrocytes may also regulate neuronal activity in an activity-dependent manner without 
Ca2+ fluctuations. Neurotransmitter uptake is as important as release in shaping patterns of 
synaptic transmission, and may be regulated in an activity-dependent manner independently 
of Ca2+ signalling. Clearance of synaptic glutamate by astrocytes has been shown to be 
regulated by neuronal activity (Perego et al., 2000; Al Awabdh et al., 2016), and the availability 
of glycine, a co-agonist of glutamate at NMDA receptors, is proposed to be regulated by GlyT1 
in an activity dependent manner (see above). In addition, activation of astrocytic GPCRs may 
result in the modulation of neuronal activity by Ca2+-independent pathways. Selective 
activation of a Gαq-coupled DREADD (designer receptor exclusively activated by designer 
drugs) expressed by glia lacking IP3R2 receptors results in diverse behavioural modifications 
on a timescale longer than that predicted for Ca2+-dependent responses; these may involve 
signalling via Gβγ or protein kinase C (PKC), for instance (Agulhon et al., 2013). Interestingly, 
it has been observed that astrocytes express receptors for the neurotransmitters released 
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specifically by the neurons they make contact with, implying that glial receptors function to 
detect synaptic transmission (Verkhratsky and Butt, 2013). Thus, spinal cord astrocytes are 
unique in expressing receptors for glycine, the dominant inhibitory neurotransmitter in the 
spinal cord (Pastor et al., 1995; Bowery and Smart, 2006). Both GlyRs and GABAA receptors 
expressed by spinal cord astrocytes carry a Cl- current, as in neurons (Pastor et al., 1995) but 
the physiological importance of these currents remains unknown. These examples suggest 
that, regardless of whether Ca2+-dependent gliotransmission influences neural activity in 
healthy animals, information processing by astrocytes may be crucial in the generation of 
behaviours by spinal networks, exceeding their established role as cellular housekeepers. 
Astrocyte identity 
Astrocytes are distinguished by the expression of several markers, most notably the 
intermediate filament protein glial fibrillary acidic protein (GFAP), but also S100B, a calcium-
binding protein, aldehyde dehydrogenase 1 family member L1 (Aldh1L1), and the glutamate 
transporters excitatory amino acid transporter 1 (EAAT1; aka glutamate and aspartate 
transporter, GLAST) and excitatory amino acid transporter 2 (EAAT2; aka glutamate 
transporter 1, GLT1) (Wang and Bordey, 2008; Tien et al., 2012). However, expression of 
these markers is not consistent, and in some cases, is not limited to astrocytes (Wang and 
Bordey, 2008). Although GFAP is widely used to identify astrocytes, it is a non-specific marker, 
being detectable in some neural progenitor cells and oligodendrocytes, and levels of 
expression differ between populations of astrocytes: in general, it is highly expressed in white-
matter fibrous astrocytes, but sporadically expressed in grey-matter protoplasmic astrocytes 
(Wang and Bordey, 2008; Tien et al., 2012). Within the spinal cord, astrocytes are 
characterised by GFAP expression, although this is more pronounced in the white than in the 
grey matter in the early postnatal period (Tien et al., 2012); they are further distinguished 
electrophysiologically by expression of non-decaying K+ currents (Chvátal et al., 1995).  
Oligodendrocytes, by contrast, do not express GFAP, but do exhibit positive immunostaining 
for O1 and O4 antigens. Furthermore, they display symmetrical, passive, non-decaying K+ 
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currents. Importantly, a further population of cells characterised by weak GFAP 
immunoreactivity and a complex pattern of Na+, and K+ currents is proposed to represent 
neural progenitors of the astrocyte lineage (Chvátal et al., 1995). In addition, the adult spinal 
cord contains GFAP+ multipotent neural stem cells that are quiescent within the intact spinal 
cord (Fiorelli et al., 2013). Such populations of non-astrocytic GFAP+ cells must therefore be 
taken into account when interpreting studies using GFAP as a marker of astrocytes in the 
spinal cord.  
It may be apparent from this brief description that studies of gliotransmission do not typically 
consider diversity among astrocytes, despite evidence for considerable molecular and 
physiological diversity (Bachoo et al., 2004; Khakh and Sofroniew, 2015). Studies of 
gliotransmission within spinal circuits would ideally consider the possibility of physiological 
specialisation among astrocytes, but this may require the identification of molecular markers 
to identify subpopulations (Bachoo et al., 2004). The availability of such markers may facilitate 
understanding of astrocyte function in the spinal cord, just as identification of a range of 
molecular markers has advanced the study of neuronal subpopulations within spinal circuits 
(Goulding, 2009; Kiehn, 2016). 
Outline of study 
Mammalian spinal locomotor networks are subject to modulation by neuromodulators 
originating from both supraspinal and spinal sources, ensuring network output appropriate to 
the needs of the animal (Miles and Sillar, 2011). Astrocytes are proposed to release 
gliotransmitters in response to intracellular Ca2+ elevations resulting from activation of Gαq-
linked GPCRs by neurotransmitters released during synaptic transmission. However, the 
importance of such astrocytic signalling for the operation of neural networks and in shaping 
behaviour remains controversial, in part because of methodological limitations to the study of 
behaving animals (Bazargani and Attwell, 2016). In rhythmically active spinal cords in vitro, 
activity recorded from ventral roots corresponds to signals received from the locomotor CPG 
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by the muscles in intact animals (Kiehn and Kjaerulff, 1996). Isolated spinal cords may 
therefore provide a tractable model for the study of gliotransmission in relation to behaviour. 
In Chapter 2, the effects of activating the Gαq pathway in astrocytes during ongoing rhythmic 
network activity in spinal cord preparations from postnatal mice are determined. It is shown 
that activation of the glial receptor PAR1 triggers release of ATP, which is hydrolysed to 
adenosine by extracellular ectonucleotidases, consistent with previous reports that spinal cord 
glia produce modulatory adenosine (Witts, Panetta and Miles, 2012; Carlsen and Perrier, 
2014). Adenosine derived from glial cells is shown to modulate both network output and 
synaptic inputs to ventral horn interneurons. 
Previously, it was proposed that during locomotor-related activity adenosine acts via Gαi -
coupled A1 receptors to inhibit signalling through Gαs-linked D1-like receptors to reduce the 
frequency of locomotor related activity (Acevedo et al., 2016). In Chapter 3, this interaction is 
characterised, and activation of D1-like receptors is shown to be a precondition for the 
modulation of spinal locomotor networks by glial-cell derived and bath-applied adenosine.  
Activation of NMDARs requires binding of a co-agonist, either D-serine or glycine, in addition 
to glutamate. Astrocytes are proposed to regulate the availability of both D-serine and glycine 
at excitatory synapses (Le Bail et al., 2015). In Chapter 4, the regulation of NMDARs by D-
serine and glycine during rhythmic activity of the murine locomotor CPG is characterised. 
Evidence is provided that D-serine and glycine separately gate NMDARs in an activity-
dependent and synapse-specific manner, and the glycine transporter GlyT1 is shown to be 
crucial for the regulation of network output. A direct investigation of the role of astrocytes in 
these processes is beyond the scope of this study, but is implied by the preferential expression 
of GlyT1 by astrocytes and the requirement of astrocytes for synthesis of D-serine. 
Together, the experiments presented in this study provide evidence that glia actively modulate 
the output of mammalian locomotor networks and therefore provide further evidence for that 
glial information processing is important in shaping a fundamental behaviour. 
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Chapter 2: Stimulation of glia reveals modulation of 
mammalian spinal locomotor networks by adenosine 
This chapter is adapted from previously published work (Acton and Miles, 2015) 
Introduction 
There is now considerable evidence from electrophysiological and Ca2+-imaging studies that 
glia can both respond to activity at the synapses they enwrap with elevations in cytosolic Ca2+ 
and modulate the excitability of neighbouring neurons via the Ca2+-dependent release of so-
called gliotransmitters (Araque et al., 2014; Volterra, Liaudet and Savtchouk, 2014; Bazargani 
and Attwell, 2016). However, the importance of these activities for the operation of neural 
networks and in shaping behaviours remains controversial (Hamilton and Attwell, 2010; 
Nedergaard and Verkhratsky, 2012; Fujita et al., 2014; Petravicz, Boyt and McCarthy, 2014; 
Bazargani and Attwell, 2016). This chapter will examine the role of gliotransmission and glial 
cell-derived adenosine in spinal motor networks. These networks coordinate the rhythmic 
activation of flexor and extensor muscles within and between limbs during locomotion, and for 
this reason their output is immediately relatable to a defined behaviour (Orlovsky, Deliagina 
and Grillner, 1999).  
Like other central pattern generators (CPGs) controlling stereotyped motor behaviours, spinal 
motor networks are subject to extensive neuromodulation, allowing network output to be varied 
according to the requirements of different environmental conditions, physiological states and 
developmental stages (Grillner, 2006; Miles and Sillar, 2011). Although many modulators are 
neuronal in origin, previous studies have reported modulation of spinal cord and brainstem 
CPGs following release of glutamate and the purines ATP and adenosine from glia (Gourine 
et al., 2010; Huxtable et al., 2010; Witts, Panetta and Miles, 2012). 
Adenosine is among the most widespread neuromodulators in the nervous system and 
participates in diverse processes in health and disease (Cunha, 2001; Fredholm et al., 2005). 
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Modulatory adenosine may be released from cells either directly or result from the hydrolysis 
of ATP by extracellular ectonucleotidases (Cunha, 2001; Klyuch, Dale and Wall, 2012; Wall 
and Dale, 2013). Several studies have detected Ca2+-dependent release of ATP from glia, with 
subsequent degradation of ATP to adenosine and activation of neuronal A1 or A2A adenosine 
receptors (Pascual et al., 2005; Serrano et al., 2006; Panatier et al., 2011; Carlsen and Perrier, 
2014). 
Adenosinergic modulation has previously been detected in motor networks of the spinal cord 
and brainstem. In the spinal cord of Xenopus tadpoles, ATP released during episodes of 
swimming excites the locomotor CPG and extends the duration of bouts of swimming (Dale 
and Gilday, 1996; Dale, 1998). As swimming progresses, ATP is hydrolysed to adenosine, 
which activates A1 receptors to drive down network activity (Brown and Dale, 2000). Similarly, 
it was recently shown that adenosine derived from the hydrolysis of ATP acts on A1 receptors 
to reduce the frequency of locomotor-related bursting in the spinal locomotor CPG of postnatal 
mice (Witts, Panetta and Miles, 2012; Acevedo et al., 2016). At the cellular level, adenosine 
reduces the frequency and amplitude of synaptic inputs to interneurons and induces a 
hyperpolarising current in interneurons in acute slices from mice (Witts, Nascimento and Miles, 
2015). Spinal locomotor networks of postnatal rats are also modulated by adenosine but may 
be less sensitive compared to equivalent networks in mice (Taccola et al., 2012).  
In mice, modulation of locomotor-related activity by endogenous adenosine is abolished 
following pharmacological ablation of glia, indicating that glia rather than neurons are the 
principal source of modulatory adenosine in murine spinal motor networks (Witts, Panetta and 
Miles, 2012). In support of these observations, excitatory transmission at synapses onto 
ventral horn interneurons is augmented following chelation of Ca2+ in neighbouring astrocytes; 
conversely, it is depressed by a mechanism involving both ATP hydrolysis and activation of 
A1 receptors when neighbouring glia are stimulated (Carlsen and Perrier, 2014).  
Mammalian brainstem networks controlling respiration, another rhythmic motor behaviour, are 
also depressed under the influence of adenosine. As in the spinal cord of Xenopus tadpoles, 
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inhibition of network activity by adenosine is reported to follow ATP-mediated excitation (Lorier 
et al., 2007). In addition, adenosine exerts a tonic depression of network activity that is most 
evident in foetal stages (Kawai et al., 1995; Schmidt, Bellingham and Richter, 1995; Mironov, 
Langohr and Richter, 1999; Huxtable et al., 2009).  
This chapter considers whether direct stimulation of glial cells leads to modulation of ongoing 
locomotor-related network activity in spinal cord preparations isolated from postnatal mice, 
and whether any such modulation involves adenosinergic signalling. Experimental stimulation 
of Ca2+ signalling in glia is proposed to replicate endogenous responses to neuronal activity 
and evokes release of neuromodulators in different systems (Araque et al., 2014; Bazargani 
and Attwell, 2016); however, the effects of glial stimulation during locomotor-related activity 
are unknown. It is shown here that enhancement of glial Ca2+ signalling via activation of the 
Gαq pathway results in the modulation of locomotor network activity, and that this entails the 
secretion by glia of ATP and its subsequent hydrolysis to adenosine. Interestingly, no evidence 
of other glial cell-derived modulators affecting spinal locomotor networks is apparent. 
Evidence is also provided to show that adenosinergic modulation of locomotor networks scales 
with network activity, likely reflecting proportional release of adenosine. This implies that glia 
possess a mechanism for detecting activity in adjacent neurons, a key element of the tripartite 
synapse model (Araque et al., 1999), and that they provide negative feedback to regulate the 
output of spinal motor circuitry. The use of three-enzyme microelectrode biosensors for the 
detection of adenosine (Sarissa Biomedical Ltd, Coventry, UK) (Llaudet et al., 2003) in murine 
spinal cord preparations is also considered. These are shown to lose sensitivity when applied 
to hemicords from neonatal mice, and they are therefore unsuitable for the detection of 
adenosine from glia during locomotor-related network activity. Finally, it is shown that 
adenosinergic modulation of network activity recorded from ventral roots is associated with 
changes in the frequency but not the amplitude of synaptic inputs to ventral horn interneurons. 
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Together, these findings suggest that adenosine is the primary glial cell-derived modulator of 
spinal motor networks and implicate glia as active participants in the modulation of these 
networks and thus of locomotor behaviour. 
Methods 
Ethics Statement  
All procedures performed on animals were conducted under project licence 60/13802 and 
personal licence 60/13802 in accordance with the UK Animals (Scientific Procedures) Act 
1986 and were approved by the University of St Andrews Animal Welfare and Ethics 
Committee. 
Tissue preparation 
For physiological experiments, spinal cords were isolated from postnatal day (P)1-P4 C57BL/6 
mice as previously described (Jiang, Carlin and Brownstone, 1999). In summary, animals were 
killed by cervical dislocation, decapitated and eviscerated before being transferred to a 
dissection chamber containing recording artificial cerebrospinal fluid (aCSF) for whole spinal 
cords, or dissection aCSF for hemicords. aCSF was maintained at ~4°C and equilibrated with 
95% oxygen and 5% carbon dioxide. Spinal cords were then isolated between midthoracic 
and upper sacral segments, and ventral and dorsal roots were trimmed. To produce hemicords, 
spinal cords were pinned ventral-side-up in the dissecting chamber, and an insect pin (base 
diameter: 0.1 mm) was passed through the midline from caudal to rostral segments, 
separating the left and right sides of the spinal cord. 
Ventral root recordings from whole spinal cords 
Isolated spinal cords were pinned ventral-side up in a recording chamber perfused with 
recording aCSF (equilibrated with 95% oxygen, 5% carbon dioxide; RT) at 10 ml/min. Glass 
suction electrodes were attached to the first or second lumbar ventral roots (L1, L2) on each 
side of the spinal cord to record flexor-related activity. In some experiments a further suction 
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electrode was attached to the fifth lumbar ventral root (L5) to record the corresponding 
extensor-related activity. Locomotor-related activity was evoked by bath application of N-
methyl-D-aspartic acid (NMDA; 5 µM), 5-hydroxytryptamine (5-HT; 10 µM) and dopamine (DA; 
50 µM), unless otherwise stated, and was characterised by rhythmic bursting alternating 
contralaterally between upper ventral roots and ipsilaterally between upper ventral roots and 
L5. For disinhibited preparations (Bracci, Ballerini and Nistri, 1996; Witts, Panetta and Miles, 
2012), strychnine (1 µM) and picrotoxin (60 µM) were applied to evoke rhythmic bursting that 
was synchronous in all roots. In some experiments theophylline (20 µM); SCH58261 (25 µM); 
8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 50 µM); ARL67156 (50 µM); methionine 
sulfoximine (MSO; 100 µM) and glutamine (1.5 mM); or fluoroacetate (FA; 5 mM) and 
glutamine (1.5 mM) were bath-applied upon the onset of locomotor-related bursting at 
concentrations previously employed in this preparation (Witts, Panetta and Miles, 2012). In all 
experiments, stable rhythmic bursting was established over a period of ~1 h prior to bath-
application of the PAR1-specific agonist TFLLR (Lee et al., 2007; Lalo et al., 2014). In all 
experiments, any drugs present in the control stage were also present during TFLLR 
application and washout. Rhythmic bursting was considered stable when the frequency, 
amplitude and duration of bursts were unchanged over several minutes. TFLLR application 
was limited to 5 min, consistent with methods previously employed (Lee et al., 2007; Lalo et 
al., 2014). Data were amplified and filtered (band-pass filter 30-3,000 Hz, Qjin Design) and 
acquired at a sampling frequency of 6 kHz with a Digidata 1440A analogue-digital converter 
and Axoscope software (Molecular Devices, Sunnyvale, CA). Custom-built amplifiers (Qjin 
Design) enabled simultaneous online rectification and integration (50-ms time constant) of raw 
signals. 
Ventral root recordings from hemicords 
Isolated hemicords were pinned, with the exposed midline surface facing up, to transparent 
Sylgard in a recording chamber perfused with recording aCSF (equilibrated with 95% oxygen, 
5% carbon dioxide; RT) at 3 ml min-1. A glass suction electrode was attached to the L1 or L2 
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ventral root. Locomotor-related activity was evoked by bath application 5-HT (10 µM), NMDA 
(5 µM) and DA (50 µM), and was characterised by rhythmic bursting. Any drugs present during 
the control period were also present during application of additional pharmacological agents 
and during washout. In all experiments, stable rhythmic bursting was established over a period 
of ~1 h prior to the control period. Rhythmic bursting was considered stable when the 
frequency, amplitude and duration of bursts were unchanged over several minutes. Data were 
acquired as for whole spinal cord experiments. 
Whole-cell patch-clamp recordings 
All recordings were made in a chamber perfused with recording aCSF (equilibrated with 95% 
oxygen, 5% carbon dioxide; RT) at 3 ml min-1. Recordings were taken from ventral horn 
interneurons on the exposed midline surface of hemicords visualized under infrared-
differential interference contrast microscopy. Recordings were made from a heterogeneous 
population of interneurons (average whole cell capacitance 13.5 ± 2.1 pF; average input 
resistance 758.5 ± 54.2 MΩ; n = 33). Interneurons were not readily classifiable into distinct 
subpopulations based on location, passive properties, or their responses to adenosine, TFLLR 
or DPCPX. Patch-clamp electrodes (3–5 MΩ) were pulled on a horizontal puller (Sutter 
Instrument, Novato, CA) from borosilicate glass (World Precision Instruments, Sarasota, FL). 
Signals were amplified and filtered (4 kHz low-pass Bessel filter) with a MultiClamp 700B 
amplifier (Molecular Devices) and acquired at 10 kHz with a Digidata 1440A A/D board and 
pCLAMP software (Molecular Devices). Correction for the liquid junction potential, which was 
calculated as 14.2 mV for solutions used here, was not made (Clampex JPCalcW). 
Biosensor recordings 
Isolated hemicords were pinned, with the exposed midline surface facing up, to transparent 
Sylgard in a 15 ml recording chamber perfused with recording aCSF (equilibrated with 95% 
oxygen, 5% carbon dioxide; RT) at 3 ml min-1. A glass suction electrode was attached to the 
L1 or L2 ventral root to stabilise the preparation.  
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Adenosine and inosine biosensors were obtained from Sarissa Biomedical Ltd (Coventry, UK). 
The fabrication and use of these biosensors were previously described (Frenguelli, Llaudet 
and Dale, 2003; Llaudet et al., 2003). Briefly, adenosine sensors consisted of a Pt/Ir wire with 
a diameter of 50 µm mounted within a glass pipette. A 2 mm length of wire protruding from the 
tip of the pipette bore an enzyme cascade consisting of adenosine deaminase, purine 
nucleoside phosphorylase and xanthine oxidase within a lactobionamide and amphiphilic 
polypyrrole matrix. Inosine (null) biosensors lacked adenosine deaminase but were otherwise 
identical. The exposed wire tips of biosensors were angled so that they would lie flat against 
the exposed midline surface of hemicords during experiments (Fig. 8, A). Biosensors were 
prepared for use in accordance with the manufacturer’s guidelines. Biosensor tips were 
rehydrated for > 10 min and thereafter stored in a solution of 2 mM NaPi buffer, pH 7.4, 100 
mM NaCl, 1 mM MgCl2, 2 mM glycerol. Following rehydration, exposure of biosensor tips to 
the air was minimised to prevent drying. Biosensor tips were either submerged in the recording 
chamber when no tissue was present or placed in contact with the exposed midline surface of 
the ventral horn within segment L1 or L2 (Fig. 8, A and B). A MultiClamp 700B amplifier 
(Molecular Devices, Sunnyvale, CA) was used to polarise biosensors. Sensors were 
positioned in recording aCSF and cycled between -500 mV and +500 mV at 100 mV/s for 10 
cycles before use to maximise sensitivity. Sensors were polarised to +500 mV throughout 
experiments. Signals were allowed to stabilise over 10-20 min prior to recording. Data was 
acquired at 10 kHz with a Digidata 1440A A/D board and pCLAMP software (Molecular 
Devices). 
Data analysis 
Recordings from ventral roots were analysed off-line with DataView software (courtesy of Dr 
W.J. Heitler, University of St Andrews). Ventral-root bursts were identified from 
rectified/integrated traces and their instantaneous frequencies, peak-to-peak amplitudes, and 
durations were then measured from the corresponding raw traces. Amplitude was measured 
as a non-calibrated unit and is presented here as an arbitrary unit (a.u.). For time-course plots, 
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data were averaged across 1-min bins and normalised to a 10-min pre-control period to permit 
comparison between preparations. Duty cycle was calculated as burst duration divided by 
cycle period. For whole spinal cord preparations, statistical comparisons were performed on 
raw data averaged over 3-min periods for locomotor-related activity or 6-min periods for 
disinhibited activity. For hemicords, statistical comparisons were performed on raw data 
averaged over six consecutive bursts and intra-burst intervals. Whole cell patch-clamp 
recordings were analysed with Clampfit software (Molecular Devices) or, for analyses of 
synaptic events, the Mini Analysis Program (Synaptosoft, Fort Lee, NJ). Biosensor currents 
were analysed offline with pCLAMP software (Molecular Devices). Averaged currents during 
the final 30 s of control, drug and wash were analysed. Data are reported as means ± SE. 
Data were analysed with repeated-measures ANOVA, one-way ANOVA, or Student’s t-tests. 
Where appropriate, Bonferroni post-hoc tests were used for pairwise comparisons. Sphericity 
was assessed with Mauchly’s test, and Greenhouse-Giesser corrections were applied where 
necessary. p values < 0.05 were considered significant. Cohen’s d effect size was also 
determined where appropriate (Cohen, 1988). Tests were performed in SPSS Statistics for 
Windows, Version 21.0 (IBM Corp. Armonk, NY) or Excel 2013 (Microsoft Corp. Redmond, 
WA). 
Immunohistochemistry 
P4-P11 C57BL/6 mice were dissected in recording aCSF as above, and spinal cords were 
incubated in fixative containing 4% (w/v) paraformaldehyde and 0.1 M phosphate buffer (pH 
7.4) for 16 h at 4°C, before being washed with 0.1 M phosphate-buffered saline (PBS; pH 7.4) 
and stored in PBS at 4°C. Slices from segments L1-L3 were cut at a thickness of 50 µm on a 
vibratome (Leica, Nussloch, Germany). Free-floating slices were incubated for 48 h at 4°C in 
solution containing primary antibodies, PBS, 1% (w/v) bovine serum albumin (BSA) and 0.1% 
(v/v) Triton X-100. Slices were then washed with PBS and incubated for 24 h at 4°C in solution 
containing secondary antibodies, PBS and 1% BSA. Slices were washed again with PBS and 
mounted with Vectashield (Vector Labs, Peterborough, UK). The stained tissue was examined 
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with an epifluorescence microscope and structured illumination (Imager.M2 fitted with 
ApoTome.2, Carl Zeiss Microscopy, Göttingen, Germany). Primary antibodies were used at 
the following concentrations: chicken polyclonal anti-microtubule-associated protein 2 (MAP2; 
Millipore AB5543) (McDowell et al., 2010; Karumbaiah et al., 2012; Xu et al., 2013), 1:200; 
rabbit polyclonal anti-protease activated receptor-1 (PAR1; Bioss bs-0828R) (Liu et al., 2015), 
1:100; chicken polyclonal anti-glial fibrillary acidic protein (GFAP; Aves GFAP) (Benoit et al., 
2009; White, McTigue and Jakeman, 2010; Daadi et al., 2012), 1:100. Secondary antibodies 
were used at the following concentrations: polyclonal anti-chicken FITC (Aves F-1005), 1:200; 
polyclonal anti-rabbit Cy3 (Jackson Immunoresearch 111-165-003), 1:500. 
Drug and Solution Preparation 
Recording aCSF contained (in mM) 127 NaCl, 26 NaHCO3, 10 glucose, 3 KCl, 2 CaCl, 1.25 
NaH2PO4, and 1 MgCl2. Dissection aCSF contained (in mM) 25 NaCl, 188 sucrose, 1.9 KCl, 
1.2 NaH2PO4, 10 MgSO4, 1 CaCl2, 26 NaHCO3, 25 D-glucose, and 1.5 kynurenic acid. The 
patch-clamp pipette solution contained (in mM) 140 potassium methanesulfonate, 10 NaCl, 1 
CaCl2, 10 HEPES, 1 EGTA, 3 Mg-ATP, and 0.4 GTP-Na2 (pH 7.2-7.3, adjusted with KOH). 
Adenosine, DA, NMDA, TFLLR, theophylline, MSO, FA and glutamine were supplied by 
Sigma-Aldrich (Poole, UK); 5-HT, DPCPX and SCH58261 were supplied by Abcam 
(Cambridge, UK); ARL67156 was supplied by Tocris Bioscience (Bristol, UK). Drugs were 
dissolved in reverse-osmosis water, except adenosine, picrotoxin, DPCPX and SCH58261, 
which were dissolved in DMSO. The concentration of DMSO in working solutions did not 
exceed 0.1% (v/v). 
Results 
Stimulation of glia modulates locomotor network output 
Protease activated receptor-1 (PAR1), an endogenous G-protein coupled receptor, is 
preferentially expressed by astrocytes in the brain, and application of the peptide agonist 




Fig. 1. PAR1 immunoreactivity co-localises with GFAP but not with MAP2 in the lumbar 
ventral spinal cord. A: representative images showing 50 µm transverse sections taken from 
the upper lumbar spinal cord of a P6 C57BL/6 mouse. Sections were stained with antibodies 
raised against GFAP (green) and PAR1 (orange). B: representative images showing 50 µm 
transverse sections taken from the upper lumbar spinal cord of a mouse. Sections were 
stained with antibodies raised against MAP2 (green) and PAR1 (orange). Arrows in Bi indicate 
areas of PAR1 staining between MAP2+ cells. Scale bars: 20 µm. 
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(Lee et al., 2007; Shigetomi et al., 2008; Lalo et al., 2014). To assess the suitability of PAR1 
activation as a strategy for selectively stimulating glia during ongoing rhythmic activity of spinal 
motor networks in vitro, expression of PAR1 in the spinal cord was examined. In spinal cord 
slices taken from segments L1-L3 of P4-11 mice, PAR1 immunoreactivity co-localised with the 
astrocyte marker GFAP throughout the ventral horn (Rexed’s laminae VII-IX; Fig. 1A; n = 4). 
By contrast, PAR1 immunoreactivity was not exhibited by cells positive for the pan-neuronal 
marker MAP2 (Fig. 1B; n = 4), but was instead restricted to cells located between those 
labelled with MAP2 (Fig. 1Bii, arrows). This pattern of expression, which was consistent across 
P4-11 tissue, resembles that previously reported in the brain and supports the use of 
endogenous PAR1 for the specific stimulation of Ca2+-dependent processes in spinal cord glia 
(Weinstein et al., 1995; Junge et al., 2004). 
To determine the contribution of glial-neuronal signalling to the modulation of the mammalian 
spinal circuitry controlling locomotion, the PAR1-specific agonist TFLLR (10 µM) (Lee et al., 
2007; Lalo et al., 2014) was briefly bath applied to isolated mouse spinal cord preparations 
while ongoing pharmacologically-induced (10 µM 5-HT, 50 µM DA, 5 µM NMDA) fictive 
locomotor-related activity was recorded from lumbar ventral roots (Fig. 2A). A 5-min 
application of TFLLR caused a transient reduction in the frequency of locomotor-related 
bursting, beginning within the first minute, and with a maximum effect of 11.5 ± 2.9% after 5 
min (Fig. 2, A and B; F[2,18] = 9.1, p < 0.01, d = 0.43, n = 10). Burst duration was found to 
increase during TFLLR application (21.0 ± 6.7%; F[2,18] = 9.6, p < 0.01, n = 10) whereas duty 
cycle did not change significantly (F[2,18] = 0.8, p > 0.05, n = 10). In addition, TFLLR 
application had no effect on the peak-to-peak amplitude of bursts (Fig. 2C; F[2,18] = 3.9, p > 
0.05, n = 10). Alternation of bursts, both between contralateral roots and between ipsilateral 
roots L2 and L5, was maintained throughout the drug application and wash periods (Fig. 2A). 
To confirm that the reduced frequency of locomotor-related bursting detected upon TFLLR 
application was mediated by glia, and that TFLLR had no direct effects on neurons, TFLLR 




Fig. 2. Stimulation of glia during ongoing locomotor-related activity results in a 
transient reduction in burst frequency. A: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots and the right L5 ventral root showing the 
effect of the PAR1 agonist TFLLR (10 µM). Bi: locomotor-burst frequency over 3 min during a 
control period, immediately following TFLLR application, and following a 20 min washout 
period. Individual data points are shown in grey, and means are represented by black lines. 
Bii: time course plot of normalised data aggregated into 1-min bins showing a reduction in 
burst frequency upon application of TFLLR. Ci: locomotor-burst amplitude over 3 min during 
a control period, immediately following TFLLR application, and following a 20 min washout 
period. Cii: time course plot of normalised data aggregated into 1-min bins showing no change 
in burst amplitude upon application of TFLLR. n = 10 preparations. Error bars: ± SEM. 






Fig. 3. TFLLR has no effect on locomotor-related bursting following pharmacological 
ablation of glia. A: raw (top) and rectified/integrated (bottom) traces recorded from left (L) 
and right (R) L2 ventral roots showing the effect of the PAR1 agonist TFLLR (10 µM) following 
glial ablation with methionine sulfoximine (MSO; 100 µM), which was co-applied with 
glutamine (Gln; 1.5 mM). B: locomotor-burst frequency in the presence of MSO and Gln over 
3 min during a control period, immediately following TFLLR application, and following a 20 min 
washout period. Individual data points are shown in grey, and means are represented by black 













(Hülsmann et al., 2000; Huxtable et al., 2010; Witts, Panetta and Miles, 2012). Stable 
locomotor-like bursting resembling that observed in the absence of toxins persisted following 
application of MSO (100 µM) or FA (5 mM), both of which selectively disrupt glial metabolism, 
when the aCSF was supplemented with glutamine (1.5 mM) to sustain synthesis of glutamate 
and GABA (Hülsmann et al., 2000; Huxtable et al., 2010; Witts, Panetta and Miles, 2012). 
Burst frequency was found to be unaffected by TFLLR applied 1 hr after either MSO (Fig. 3, 
A and B; F[2,18] = 1.0, p > 0.05, n = 10) or FA (5 mM; F[2,18] = 0.2, p > 0.05, n = 10), 
demonstrating that the effect of TFLLR on locomotor network activity is mediated by glia and 
that TFLLR does not directly affect neurons. Together these findings indicate that, when 
stimulated via an endogenous GPCR, spinal cord glia are capable of releasing a factor or 
factors that reduce the frequency of rhythmic activity generated by locomotor circuits. 
Network modulation following PAR1 activation is mediated by adenosine 
derived from ATP  
The identity of the neuromodulatory factor or factors released by glia upon PAR1 activation 
was next considered. Previously, it was shown that spinal motor networks are modulated by 
endogenous adenosine that appears to derive from glia (Witts, Panetta and Miles, 2012). It 
was therefore investigated whether adenosine mediated a component of the network 
response to PAR1 activation by applying TFLLR in the presence of the non-selective 
adenosine receptor antagonist theophylline (20 µM). In these preparations TFLLR had no 
effect on the frequency of locomotor-related bursting (Fig. 4, A and B; F[2,18] = 2.8, p > 0.05, 
n = 10), implying that adenosine is the dominant modulator released by glia following PAR1 
activation. To investigate the adenosine receptor subtypes activated by glial cell-derived 
adenosine, TFLLR was applied in the presence of antagonists selective for A1 or A2A receptors, 
both of which are broadly expressed high-affinity adenosine receptor subtypes (Cunha, 2001). 
Like theophylline, the A1-subtype specific antagonist DPCPX (50 µM) efficiently abolished the 
modulation of burst frequency by PAR1 activation (Fig. 4, C and D; F[2,18] = 1.9, p > 0.05, n 














Fig. 4. Glial stimulation results in release of adenosine and activation of neuronal A1 
receptors. A: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right 
(R) L2 ventral roots showing the effect of the PAR1 agonist TFLLR (10 µM) applied in the 
presence of theophylline (20 µM). B: locomotor-burst frequency in the presence of the non-
selective adenosine receptor antagonist theophylline over 3 min during a control period, 
immediately following TFLLR application, and following a 20 min washout period (n = 10). C: 
raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral 
roots showing the effect of the PAR1 agonist TFLLR (10 µM) applied in the presence of the 
A1-receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 50 µM). D: locomotor-
burst frequency in the presence of DPCPX over 3 min during a control period, immediately 
following TFLLR application, and following a 20 min washout period (n = 10). E: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of the PAR1 agonist TFLLR (10 µM) applied in the presence of SCH58261 (25 µM). 
F: locomotor-burst frequency in the presence of the A2A-receptor antagonist SCH58261 over 
3 min during a control period, immediately following TFLLR application, and following a 20 min 
washout period (n = 10). Individual data points are shown in grey, and means are represented 
by black lines. Error bars: ± SEM. Statistically significant differences in pairwise comparisons: 










PAR1 activation caused a transient reduction in the frequency of locomotor-related bursting 
of a similar magnitude to that measured in the absence of receptor antagonists (9.1 ± 2.3%; 
Fig. 4, E and F; F[2,18] = 7.0, p < 0.01, d = 0.43 n = 10). In addition, PAR1 activation in the 
presence of SCH58261 did not affect burst amplitude (F[2,18] = 0.267, p > 0.05, n = 10). 
Adenosine may be released from cells directly or result from the ectonucleotidase-mediated 
hydrolysis of ATP following its release into the extracellular space. To further investigate the 
release of adenosine by glia during network activity, TFLLR was applied in the presence of 
the ectonucleotidase inhibitor ARL67156 (50 µM). In preparations to which ARL657156 was 
pre-applied, PAR1 activation did not modulate the frequency of locomotor-related bursting (Fig. 
5, A and B; F[2,20] = 1.7, p > 0.05, n = 11), implying that glia do not release adenosine directly, 
but instead release ATP, which is subsequently degraded to adenosine. Together these data 
indicate that glia associated with spinal motor control networks release ATP following PAR1 
activation, and that the adenosine produced by hydrolysis of ATP in the extracellular space 
acts on neuronal A1 but not A2A receptors to inhibit locomotor-related activity. 
Glial cell-derived adenosine does not modulate excitatory components of the 
locomotor circuitry 
Following the discovery that PAR1 activation results in the release of ATP-adenosine from 
glia, the cellular targets of glial cell-derived adenosine within spinal motor circuitry were 
considered. To investigate the relative sensitivity of excitatory versus inhibitory components 
of spinal motor networks to adenosine derived from glia, experiments were performed in 
preparations in which inhibitory transmission was blocked by the glycine receptor antagonist 
strychnine (1 µM) and the GABAA channel antagonist picrotoxin (60 µM) (Bracci, Ballerini and 
Nistri, 1996; Witts, Panetta and Miles, 2012). Blockade of inhibitory transmission results in 
slow (0.032 ± 0.003 Hz, n = 13), rhythmic, large-amplitude bursts that are synchronous across 
all ventral roots (Fig. 6A). To assess whether adenosine released from glia during network 
activity modulated disinhibited bursting, DPCPX (50 µM) was applied to block A1 receptors. 




Fig. 5. Modulation of locomotor network output upon glial stimulation requires 
extracellular degradation of ATP to adenosine. A: raw (top) and rectified/integrated (bottom) 
traces recorded from left (L) and right (R) L2 ventral roots showing the effect of the PAR1 
agonist TFLLR (10 µM) applied in the presence of the ectonucleotidase inhibitor ARL67156 
(50 µM). B: locomotor-burst frequency in the presence of ARL67156 (50 µM) over 3 min during 
a control period, immediately following TFLLR application, and following a 20 min washout 















Fig. 6. ATP-adenosine released endogenously or following stimulation of glia 
modulates inhibitory components of locomotor networks. A: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of the A1-receptor antagonist DPCPX (50 µM) in preparations in which inhibitory 
transmission was blocked by the GABAA-receptor antagonist pictrotoxin (10 µM) and the 
glycine-receptor antagonist strychnine (1 µM). The locomotor drugs 5-HT (10 µM), NMDA (5 
µM) and DA (50 µM) were also present throughout. B: locomotor-burst frequency over 10 min 
during a control period, at the end of a 40 min application of DPCPX, and at the end of a 40 
min washout. C: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and 
right (R) L2 ventral roots showing the effect of the PAR1 agonist TFLLR (10 µM) applied to 
preparations in which inhibitory transmission was blocked by pictrotoxin and strychnine. D: 
locomotor-burst frequency in disinhibited preparations over 6 min during a control period, 
immediately following TFLLR application, and following a 20 min washout period (n = 13). 





n = 6) nor amplitude (F[2,10] = 2.1, p > 0.05, n = 6). Similarly, burst frequency (Fig. 6, C and 
D; F[2,24] = 1.2, p > 0.05, n = 13) and amplitude (F[2,24] = 2.294, p > 0.05, n = 13) were 
unchanged following a 10-min bath application of TFLLR to stimulate glia. These results 
suggest that adenosine produced during locomotor-related activity or upon PAR1 activation 
primarily modulates the activity of inhibitory interneurons or microcircuits not active within 
disinhibited preparations.  
Glial cell-derived adenosine mediates feedback inhibition of locomotor network 
activity 
It was then considered whether modulation of the murine locomotor CPG by endogenous glial 
cell-derived adenosine scales with network activity, as predicted by the tripartite synapse 
model of bidirectional signalling between neurons and glia (Araque et al., 1999, 2014). Stable 
locomotor-related bursting was generated by bath application of 5-HT (10 µM), DA (50 µM) 
and three different concentrations of NMDA to generate a range of control frequencies (0 µM 
NMDA: 0.097 ± 0.017 Hz, n = 11; 3 µM NMDA: 0.131 ± 0.008 Hz, n = 16; 5 µM NMDA: 0.175 
± 0.001 Hz, n = 14) (Talpalar and Kiehn, 2010), and the effect of endogenous adenosine at 
each level of network activity was revealed by application of DPCPX (50 µM) to block A1 
receptors, as previously described (Witts, Panetta and Miles, 2012). The change in frequency 
of locomotor-related bursting following DPCPX application increased with NMDA 
concentration (Fig. 7, A-D; F[2,41] = 14.2, p < 0.001, n = 11-17). The frequency of locomotor-
related bursting following DPCPX application was not significantly altered in 0 μM NMDA (3.1 
± 4.4%; Fig. 7, A and D; F[2,20] = 1.0, p > 0.05, n = 11) but increased by 13.1 ± 3.1% in 3 μM 
NMDA (Fig. 7, B and D; F[2,30] = 6.1, p < 0.05, n = 16) and by 24.4 ± 2.5% in 5 μM NMDA 
(Fig. 7, C and D; F[2,32] = 11.9, p < 0.01, n = 17). To confirm that the effect of endogenous 
adenosine was related to the baseline frequency of locomotor-related activity and was not 
instead mediated by a direct action of NMDA on glia, the effect of DPCPX on low-frequency 
activity generated by 10 µM 5-HT and 50 µM DA in standard aCSF containing 3 mM K+ was 




Fig. 7. Adenosinergic modulation of locomotor networks scales with network activity. 
A-C: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 
ventral roots showing the effect of the A1-receptor antagonist DPCPX (50 µM) in preparations 
in which locomotor-related activity was evoked by 5-HT (10 µM) and DA (50 µM) alone (A) or 
with 3 µM NMDA (B) or 5 µM NMDA (C). D: percentage change in locomotor-burst frequency 
in response to DPCPX application in preparations in which locomotor-related activity was 
evoked at different frequencies using 0 µM NMDA (n = 11), 3 µM NMDA (n = 16) and 5 µM 
NMDA (n = 17), calculated by comparing a 10 min control period with the last 10 min of a 30 
min application of DPCPX. Individual data points are shown in grey, and means are 
represented by black lines. Error bars: ± SEM. Statistically significant differences in pairwise 
comparisons: *p < 0.05, ***p < 0.001. 
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Hz, n = 6) induced by 5-HT and DA at the same concentrations in aCSF containing 5 mM K+. 
In high-K+ solution, DPCPX raised burst frequency by 23.0 ± 6.6 % (F[2,10] = 8.7, p < 0.01, n 
= 6), differing significantly from its effect in 3 mM K+ solution (n = 11; Student’s t-test, p < 0.05). 
Together these findings indicate that the influence of adenosine on locomotor-related bursting 
scales with the level of network activity, suggesting detection of neural activity by glia and 
proportional release of ATP-adenosine. 
Three-enzyme microelectrode biosensors for the detection of adenosine are not 
suitable for use in a mouse spinal cord preparation 
It was then considered whether activity-dependent production of adenosine could be 
confirmed in hemicords by means of three-enzyme microelectrode biosensors. Hemicords, 
unlike intact spinal cords, provide a surface along which the ventral-horn grey matter 
containing cells of the locomotor circuitry is exposed (Fig. 8, A and B).  
In brief, Sarissa adenosine biosensors consist of three enzymes held in a composite matrix 
surrounding a Pt/Ir microelectrode: adenosine deaminase converts adenosine to inosine and 
NH3; purine nucleoside phosphorylase converts inosine and Pi to hypoxanthine and ribose-
phosphate; and xanthine oxidase converts hypoxanthine to xanthine and H2O2, and xanthine 
to urate and H2O2; finally, H2O2 is converted to electrogenic H+ and H2O on the Pt/Ir 
microelectrode when the latter is polarised to +500 mV. Thus, adenosine generates a current 
in the biosensor proportionate to its concentration. Because other electrogenic substances 
(e.g. DA), as well as substrates of purine nucleoside phosphorylase and xanthine oxidase, 
may also be present in neural tissue, a sensor lacking adenosine deaminase but otherwise 
identical to the adenosine sensor was used in these experiments as a control.  
To test the sensitivity and specificity of adenosine and inosine (null) biosensors, they were 
positioned in a 15 ml bath containing aCSF and washed with control solutions. Bath application 
of adenosine (10 µM; Fig. 8C) induced robust currents in adenosine sensors (mean = 2290.0 












Fig. 8. Microelectrode biosensors for adenosine lose sensitivity when in contact with 
mouse spinal cord tissue. A: schematic illustrating the positioning of adenosine and null 
(inosine) biosensors within the same lumbar segment on the cut surface of a hemicord. B: 
light-microscope image showing the same preparation from above. C: example traces 
showing the responses of adenosine (top) and null (bottom) biosensors to bath applied 
adenosine, 5-HT and NMDA, and DA when sensors were placed in the bath without contact 
with tissue, and to adenosine when sensors were positioned as shown in A and B, and when 
sensors were placed again in the bath away from tissue. D: corrected (adenosine - null) peak 
currents recorded from biosensors positioned in the bath, without contact with tissue, upon 
application of (i) 10 µM adenosine (n = 14), (ii) 10 µM 5-HT and 5 µM NMDA (n = 6), and (iii) 
50 µM DA (n = 4). Individual data points representing currents are shown in grey, and means 
are represented by black lines. E: corrected (adenosine - null) currents recorded from 
biosensors positioned in contact with spinal cord tissue as in A and B upon bath application 
of 10 µM adenosine (n = 9). Error bars: ± SEM. Statistically significant difference from control: 












Mean corrected current (adenosine - null sensor) was 2220.0 ± 197.7 pA (Fig. 8Di; p < 0.001, 
n = 14), similar to previous reports (Llaudet et al., 2003; Wall and Dale, 2007), and indicating 
a selective response to adenosine. The response of biosensors to drugs used to elicit 
locomotor-related activity in spinal cord preparations was also tested. Although biosensors 
displayed modest responses to co-applied 5-HT (10 µM) and NMDA (5 µM; Fig. C; adenosine 
senor: 272.2 ± 83.1 pA, n = 6; null senor: 268.4 ± 71.6 pA, n = 6), the corrected response was 
not significant (Fig. 8Dii; p > 0.05, n = 6). Similarly, biosensors displayed modest responses 
to DA (50 µM; Fig. C; adenosine senor: 482.9 ± 44.6 pA, n = 4; null senor: 472.1 ± 91.4 pA; n 
= 6), but the corrected response was not significant (Fig. 8Diii; p > 0.05, n = 4). Together, 
these results indicate that biosensors could be used for the selective detection of adenosine 
in preparations to which 5-HT, NMDA and DA have been applied. 
The sensitivity of biosensors to adenosine when they were placed in contact with spinal cord 
preparations was then assessed. Biosensors were positioned so that the lower surface of the 
wire probe made contact with the exposed midline surface of hemicords, leaving the upper 
surface of the probe exposed. Surprisingly, sensitivity to adenosine was lost under these 
conditions (Fig. 8, C and E; p > 0.05, n = 9), but in 2/2 experiments adenosine-sensitivity was 
restored when sensors were moved from the tissue to the bath (Fig. 8C). These findings 
indicate that adenosine biosensors of this design are unsuitable for use in the mouse spinal 
cord. 
Adenosine modulates the frequency of synaptic inputs onto interneurons 
during locomotor-related activity in hemicords 
To determine the effects of glial cell-derived adenosine on synaptic transmission and the 
passive membrane properties of interneurons during network activity, whole-cell patch-clamp 
recordings in voltage-clamp mode were made from rhythmically active cells at the exposed 
midline surface of hemicord preparations (Zagoraiou et al., 2009). Rhythmic activity was 










Fig. 9. PAR1 stimulation reduces ventral-root bust frequency and synaptic inputs onto 
interneurons in hemicords. A: voltage-clamp recording from a ventral horn interneuron held 
at -60mV (top trace) and raw (top) and rectified/integrated (bottom) traces recorded from the 
L2 ventral root in a hemicord showing the effects of the TFLLR (10 µM). Bi: locomotor-burst 
frequency over six bursts at the end of a control period, a 5-min application of TFLLR, and a 
20 min washout period. n = 13 preparations. Individual data points are shown in grey, and 
means are represented by black lines. Bii: locomotor-burst amplitude over six bursts at the 
end of a control period, a 5-min application of TFLLR, and a 20 min washout period. n = 13. 
Ci: voltage-clamp recording from a ventral horn interneuron held at -60mV in a rhythmically 
active hemicord showing no change in holding current upon application of TFLLR. n = 12 cells. 
Cii: Holding current (Imemb) over 30 s at the end of a control period and a 5-min application of 
TFLLR. n = 12. D: voltage-clamp recording from a ventral horn interneuron held at -60mV in 
a rhythmically active hemicord showing synaptic inputs during a ventral-root burst in a control 
period and at the end of a 5-min application of TFLLR. n = 12. Ei: the interval between synaptic 
events recorded from a ventral horn interneuron held at -60mV over six bursts and interburst 
intervals at the end of a control period, a 5-min application of TFLLR and a 20-min washout. 
n = 12. Eii: percentage change in the interval between synaptic events elicited by a 5-min 
application of TFLLR during ventral-root bursts, between ventral-root bursts and in total. n = 
12. Eiii: the amplitude of synaptic events recorded from a ventral horn interneuron held at -
60mV over six bursts and interburst intervals at the end of a control period, a 5-min application 
of TFLLR and a 20-min washout. n = 12. Eiv: percentage change in the amplitude of synaptic 
events elicited by a 5-min application of TFLLR during ventral-root bursts, between ventral-
root bursts and in total. n = 12. Error bars: ± SEM. Significantly different from control: *p < 













Fig. 10. Adenosine reduces ventral-root bust frequency and synaptic inputs onto 
interneurons in hemicords. A: voltage-clamp recording from a ventral horn interneuron held 
at -60mV (top trace) and raw (top) and rectified/integrated (bottom) traces recorded from the 
L2 ventral root in a hemicord showing the effects of the adenosine (75 µM). Bi: locomotor-burst 
frequency over six bursts at the end of a control period, a 15-min application of adenosine, 
and a 20 min washout period. n = 16 preparations. Individual data points are shown in grey, 
and means are represented by black lines. Bii: locomotor-burst amplitude over six bursts at 
the end of a control period, a 15-min application of adenosine, and a 20 min washout period. 
n = 16. Ci: voltage-clamp recording from a ventral horn interneuron held at -60mV in a 
rhythmically active hemicord showing no change in holding current following application of 
adenosine. n = 14 cells. Cii: holding current (Imemb) over 30 s at the end of a control period and 
a 15-min application of adenosine. n = 14. D: voltage-clamp recording from a ventral horn 
interneuron held at -60mV in a rhythmically active hemicord showing synaptic inputs during a 
ventral-root burst in a control period and at the end of a 15-min application of adenosine. n = 
14. Ei: the interval between synaptic events recorded from a ventral horn interneuron held at 
-60mV over six bursts and interburst intervals at the end of a control period, a 15-min 
application of adenosine and a 20-min washout. n = 14. Eii: percentage change in the interval 
between synaptic events elicited by a 15-min application of adenosine during ventral-root 
bursts, between ventral-root bursts and in total. n = 14. Eiii: the amplitude of synaptic events 
recorded from a ventral horn interneuron held at -60mV over six bursts and interburst intervals 
at the end of a control period, a 15-min application of adenosine and a 20-min washout. n = 
14. Eiv: percentage change in the amplitude of synaptic events elicited by a 15-min application 
of adenosine during ventral-root bursts, between ventral-root bursts and in total. n = 14. Error 





and DA (50 µM). Interneurons within the same segment as the ventral root received synaptic 
inputs both during and between ventral-root bursts (holding potential: -60 mV; Fig. 9A, 10A 
and 11A). Cells were determined to receive inputs in a rhythmic manner related to ventral-root 
bursting if the interval between synaptic inputs was smaller within than between bursts. For 
rhythmically active cells, the average intraburst interval was 198.9 ± 24.0 ms and the average 
interburst interval was 305.1 ± 36.8 ms (p < 0.001; n = 36). 
To determine whether adenosinergic modulation is similar between hemicords and whole 
spinal cords, TFLLR, adenosine and DPCPX were applied to rhythmically active hemicords. 
Stimulation of glia by TFLLR (10 µM) resulted in a reduction in the frequency (18.6 ± 4.4%; 
Fig. 9, A and Bi; p < 0.01; n = 13) of ventral-root activity in hemicords, with no change in its 
amplitude (Fig. 9, A and Bii; p > 0.05; n = 13). Similarly, bath application of adenosine (75 µM) 
(Witts, Panetta and Miles, 2012) resulted in a reduction in the frequency of activity (28.6 ± 
8.2%; Fig. 10, A and Bi; p < 0.05; n = 16) with no change in amplitude (Fig. 10, A and Bii; p > 
0.05; n = 16). Conversely, blockade of A1 receptors by DPCPX (1 µM) (Acevedo et al., 2016) 
resulted in a substantial increase in the frequency of activity (105.2 ± 34.9%; Fig. 11, A and 
Bi; p < 0.05; n = 10) that typically did not reverse during washout, with no change in amplitude 
(Fig. 11, A and Bii; p > 0.05; n = 10). Thus, adenosinergic modulation of network activity is 
similar in hemicords and whole spinal-cord preparations. 
Given previous reports that bath applied adenosine induces a hyperpolarising current in 
ventral horn interneurons held at -60 mV in acute slices (Witts, Nascimento and Miles, 2015), 
it was next assessed whether TFLLR, adenosine or DPCPX has a similar effect on 
rhythmically active cells. However, no deflection in the membrane holding current (Imemb) was 
detected in interneurons in hemicords when TFLLR (Fig. 9C; p > 0.05; n = 12), adenosine 
(Fig. 10C; p > 0.05; n = 14) or DPCPX (Fig. 11C; p > 0.05; n = 10) were applied. 
Because, in slices, adenosine acting at A1 receptors modulates both the frequency and 
amplitude of postsynaptic currents recorded from interneurons, whereas A1 blockade alone 










Fig. 11. A1 receptor blockade reduces ventral-root bust frequency and synaptic inputs 
onto interneurons in hemicords. A: voltage-clamp recording from a ventral horn interneuron 
held at -60mV (top trace) and raw (top) and rectified/integrated (bottom) traces recorded from 
the L2 ventral root in a hemicord showing the effects of the DPCPX (1 µM). Bi: locomotor-burst 
frequency over six bursts at the end of a control period, a 20-min application of DPCPX, and 
a 20 min washout period. n = 10 preparations. Individual data points are shown in grey, and 
means are represented by black lines. Bii: locomotor-burst amplitude over six bursts at the 
end of a control period, a 20-min application of DPCPX, and a 20 min washout period. n = 10. 
Ci: voltage-clamp recording from a ventral horn interneuron held at -60mV in a rhythmically 
active hemicord showing no change in holding current following application of DPCPX. n = 10 
cells. Cii: holding current (Imemb) over 30 s at the end of a control period and a 20-min 
application of DPCPX. n = 10. D: voltage-clamp recording from a ventral horn interneuron held 
at -60mV in a rhythmically active hemicord showing synaptic inputs during a ventral-root burst 
in a control period and at the end of a 20-min application of DPCPX. n = 10. Ei: the interval 
between synaptic events recorded from a ventral horn interneuron held at -60mV over six 
bursts and interburst intervals at the end of a control period, a 20-min application of DPCPX 
and a 20-min washout. n = 10. Eii: percentage change in the interval between synaptic events 
elicited by a 20-min application of DPCPX during ventral-root bursts, between ventral-root 
bursts and in total. n = 10. Eiii: the amplitude of synaptic events recorded from a ventral horn 
interneuron held at -60mV over six bursts and interburst intervals at the end of a control period, 
a 20-min application of DPCPX and a 20-min washout. n = 10. Eiv: percentage change in the 
amplitude of synaptic events elicited by a 20-min application of DPCPX during ventral-root 
bursts, between ventral-root bursts and in total. n = 10. Error bars: ± SEM. Significantly 





DPCPX on synaptic inputs to rhythmically active interneurons were assessed next. 
Depolarising synaptic events represent combined excitatory and inhibitory postsynaptic 
currents (EPSCs; IPSCs), as a function of a -60 mV holding potential and the reversal potential 
of Cl- in the solutions used here. When TFLLR was applied to hemicords to induce release of 
ATP-adenosine from glia, the interval between synaptic events in rhythmically active 
interneurons increased (34.2 ± 5.1%; Fig. 9, A, D, Ei and Eii; p < 0.05; n = 12), but the 
amplitude was unchanged (Fig. 9, A, D, Eiii and Eiv; p > 0.05; n = 12). Similarly, bath-applied 
adenosine increased the interval between synaptic events (46.9 ± 9.7%; Fig. 10, A, D, Ei and 
Eii; p < 0.05; n = 14) but did not modulate amplitude (Fig. 10, A, D, Eiii and Eiv; p > 0.05; n = 
14). Conversely, blockade of A1 receptors with DPCPX reduced the interval between synaptic 
events (30.7 ± 6.7%; Fig. 11, A, D, Ei and Eii; p < 0.05; n = 10), but also did not alter their 
amplitude (Fig. 11, A, D, Eiii and Eiv; p > 0.05; n = 10). Although cells received more synaptic 
inputs during than between bursts, event frequency was modulated to a similar degree during 
intra- and interburst periods by TFLLR (Fig. 9Eii), adenosine (Fig. 10Eii) and DPCPX (Fig. 
11Eii). These results indicate that endogenous and exogenous adenosine modulate the 
frequency but not the amplitude of synaptic inputs in hemicords, consistent with changes in 
the frequency of ventral-root bursting.  
Discussion 
This chapter provides evidence that glia contribute to the operation of spinal motor networks 
by the secretion of neuromodulatory ATP-adenosine in an activity-dependent manner. This 
study extends a previous characterisation of the modulation of network output by purines and 
corroborates the proposal that glia are the source of neuromodulatory adenosine in the spinal 
motor circuitry (Witts, Panetta and Miles, 2012). Furthermore, adenosine is proposed as the 




Glia have been shown to release a number of substances including glutamate, D-serine, ATP 
and GABA upon experimental stimulation in both the brain and spinal cord, with diverse effects 
on synaptic transmission (Araque et al., 1999, 2014). Stimuli are proposed to reproduce the 
cytosolic Ca2+ elevations evoked in glia following the activation of endogenous receptors by 
transmitters released during neuronal activity, a phenomenon that has been observed 
throughout the CNS, both in vitro and in vivo (Nedergaard and Verkhratsky, 2012; Volterra, 
Liaudet and Savtchouk, 2014). Here, it is shown that experimental stimulation of glia by 
activation of PAR1 during ongoing locomotor-like activity within spinal motor networks results 
in a reversible reduction in the frequency of locomotor-related bursting associated with an 
increase in burst duration, with no effect on duty cycle or burst amplitude.  
PAR1 is an endogenous G-protein coupled receptor associated with Gαq proteins, and its 
activation results in the release of Ca2+ from internal stores in cortical slice preparations, 
followed by Ca2+-dependent release of glutamate or ATP (Lee et al., 2007; Shigetomi et al., 
2008; Lalo et al., 2014). Similar glial cell-specific effects of PAR1 activation are proposed in 
the ventral horn of the spinal cord (Carlsen and Perrier, 2014). It is shown in the present study 
that GFAP+ cells in the spinal cord preferentially express PAR1. Although these cells are likely 
to be astrocytes, consistent with reports of preferential expression by astrocytes in the brain 
and brainstem (Weinstein et al., 1995; Junge et al., 2004), the possibility that neural precursor 
cells of the astrocyte lineage also express PAR1 cannot be excluded; previously it was 
suggested that a subset of these cells expresses GFAP in the spinal cords of postnatal rats 
(Chvátal et al., 1995). Although clear PAR1 immunofluorescence in MAP2+ neurons is not 
detected, this finding cannot exclude the possibility of low-level PAR1 expression by neurons. 
To confirm that the effects of PAR1 activation on network output are mediated by glia and that 
the PAR1-selective agonist TFLLR has no off-target effects on neurons, TFLLR was applied 
to preparations following pharmacological ablation of glia by FA and MSO. Toxins that disrupt 
normal glial metabolism have been used in several studies to elucidate the role of glia in 
neuromodulation and homeostasis (Clarke, 1991; Fonnum, Johnsen and Hassel, 1997; Zhang 
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et al., 2003; Huxtable et al., 2010; Witts, Panetta and Miles, 2012; Li et al., 2013; Wall and 
Dale, 2013). Although both MSO, an inhibitor of glutamine synthetase (Ronzio, Rowe and 
Meister, 1969) and FA, a precursor of the aconitase inhibitor fluorocitrate (Fonnum, Johnsen 
and Hassel, 1997), are able to cross neuronal membranes (Hassel et al., 1992) and have 
actions that may not result directly from the disruption of glial metabolism (Clarke, 1991; Largo, 
Ibarz and Herreras, 1997; Young et al., 2005), neither prevents the rhythmic activity of motor 
networks when co-applied with glutamine to ensure continued synthesis of glutamate and 
GABA (Hülsmann et al., 2000; Huxtable et al., 2010; Witts, Panetta and Miles, 2012). 
Furthermore, FA and MSO do not prevent the modulation of motor networks by exogenously 
applied neuromodulators (Huxtable et al., 2010; Witts, Panetta and Miles, 2012). It is therefore 
proposed that the modulation of locomotor network output by TFLLR reflects selective 
activation of PAR1 expressed by spinal glia rather than any off-target effects on neurons, 
consistent with previous reports that TFLLR does not act on neurons in the brain (Lee et al., 
2007; Lalo et al., 2014). 
The effects of PAR1 activation on network output closely resemble those of exogenously 
applied adenosine, which likewise depresses the frequency of locomotor-related bursting 
without modulating burst amplitude or left-right alternation (Witts, Panetta and Miles, 2012). In 
support of A1 adenosine receptor-mediated modulation of the locomotor CPG following PAR1 
activation, the modulation of network output is efficiently prevented by either the general 
adenosine-receptor antagonist theophylline or the A1 antagonist DPCPX, but not by the A2A 
antagonist SCH58261. Similarly, inhibition of A1 receptors, but not A2A receptors is sufficient 
to abolish the modulation of locomotor-related activity by endogenous adenosine (Witts, 
Panetta and Miles, 2012), and DPCPX abolishes the PAR1-evoked modulation of excitatory 
currents recorded from ventral horn interneurons (Carlsen and Perrier, 2014). Of the four 
known adenosine receptor subtypes, A1 and A2A receptors have the highest affinity for 
adenosine, and in many regions A1-mediated inhibition balances A2A-mediated facilitation 
(Cunha, 2001). Although both receptors are expressed throughout the spinal cord (Reppert et 
73 
 
al., 1991; Deuchars, Brooke and Deuchars, 2001; Paterniti et al., 2011), A2A receptors do not 
appear to modulate the activity of the locomotor CPG (Fig. 4, E and F; Witts, Panetta and 
Miles, 2012). 
Given that glia are shown in numerous systems to be competent to release a range of 
modulators (Araque et al., 1999, 2014), and that diverse neuromodulators regulate spinal 
motor networks (Miles and Sillar, 2011), it may be surprising that PAR1 stimulation of glia 
results in the modulation of locomotor network activity by adenosine alone. Although glia are 
proposed to exercise fine control over synaptic transmission (Araque et al., 1999; Perea, 
Navarrete and Araque, 2009; Navarrete and Araque, 2011), the findings presented in this 
chapter suggest that the diversity of neuronal signalling mechanisms in the spinal cord is not 
reflected by a similar diversity of gliotransmitters. Instead, adenosine derived from glia appears 
to provide broad negative feedback control of locomotor networks. It should, however, be 
noted that the choice of technique employed to stimulate glia may influence gliotransmitter 
release (Shigetomi et al., 2008; Wang et al., 2013) and for this reason the possibility that spinal 
glia release other gliotransmitters in response to different stimuli cannot be excluded. 
Under non-pathological conditions, extracellular adenosine is largely derived from the 
hydrolysis of ATP by ectonucleotidases (Dunwiddie, Diao and Proctor, 1997); however, it may 
also be released directly via exocytosis or equilibrative nucleoside transporters (Klyuch, Dale 
and Wall, 2012; Wall and Dale, 2013). Several studies show Ca2+-dependent release of ATP 
by glia, with subsequent conversion of ATP to adenosine and activation of either A1 or A2A 
receptors (Pascual et al., 2005; Serrano et al., 2006; Panatier et al., 2011; Carlsen and Perrier, 
2014). The reduction in frequency of locomotor-like bursting detected following PAR1 
activation is abolished in the presence of the ectonucleotidase inhibitor ARL67156, implying 
that ATP and not adenosine is released by glia following stimulation. In other networks, 
including the mammalian respiratory CPG (Lorier et al., 2007) and tadpole locomotor CPG 
(Dale and Gilday, 1996), modulation of neuronal activity by adenosine opposes modulation by 
ATP. By contrast, the present study indicates that spinal motor networks in the mouse are 
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modulated by adenosine derived from the extracellular hydrolysis of ATP, but not by ATP 
directly, a finding supported by a previous investigation of purinergic modulation of the murine 
locomotor CPG (Witts, Panetta and Miles, 2012). 
Neither blockade of A1 receptors nor stimulation of glia influences the frequency of 
synchronous, disinhibited bursting generated and coordinated exclusively by excitatory 
components of the motor circuitry, consistent with a previous finding that exogenously applied 
adenosine has no effect on disinhibited bursting (Witts, Panetta and Miles, 2012). Although it 
remains uncertain whether common circuit elements underlie both disinhibited and left-right 
alternating rhythms, these data suggest that adenosine modulates the frequency of locomotor-
related bursting by acting on inhibitory interneurons. Because adenosine does not affect the 
contralateral alternation of locomotor related bursts, Witts et al. (2012) proposed a model 
whereby adenosine modulated the activity of ipsilaterally projecting inhibitory interneurons, of 
which V1 local circuit inhibitory neurons are an example (Alvarez et al., 2005; Witts, Panetta 
and Miles, 2012). The ablation or inactivation of V1 interneurons results in a reduction in the 
frequency of locomotor-like activity (Gosgnach et al., 2006), making them a candidate for 
future studies aiming to decipher the cellular targets of modulatory adenosine. However, 
recent studies (Carlsen and Perrier, 2014; Witts, Nascimento and Miles, 2015) and the data 
presented here (here) indicate that adenosine modulates a broader population of interneurons 
within the ventral horn.  
Evidence is provided to show that the influence of endogenous adenosine on network output 
increases with the frequency of network activity, likely reflecting enhanced release of ATP-
adenosine from glia and implying a mechanism for the detection of neuronal activity by glia. 
In other preparations, glial Ca2+ signalling is triggered by the spillover of neurotransmitters 
from synapses (Araque et al., 1999). A similar mechanism operating in the spinal cord may 
therefore involve the spillover of glutamate, glycine or GABA, all of which are endogenous 
neurotransmitters to which spinal glia have been shown to respond (Pastor et al., 1995; Ziak, 
Chvátal and Syková, 1998).  
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Activity-dependent increases in extracellular adenosine are reported in several preparations 
(Wall and Dale, 2008). Of particular relevance to this study is the Xenopus tadpole spinal cord, 
in which ATP is released during swimming episodes and enhances the excitability of motor 
networks (Dale and Gilday, 1996). The hydrolysis of ATP by ectonucleotidases as swimming 
proceeds raises the concentration of extracellular adenosine, which opposes ATP to reduce 
network excitability and terminate swimming. By contrast, in murine spinal locomotor networks, 
ATP does not appear to act as a neuromodulator (Witts, Panetta and Miles, 2012; Carlsen 
and Perrier, 2014). Since ATP is consumed by neurons during activity, raising cytoplasmic 
adenosine levels, an efficient coupling mechanism would entail direct release of adenosine 
via neuronal equilibrative nucleoside transporters, with autocrine inhibition of activity via A1 
receptors (Cunha, 2001; Fredholm et al., 2005). This mechanism does not appear to operate 
in mouse spinal motor networks or other systems in which the source of adenosine is ATP 
released into the extracellular space from either neurons or glia (Wall and Dale, 2008; Witts, 
Panetta and Miles, 2012). Whether adenosine production is direct or indirect, the functional 
consequences of the negative feedback it provides may include the stabilisation of network 
activity and the prevention of excitotoxicity and metabolic exhaustion. 
Direct measurement of adenosine within the spinal cord could be used to confirm that glia 
release adenosine in an activity-dependent manner, perhaps avoiding confounding factors 
associated with measurements of neuronal activity. To this end, the suitability of Sarissa three-
enzyme biosensors for use in murine spinal cord tissue was investigated. Microelectrode 
biosensors detect release of adenosine in real time, cause minimal damage to tissue and are 
highly selective (Dale, 2013). In addition, they permit relative and, under some experimental 
conditions, absolute quantitation of adenosine. These properties have been useful in 
demonstrating activity dependent adenosine production in a variety of preparations (Wall and 
Dale, 2008). Evidence is provided that Sarissa three-enzyme biosensors are unsuitable for 
use in the mouse spinal cord. Detection of control applications of adenosine by biosensors is 
abolished when biosensors make contact with spinal cord tissue. It is unlikely that this 
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inhibition of sensor function is due to restricted diffusion of adenosine within spinal cord tissue, 
as the upper surface of the probe was exposed in these experiments. Instead, it is likely that 
the mouse spinal cord, unlike the brain, contains at least one diffusible factor that reversibly 
inhibits the function of one or more enzymes of the biosensor. Consistent with these data, it is 
reported that sensors had reduced sensitivity to adenosine in the spinal cord of Xenopus 
tadpoles compared to the brain (Llaudet et al., 2003). An alternative method such as 
microdialysis in conjunction with HPLC may be more useful in confirming the activity-
dependent production of adenosine from glia implied by electrophysiological recordings from 
neurons. 
Adenosinergic modulation of synaptic activity and the passive membrane properties of ventral 
horn interneurons was previously reported in slice preparations (Carlsen and Perrier, 2014; 
Witts, Nascimento and Miles, 2015); however, it was not determined whether effects 
previously reported are relevant to cells in rhythmically active preparations. In slices, 
adenosine reduces the frequency of synaptic events by a presynaptic mechanism (Witts, 
Nascimento and Miles, 2015). Similarly, in rhythmically active hemicords, the frequency of 
synaptic events recorded from interneurons decreases when adenosine is bath applied or 
released from glia following PAR1 activation. Conversely, blockade of A1 receptors increases 
the frequency of postsynaptic currents. Despite the considerable genetic and physiological 
heterogeneity of spinal cord interneurons (Kiehn, 2006; Bikoff et al., 2016), and the 
expectation that adenosine modulates only a subset of inhibitory interneurons (see above), 
these effects are consistent across the interneurons sampled. Similarly, interneurons in acute 
slices display consistent responses to adenosine (Carlsen and Perrier, 2014; Witts, 
Nascimento and Miles, 2015). In slices, adenosine reduces the frequency of synaptic events 
in the presence of TTX, implying that this effect is not network dependent (Witts, Nascimento 
and Miles, 2015). Furthermore, changes in synaptic activity in hemicords are evenly distributed 
across intra- and interburst periods, suggesting that A1 receptor activation results in a 
generalised reduction in gain during network activity. However, the possibility cannot be 
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excluded that the changes in the frequency of synaptic inputs to interneurons observed in 
hemicords reflect changes in network activity rather than direct effects of adenosine. In support 
of this, changes in the frequency of synaptic inputs are consistent with changes in the 
frequency of bursting in ventral roots. In addition, synaptic effects observed in hemicords in 
the presence of DA may not be comparable with those observed in slices in its absence, as 
adenosine does not modulate network activity in the absence of DA (see Chapter 3). 
Interneurons in rhythmically active networks differ from interneurons in slices in some of their 
responses to adenosine and DPCPX. In slices, adenosine induces a hyperpolarising current 
in interneurons that likely results from the opening of leak K+ channels (Witts, Nascimento and 
Miles, 2015). This current is abolished in the presence of TTX, suggesting that it entails 
network activity. In rhythmically active hemicords, however, a hyperpolarising current is not 
observed. In addition, adenosine reduces the amplitude of postsynaptic currents in 
interneurons in slices (Witts, Nascimento and Miles, 2015), but in rhythmically active 
hemicords the amplitude of synaptic events is unaltered by adenosine applied at the same 
concentration or following PAR1 activation. The reason for these differences is unclear; it is 
possible that adenosinergic modulation of cells within murine spinal networks displays state 
dependency (see below). 
Blockade of A1 receptors abolishes the effects of bath-applied adenosine in interneurons in 
slices but does not otherwise alter synaptic activity (Witts, Nascimento and Miles, 2015). By 
contrast, blockade of A1 receptors results in a pronounced increase in the frequency of 
postsynaptic currents recorded from interneurons in hemicords. This may reflect greater 
endogenous activation of A1 receptors in hemicords, perhaps because of activity-dependent 
release of adenosine. Alternatively, it may reflect differential effects of A1-receptor signalling 
in a state-dependent manner, perhaps owing to the presence of other neuromodulators. For 
instance, A1 and D1-like receptors are proposed to interact in the spinal cord to modulate 
locomotor-related activity (Acevedo et al., 2016). Whereas DA is bath applied to activate D1-
like receptors in rhythmically active whole spinal cords and hemicords, it is likely that there is 
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little endogenous activation of D1-like receptors in slices. These differences in modulatory 
effects in hemicords and slices require further investigation, and illustrate the importance of 
recording from neurons during network activity where possible. 
Despite considerable evidence from in vitro brain preparations that glia sense activity in 
neighbouring neurons and, in turn, modulate that activity in a Ca2+-dependent manner, there 
is a paucity of evidence that gliotransmission is important for the operation of brain networks 
and the behaviours they direct (Nedergaard and Verkhratsky, 2012; Fujita et al., 2014; 
Petravicz, Boyt and McCarthy, 2014). Rhythmically active CPGs in the spinal cord and 
brainstem provide a tractable model for studying the contribution of gliotransmission to 
network output and thus behaviour. Previously it was shown that glia mediate purinergic 
modulation of rhythmically-active inspiratory networks in the brainstem, most likely owing to 
the Ca2+-dependent release of glutamate (Huxtable et al., 2010). It was also shown that 
brainstem glia release ATP in a Ca2+-dependent manner upon acidification of the extracellular 
medium, stimulating activity in the phrenic nerve (Gourine et al., 2010). In addition, it was 
recently demonstrated that glia release the Ca2+-binding protein S100β in a Ca2+-dependent 
manner to confer rhythmic bursting properties on associated neurons in the brainstem circuity 
for mastication (Morquette et al., 2015). This study provides evidence that activity-dependent 
release of ATP-adenosine from glia in the mammalian spinal cord provides negative feedback 
onto the circuitry that controls locomotion. This feedback may stabilise activity, delay metabolic 
rundown and/or have a neuroprotective role. The present study informs understanding of the 
regulation of locomotor networks and provides an insight into the role of glia in shaping activity 







Chapter 3: Adenosine derived from glia activates A1 
receptors to inhibit signalling by excitatory D1-like 
dopamine receptors 
Introduction 
In the previous chapter, it was shown that glia release ATP-adenosine when stimulated, and 
that this results in activation of A1 receptors and inhibition of locomotor-related network activity. 
In this chapter, the cellular pathway by which glial adenosine acts to inhibit neuronal activity 
is investigated. 
Within isolated murine spinal cords, endogenous adenosine acts at A1 receptors to reduce the 
frequency but not the amplitude of ongoing locomotor-related activity (Witts, Panetta and 
Miles, 2012; Acevedo et al., 2016; Chapter 2). By contrast, A2A receptors, although expressed 
in the ventral horn (Paterniti et al., 2011), do not modulate locomotor networks (Witts, Panetta 
and Miles, 2012; Acevedo et al., 2016; Chapter 2). Glia are proposed as the principle source 
of adenosine in spinal motor networks, since adenosinergic modulation does not occur when 
glia are pharmacologically ablated (Witts, Panetta and Miles, 2012; Chapter 2); conversely, 
selective activation of protease-activated receptor-1 (PAR1), a Gαq-linked G-protein coupled 
receptor (GPCR) preferentially expressed by glia, stimulates production of adenosine and 
activation of A1 receptors (Chapter 2). Adenosine may be released from cells either directly or 
in the form of ATP, which is hydrolysed to adenosine in the extracellular space by 
ectonucleotidases (Cunha, 2001; Klyuch, Dale and Wall, 2012; Wall and Dale, 2013). 
Application of an ectonucleotidase inhibitor prevents activation of A1 receptors in the spinal 
cord, either by adenosine derived from glia or when ATP is bath-applied, indicating that glia 




Recently, it was proposed that A1 receptors interact with D1-like dopamine (DA) receptors in 
spinal locomotor circuitry (Acevedo et al., 2016), as is reported in the basal ganglia (Popoli et 
al., 1996). A1 receptors are tightly coupled to the Gαi pathway, which mediates inhibition of 
adenylyl cyclase and reduces production of cyclic adenosine monophosphate (cAMP). By 
contrast, D1-like receptors signal through Gαs to stimulate adenylyl cyclase and cAMP 
production, resulting in activation of protein kinase A (PKA). PKA regulates diverse proteins, 
including ion channels and neurotransmitter receptors (Abdel-Majid et al., 1998; Pieper, 
Clerkin and MacFarlane, 2011).  
DA is released within the ventral horn during locomotion (Gerin, Becquet and Privat, 1995; 
Gerin and Privat, 1998). DA is released principally from inputs originating in the A11 region of 
the hypothalamus, although other descending inputs are described (Björklund and 
Skagerberg, 1979; Commissiong, Gentleman and Neff, 1979; Hökfelt, Phillipson and 
Goldstein, 1979; Skagerberg and Lindvall, 1985). The five DA receptor subtypes are classified 
as either D1- or D2-like, and these subfamilies signal through distinct pathways (Abdel-Majid 
et al., 1998; Pieper, Clerkin and MacFarlane, 2011). All receptor subtypes are expressed in 
the rodent spinal cord (Dubois et al., 1986; Fleetwood-Walker, Hope and Mitchell, 1988; Zhu 
et al., 2007, 2008).  
DA has diverse modulatory actions within mammalian spinal locomotor networks mediated by 
both D1- or D2-like receptors (Madriaga et al., 2009; Humphreys and Whelan, 2012; Sharples 
et al., 2014, 2015). Although D1-like receptors typically have excitatory effects, they are 
reported not to increase burst frequency in the spinal cord of postnatal mice (Humphreys and 
Whelan, 2012; Sharples et al., 2015), but instead enhance the stability of rhythmic bursting 
(Sharples et al., 2015). However, selective activation of D1-like receptors initiates locomotor 
activity in spinalised adult mice (Lapointe et al., 2009) and in isolated spinal cords from 
postnatal rats (Barrière, Mellen and Cazalets, 2004).Signalling by D1-like receptors in spinal 
cord interneurons that determine the frequency has not been reported; however activation of 
D1-like receptors expressed by motoneurons increases the open probability and open duration 
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of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor channels in a 
PKA-dependent manner, but does not alter insertion of receptors (Han and Whelan, 2009). 
In the spinal cord, A1 inhibition fails to alter the frequency of locomotor-related network activity 
when DA is absent or when D1-like receptors are blocked (Acevedo et al., 2016). A1 blockade 
is similarly ineffective when PKA activity is inhibited (Acevedo et al., 2016). However, 
modulation of locomotor-related bursting by A1 receptors is restored when forskolin is applied 
to activate adenylyl cyclase independently of D1-like receptor activation (Acevedo et al., 2016). 
Thus, adenosine is proposed to inhibit adenylyl cyclase in the spinal cord, blocking signalling 
through the D1-like receptor pathway. Suppression of PKA activity in this way results in a 
reduction in the frequency of locomotor-related activity. However, D1-like receptors have not 
been shown to have the excitatory effect on network activity that is implied by this mechanism 
(Humphreys and Whelan, 2012; Sharples et al., 2015). Furthermore, adenosine is reported to 
modulate neuronal passive electrical properties and synaptic activity in the ventral horn in the 
absence of DA (Witts, Nascimento and Miles, 2015; Acevedo et al., 2016), and it has not been 
shown directly that adenosine released from glia requires D1-like receptor activation in order 
to modulate neuronal activity. 
This study assesses the role of D1-like receptor signalling and the mechanism by which glial 
adenosine acts during ongoing locomotor-related activity in isolated spinal cord preparations 
from postnatal mice. Contrary to previous reports (Humphreys and Whelan, 2012; Sharples et 
al., 2015), it is shown that selective activation of D1-like receptors enhances the frequency of 
locomotor-related activity. Activation of D1-like receptors is shown to be necessary for the 
previously-reported modulatory actions of bath-applied adenosine, endogenous adenosine 
acting at A1 receptors and adenosine released from glia following PAR1 stimulation. Finally, 






All procedures performed on animals were conducted under project licence 60/13802 and 
personal licence 60/13802 in accordance with the UK Animals (Scientific Procedures) Act 
1986 and were approved by the University of St Andrews Animal Welfare and Ethics 
Committee. 
Tissue preparation 
Spinal cords were isolated from postnatal day (P)1-P4 C57BL/6 mice as previously described 
(Jiang, Carlin and Brownstone, 1999). In summary, animals were killed by cervical dislocation, 
decapitated and eviscerated, before being transferred to a dissection chamber containing 
artificial cerebrospinal fluid (aCSF; equilibrated with 95% oxygen, 5% carbon dioxide, ~4°C). 
Spinal cords were then isolated between midthoracic and upper sacral segments, and ventral 
and dorsal roots were trimmed.  
Ventral root recordings 
Isolated spinal cords were pinned ventral-side up in a recording chamber perfused with aCSF 
(equilibrated with 95% oxygen, 5% carbon dioxide; RT) at 10 ml min-1. Glass suction 
electrodes were attached to the first or second lumbar ventral roots (L1, L2) on each side of 
the spinal cord to record flexor-related activity. Locomotor-related activity was evoked by bath 
application of 5-hydroxytryptamine (5-HT; 15 µM) and N-methyl-D-aspartic acid (NMDA; 5 
µM), and was characterised by rhythmic bursting alternating between contralateral ventral 
roots. In some experiments, protein kinase inhibitor-(14-22)-amide (14-22 amide) or (±)-1-
Phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide (SKF 38393; 100 nM) 
was bath-applied at the onset of locomotor-related bursting. All drugs present during the 
control period were also present during application of further drugs and during washout. In all 
experiments, stable rhythmic bursting was established over a period of ~1 h prior to the control 
period. Rhythmic bursting was considered stable when the frequency, amplitude and duration 
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of bursts were unchanged over several minutes. Data were amplified and filtered (band-pass 
filter 30-3,000 Hz, Qjin Design), and acquired at a sampling frequency of 6 kHz with a Digidata 
1440A analogue-digital converter and Axoscope software (Molecular Devices, Sunnyvale, 
CA). Custom-built amplifiers (Qjin Design) enabled simultaneous online rectification and 
integration (50-ms time constant) of raw signals. 
Data analysis 
Data were analysed offline with DataView software (courtesy of Dr W.J. Heitler, University of 
St Andrews). Ventral-root bursts were identified from rectified/integrated traces and their 
instantaneous frequencies, peak-to-peak amplitudes, and durations were then measured from 
the corresponding raw traces. Amplitude was measured as a non-calibrated unit and is 
presented here in arbitrary units (a.u.). For time-course plots, data were averaged across 1-
min bins and normalised to a 10-min pre-control period to permit comparison between 
preparations. Statistical comparisons were performed on raw data averaged over 3-min 
periods for experiments testing the effects of PAR1 stimulation with TFLLR or 5-min periods 
in experiments to test other drugs. Data were analysed with repeated-measures ANOVA or 
Student’s t-tests. Bonferroni post-hoc tests were applied to pairwise comparisons. Where 
appropriate, sphericity was assessed with Mauchly’s test and Greenhouse-Giesser 
corrections were applied. p values < 0.05 were considered significant. Tests were performed 
in SPSS Statistics for Windows, Version 21.0 (IBM Corp. Armonk, NY) or Excel 2013 
(Microsoft Corp. Redmond, WA). 
Solution, drug and enzyme preparation 
The aCSF used for dissections and recordings contained (in mM) 127 NaCl, 26 NaHCO3, 10 
glucose, 3 KCl, 2 CaCl, 1.25 NaH2PO4, and 1 MgCl2. Adenosine and TFLLR-NH2 were 
supplied by Sigma-Aldrich (Poole, UK); DPCPX was supplied by Abcam (Cambridge, UK); 
PKI 14-22 amide, myristoylated and SKF 38393 hydrobromide were supplied by Tocris 
Bioscience (Bristol, UK). All drugs were dissolved in reverse-osmosis water, except adenosine 
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and DPCPX, which were dissolved in DMSO. The concentration of DMSO in working solutions 
did not exceed 0.1% (v/v). 
Results 
Selective activation of D1-like receptors increases the frequency of locomotor-
related network activity 
Adenosine is proposed to reduce the frequency but not the amplitude of locomotor-related 
activity by inhibiting signalling through the D1-like receptor pathway (Acevedo et al., 2016), 
implying a role for D1-like receptors in the modulation of burst frequency but not amplitude. To 
determine the contribution of the D1-like receptor pathway to the output of locomotor networks, 
the selective D1-like receptor agonist SKF 38393 (100 nM) (Neumeyer et al., 2003; Clemens 
et al., 2012) was applied to isolated spinal cord preparations from postnatal mice during stable 
locomotor-related activity induced by NMDA (5 µM) and 5-HT (10 µM). The frequency of bursts 
recorded from L2 ventral roots gradually increased over the 30 min period in which D1-like 
receptors were activated, with a maximum effect of 17.5 ± 2.6%. The frequency returned to 
the baseline value when SKF 38393 was washed out (Fig. 1, A and B; F[2,16] = 18.9, p < 
0.001, n = 9). Although burst amplitude was unchanged during application of SKF 38393, it 
increased following washout (15.1 ± 3.2%; Fig. 1, A and C; F[2,16] = 6.6, p < 0.01, n = 9). 
These data indicate that D1-like receptors modulate the frequency of locomotor-related 
bursting, but not its amplitude, in conflict with previous reports that D1-like receptors have no 
effect on burst frequency (Humphreys and Whelan, 2012; Sharples et al., 2015). 
Activation of D1-like receptors is required for the modulation of locomotor 
frequency by glial cell-derived adenosine 
Previous studies assessing the modulation of murine locomotor networks by adenosine were 
conducted in preparations in which DA was present (Witts, Panetta and Miles, 2012; Acevedo 
et al., 2016; Chapter 2). However, blockade of D1-like receptors in the presence of DA was 














Fig. 1. Activation of D1-like receptors increases the frequency but not the amplitude of 
locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces recorded 
from left (L) and right (R) L2 ventral roots showing the effect of the selective agonist of D1-like 
receptors SKF 38393 (100 nM) on locomotor-related activity induced by 5-HT (10 µM) and 
NMDA (5 µM). Bi: locomotor-burst frequency over 5 min during a control period, during a 30-
min application of SKF 38393, and during a 30-min washout. Individual data points are shown 
in grey, and means are represented by black lines. n = 9 preparations. Bii: time course plot of 
normalised data aggregated into 1-min bins showing an increase in burst frequency during 
SKF 38393 application. n = 9. Ci: locomotor-burst amplitude over 5 min during a control period, 
during a 30-min application of SKF 38393, and during a 30-min washout. n = 9. Cii: time course 
plot of normalised data aggregated into 1-min bins showing no change in burst amplitude 
during SKF 38393 application. n = 9. Error bars: ± SEM. Statistically significant difference: *p 
< 0.05, **p < 0.01. 
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To confirm that activation of D1-like receptors is required for adenosinergic modulation in 
locomotor networks, adenosine (75 µM) was bath-applied to isolated spinal cords in which 
locomotor-related activity was induced by bath-applied NMDA and 5-HT. Importantly, 
descending dopaminergic neurons are severed in this preparation (Björklund and Skagerberg, 
1979; Commissiong, Gentleman and Neff, 1979; Hökfelt, Phillipson and Goldstein, 1979; 
Skagerberg and Lindvall, 1985). Adenosine modulated neither the frequency (Fig. 2, A and B; 
p > 0.05, n = 7) nor the amplitude (Fig. 2, A and C; p > 0.05, n = 7) of locomotor-related activity 
in these experiments. When adenosine was applied in the presence of SKF 38393, burst 
frequency was reduced (19.5 ± 6.0%; Fig. 2, D and E; F[2,12] = 10.7, p < 0.01, n = 7) but 
amplitude was unchanged (Fig. 2, D and F; p > 0.05, n = 7), as reported in preparations in 
which DA is present (Witts, Panetta and Miles, 2012; Acevedo et al., 2016). Similarly, the A1-
receptor antagonist DPCPX (1-50 µM) (Witts, Panetta and Miles, 2012; Acevedo et al., 2016) 
failed to modulate either the frequency (Fig. 3, A and B; p > 0.05, n = 7) or amplitude (Fig. 3, 
A and C; p > 0.05, n = 7) of bursting in the absence of DA of SKF 38393. By contrast, as when 
it is applied in the presence of DA (Witts, Panetta and Miles, 2012; Acevedo et al., 2016), 
DPCPX (1 µM) (Acevedo et al., 2016) applied in the presence of SKF 38398 elicited an 
increase in burst frequency (23.5 ± 4.8%; Fig. 3, D and E; F[2,12] = 13.7, p < 0.001, n = 7) 
without modulating burst amplitude (Witts, Panetta and Miles, 2012; Acevedo et al., 2016); 
however, an increase in burst amplitude was recorded following washout of DPCPX (23.1 ± 
2.9%; Fig. 3, D and F; F[2,12] = 17.9, p < 0.001, n = 7). 
Stimulation of glia by selective activation of the endogenous GPCR PAR1 triggers the release 
of ATP-adenosine and activation of A1-receptors (Carlsen and Perrier, 2014; Chapter 2). 
Stimulation of glia in this way is proposed to replicate the endogenous activation of glial 
receptors by synaptically released neurotransmitters (Araque et al., 1999, 2014). Like bath-
applied adenosine (Witts, Panetta and Miles, 2012; Acevedo et al., 2016), adenosine 
produced following experimental stimulation of glia reduces the frequency but not the 













Fig. 2. Adenosine requires activation of D1-like receptors to modulate locomotor-related 
activity. A: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right 
(R) L2 ventral roots showing the effect of adenosine (75 µM) on locomotor-related activity 
induced by 5-HT (10 µM) and NMDA (5 µM). Bi: locomotor-burst frequency over 5 min during 
a control period, during a 30-min application of adenosine, and during a 30-min washout. 
Individual data points are shown in grey, and means are represented by black lines. n = 7 
preparations. Bii: time course plot of normalised data aggregated into 1-min bins showing no 
change in burst frequency during adenosine application. n = 7. Ci: locomotor-burst amplitude 
over 5 min during a control period, during a 30-min application of adenosine, and during a 30-
min washout. n = 7. Cii: time course plot of normalised data aggregated into 1-min bins 
showing no change in burst amplitude during adenosine application. n = 7. D: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of adenosine on locomotor-related activity induced by 5-HT and NMDA in the 
presence of the selective agonist of D1-like receptors SKF 38393 (100 nM). Ei: locomotor-
burst frequency over 5 min during a control period, during a 30-min application of adenosine, 
and during a 30-min washout. SKF 38393 was present throughout. n = 7. Eii: time course plot 
of normalised data aggregated into 1-min bins showing a reduction in burst frequency during 
adenosine application in the presence of SKF 38393. n = 7. Fi: locomotor-burst amplitude over 
5 min during a control period, during a 30-min application of adenosine, and during a 30-min 
washout. SKF 38393 was present throughout. n = 7. Fii: time course plot of normalised data 
aggregated into 1-min bins showing no change in burst amplitude during adenosine 
application in the presence of SKF 38393. n = 7. Error bars: ± SEM. Statistically significant 
















Fig. 3. A1 adenosine receptors require activation of D1-like receptors to modulate 
locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces recorded 
from left (L) and right (R) L2 ventral roots showing the effect of the selective A1 antagonist 
DPCPX (1 µM) on locomotor-related activity induced by 5-HT (10 µM) and NMDA (5 µM). Bi: 
locomotor-burst frequency over 5 min during a control period, during a 30-min application of 
DPCPX (1-50 µM), and during a 30-min washout. Individual data points are shown in grey, 
and means are represented by black lines. n = 5 preparations. Bii: time course plot of 
normalised data aggregated into 1-min bins showing no change in burst frequency during 
DPCPX application. n = 5. Ci: locomotor-burst amplitude over 5 min during a control period, 
during a 30-min application of DPCPX, and during a 30-min washout. n = 5. Cii: time course 
plot of normalised data aggregated into 1-min bins showing no change in burst amplitude 
during DPCPX application. n = 5. D: raw (top) and rectified/integrated (bottom) traces recorded 
from left (L) and right (R) L2 ventral roots showing the effect of DPCPX (1 µM) on locomotor-
related activity induced by 5-HT and NMDA in the presence of the selective agonist of D1-like 
receptors SKF 38393 (100 nM). Ei: locomotor-burst frequency over 5 min during a control 
period, during a 30-min application of DPCPX (1 µM), and during a 30-min washout. SKF 
38393 was present throughout. n = 7. Eii: time course plot of normalised data aggregated into 
1-min bins showing an increase in burst frequency during DPCPX application in the presence 
of SKF 38393. n = 7.Fi: locomotor-burst amplitude over 5 min during a control period, during 
a 30-min application of DPCPX, and during a 30-min washout. SKF 38393 was present 
throughout. n = 7. Fii: time course plot of normalised data aggregated into 1-min bins showing 
no change in burst amplitude during DPCPX application in the presence of SKF 38393. n = 7. 






bath-applied adenosine (Witts, Panetta and Miles, 2012; Acevedo et al., 2016), adenosine 
produced following experimental stimulation of glia reduces the frequency but not the 
amplitude of ongoing locomotor-related activity when DA is present (Chapter 2). Like 
adenosine and DPCPX, TFLLR (10 µM) (Carlsen and Perrier, 2014; Chapter 2), a selective 
agonist of PAR1, failed to modulate the frequency (Fig. 4, A and B; p > 0.05, n = 7) or the 
amplitude (Fig. 4, A and C; p > 0.05, n = 7) of locomotor-related activity in the absence of a 
DA or a SKF 38393. In the presence of SKF 38393, however, a transient reduction in burst 
frequency was detected (12.3 ± 2.3%; Fig. 4, D and E; F[2,20] = 14.9, p < 0.001, n = 11), with 
no change in amplitude (Fig. 4, D and F; p > 0.05, n = 11), as previously reported in the 
presence of DA (Chapter 2). Together, these results confirm that bath-applied adenosine, 
endogenous adenosine present in the spinal cord during locomotor-related activity and 
adenosine released following stimulation of glia modulate locomotor-related activity by a 
mechanism which requires the simultaneous activation of D1-like receptors. 
Glial-cell derived adenosine modulates locomotor-related activity in a PKA-
dependent manner 
D1-like receptors signal through Gαs to stimulate adenylyl cyclase and cAMP production, 
resulting in activation of PKA and the modulation of neuronal activity (Abdel-Majid et al., 1998; 
Pieper, Clerkin and MacFarlane, 2011), whereas A1 receptors signalling through Gαi are 
proposed to inhibit adenylyl cyclase and its downstream effectors, acting in opposition to D1-
like receptors (Acevedo et al., 2016). This suggests that adenosine released following glial 
stimulation modulates network activity by reducing the activity of PKA. To confirm this, TFLLR 
was applied to spinal cord preparations in which locomotor-related activity had been induced 
by NMDA (5 µM), 5-HT (10 µM) and DA (50 µM) in the presence of 14-22 amide (1 µM), a 
PKA inhibitor (Acevedo et al., 2016). Under these conditions, the modulation of burst 
frequency upon PAR1 activation was abolished (Fig. 5, A and B; p > 0.05, n = 8); burst 
amplitude was also unchanged (Fig. 5, A and C; p > 0.05, n = 8). These data are further 













Fig. 4. Adenosine released from glia upon PAR1 activation requires activation of D1-like 
receptors to modulate locomotor-related activity. A: raw (top) and rectified/integrated 
(bottom) traces recorded from left (L) and right (R) L2 ventral roots showing the effect of the 
PAR1 agonist TFLLR (10 µM) on locomotor-related activity induced by 5-HT (10 µM) and 
NMDA (5 µM). Bi: locomotor-burst frequency over 5 min during a control period, upon a 5-min 
application of TFLLR, and during a 25-min washout. Individual data points are shown in grey, 
and means are represented by black lines. n = 7 preparations. Bii: time course plot of 
normalised data aggregated into 1-min bins showing no change in burst frequency upon 
TFLLR application. n = 7. Ci: locomotor-burst amplitude over 5 min during a control period, 
upon a 5-min application of TFLLR, and during a 25-min washout. n = 7. Cii: time course plot 
of normalised data aggregated into 1-min bins showing no change in burst amplitude upon 
TFLLR application. n = 7. D: raw (top) and rectified/integrated (bottom) traces recorded from 
left (L) and right (R) L2 ventral roots showing the effect of TFLLR on locomotor-related activity 
induced by 5-HT and NMDA in the presence of the selective agonist of D1-like receptors SKF 
38393 (100 nM). Ei: locomotor-burst frequency over 5 min during a control period, upon a 5-
min application of TFLLR, and during a 25-min washout. SKF 38393 was present throughout. 
n = 11. Eii: time course plot of normalised data aggregated into 1-min bins showing a transient 
reduction in burst frequency upon TFLLR application in the presence of SKF 38393. n = 11. 
Fi: locomotor-burst amplitude over 5 min during a control period, upon a 5-min application of 
TFLLR, and during a 25-min washout. SKF 38393 was present throughout. n = 11. Fii: time 
course plot of normalised data aggregated into 1-min bins showing no change in burst 
amplitude upon TFLLR application in the presence of SKF 38393. n = 11. Error bars: ± SEM. 


















Fig. 5. Adenosine released from glia upon PAR1 activation requires PKA activity to 
modulate locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots showing the effect of the PAR1 agonist 
TFLLR (10 µM) on locomotor-related activity induced by 5-HT (10 µM), NMDA (5 µM) and DA 
(50 µM) in the presence of the PKA inhibitor 14-22 amide (1 µM). Bi: locomotor-burst frequency 
over 5 min during a control period, upon a 5-min application of TFLLR, and during a 25-min 
washout. Individual data points are shown in grey, and means are represented by black lines. 
n = 8 preparations. Bii: time course plot of normalised data aggregated into 1-min bins showing 
no change in burst frequency upon TFLLR application. n = 8. Ci: locomotor-burst amplitude 
over 5 min during a control period, upon a 5-min application of TFLLR, and during a 25-min 
washout. n = 8. Cii: time course plot of normalised data aggregated into 1-min bins showing 
no change in burst amplitude upon TFLLR application. n = 8. Error bars: ± SEM. 
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receptor/adenylyl cyclase/PKA pathway. 
Discussion 
The experiments described in this chapter demonstrate that endogenous glial cell-derived 
adenosine functions during locomotor-related activity as a second-order modulator, 
constraining excitatory DA signalling which is mediated through D1-like receptors and PKA.  
Metamodulation of this kind may serve to provide fine control over a modulator that has very 
broad effects within the spinal cord (Katz, 1999; Sharples et al., 2014). 
Adenosine acting at A1 receptors is proposed to act in opposition to DA acting at D1-like 
receptors to reduce the speed of locomotion. This implied a previously undemonstrated 
excitatory role for D1-like receptors in modulating the frequency of locomotor-related activity 
in mice. Accordingly, selective activation of D1-like receptors with SKF 38393 is shown here 
to increase the frequency of locomotor-related activity. This finding contradicts previous 
studies reporting no change in the frequency of ongoing locomotor-related activity when D1-
like receptors are activated with another phenylbenzazepine, SKF 81297 (Humphreys and 
Whelan, 2012; Sharples et al., 2015). SKF 81297 applied at the concentration used in these 
studies is likely also activate inhibitory D2-like receptors (Neumeyer et al., 2003), which have 
been shown to reduce the frequency of locomotor-related bursting (Humphreys and Whelan, 
2012; Sharples et al., 2015). The excitatory effect of D1-like receptors on burst frequency may 
therefore have been masked in these studies. The evidence presented here that D1-like 
receptors are indeed excitatory in postnatal mice is consistent with studies showing that D1-
like receptors stimulate locomotor activity in intact adult mice (Lapointe et al., 2009) and 
neonatal rats (Barrière, Mellen and Cazalets, 2004). Conversely, it is shown that bath-applied 
adenosine, which acts via A1 but not A2A receptors in the murine locomotor circuitry (Witts, 
Panetta and Miles, 2012; Carlsen and Perrier, 2014; Acevedo et al., 2016; Chapter 2), reduces 
the frequency of locomotor-related activity, whereas A1 blockade increases it. Importantly, the 
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effects of A1 receptor activation or inhibition are only observed when D1-like receptors are also 
activated. 
Despite evidence that D1-like receptors enhance AMPA currents in motoneurons (Han and 
Whelan, 2009), no change in the amplitude of network activity is detected upon activation of 
D1-like receptors; similarly, adenosine is reported not to modulate burst amplitude (Witts, 
Panetta and Miles, 2012; Acevedo et al., 2016; Chapter 2).  However, although burst 
amplitude is unaltered during the activation of D1-like receptors and during inhibition of A1 
receptors by DPCPX, in both cases burst amplitude increases upon drug washout. The 
mechanism by which this occurs is unclear, but it may be relevant that in both experiments 
the change in amplitude follows a period of enhanced signalling through the D1-like receptor 
pathway; in the case of DPCPX, this occurs because A1 blockade relieves the pathway of 
inhibition by endogenous adenosine. Taken together, the data presented here indicate that A1 
and D1-like receptors have opposite effects on the frequency of network activity, and that 
neither receptor modulates the amplitude or intensity of locomotor-related output. This is 
consistent with the proposal that they act via a common pathway (Acevedo et al., 2016). 
Previous studies demonstrated that A1 receptors modulate the frequency of ongoing network 
activity in murine preparations in the presence of DA (Witts, Panetta and Miles, 2012; Acevedo 
et al., 2016; Chapter 2), but not in the presence of a D1-like receptor inhibitor (Acevedo et al., 
2016). Consistent with these reports, blockade of A1 receptors fails to modulate activity in the 
rat spinal cord in the absence of DA. (Taccola et al., 2012). Here, it is shown that the previously 
reported effects of adenosine, DPCPX and PAR1 activation by TFLLR on network activity are 
absent when DA is excluded from the aCSF, but that they are restored in the presence of a 
D1-like receptor agonist. Thus, activation of D1-like receptors is a precondition of adenosinergic 
modulation of ongoing locomotor-related activity. However, it is difficult to resolve these 
findings with previous observations that adenosine modulates postsynaptic currents in 
interneurons in acute slices from postnatal mice, both when bath-applied at the same 
concentration as used here (Witts, Nascimento and Miles, 2015) and when it is released 
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endogenously following stimulation of astrocytes (Carlsen and Perrier, 2014). Furthermore, 
adenosine applied to isolated rat spinal cords in the absence of DA modulates burst amplitude 
during locomotor-related activity, the frequency of disinhibited bursting, and the duration of 
bouts of locomotor-related activity induced by dorsal-root stimulation (Taccola et al., 2012). 
Adenosine also modulates reflex potentials induced by dorsal root stimulation in rats 
(Otsuguro, Wada and Ito, 2011; Taccola et al., 2012). All of these DA-independent effects are 
abolished by A1 blockade; however, in these studies A1 blockade alone has no effect in the 
absence of DA, indicating that adenosine present at basal levels within spinal cord 
preparations does not have modulatory effects. It is therefore possible that a high 
concentration of exogenous adenosine can under some circumstances act independently of 
DA; however, the ability of adenosine to act independently of DA in slices from postnatal mice 
(Witts, Nascimento and Miles, 2015) but not, as shown here, in rhythmically active 
preparations from the same species implies that a state-dependent mechanism is involved. 
Microdialysis experiments have shown that DA is released in the spinal cord during locomotion 
(Gerin, Becquet and Privat, 1995; Gerin and Privat, 1998). There is also evidence for activity-
dependent release of adenosine, since adenosinergic modulation scales with neuronal activity 
(Chapter 2). One possibility is that the excitatory actions of DA and the inhibitory actions of 
adenosine do not perfectly overlap, such that DA promotes locomotion at low frequencies of 
network activity, but its effect is constrained by adenosine at higher frequencies. Adenosine 
may function in this way to stabilize network output, ensuring controlled locomotion at higher 
speeds, or to prevent metabolic exhaustion. Alternatively, adenosine may inhibit D1-like 
receptor signalling across all speeds of locomotion, with adenosine shaping dopaminergic 
modulation by limiting only some of its actions. Second-order modulation of this kind may 
represent an efficient and selective mechanism of control over a first-order modulator that has 
diverse actions within a network (Katz, 1999). In the case of DA, those actions are mediated 
by multiple cell types via both D1-like and D2-like receptors. It is also possible that adenosine 
modulates only a subset of D1-like receptors. Consistent with this, it was previously observed 
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that motoneurons and excitatory interneurons are insensitive to adenosine during locomotor-
related activity implying that adenosine acts via inhibitory interneurons to modulate burst 
frequency (Witts, Panetta and Miles, 2012; Chapter 2). Therefore, although D1-like receptors 
modulate AMPA currents recorded from motoneurons in slices (Han and Whelan, 2009), it is 
likely that adenosine modulates only signalling through D1-like receptors expressed by 
inhibitory interneurons. 
Inhibition of PKA prevents the modulation of locomotor-related bursting otherwise detected 
following stimulation of glia. Similarly, PKA inhibition abolishes the effect of A1 blockade 
(Acevedo et al., 2016). These findings support a role for PKA in the modulation of network 
activity by adenosine acting through the D1-like receptor pathway. PKA has diverse molecular 
targets, including ion channels and neurotransmitter receptors (Abdel-Majid et al., 1998; 
Pieper, Clerkin and MacFarlane, 2011). Although AMPA receptors may be modulated by PKA 
(Banke et al., 2000; Esteban et al., 2003), and motoneuronal AMPA receptors are modulated 
by D1-like receptors in the lumbar spinal cord (Han and Whelan, 2009), motoneuronal AMPA 
receptors are unlikely to mediate the effects of adenosine during locomotor-related activity 
(see above). The targets of PKA activity, which may include AMPA receptors expressed by 
inhibitory interneurons, therefore remain to be elucidated. 
The data presented in this chapter provide evidence that adenosine produced upon 
stimulation of glia acts via A1 receptors to inhibit signalling through D1-like receptors (Fig. 6). 
Significantly, glia are proposed as the principal source of modulatory adenosine in spinal motor 
networks (Witts, Panetta and Miles, 2012; Chapter 2). These findings support a previously 
described interaction between A1 and D1-like receptors in spinal motor networks (Acevedo et 
al., 2016). Other examples of metamodulation in spinal locomotor networks are provided by 
Xenopus tadpoles, in which nitric oxide (NO) modulates the release of noradrenaline (McLean 
and Sillar, 2004) and lampreys, in which NO modulates the activity of endocannabinoids 
(Song, Kyriakatos and El Manira, 2012). The present study reveals a mechanism by which a 
second-order neuromodulator refines the effects of a first-order neuromodulator with diverse 
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Fig. 6. Schematic illustrating proposed release of ATP-adenosine from astrocytes and 
inhibition of D1-like receptor signalling in locomotor networks. ATP is released from 
putative spinal cord astrocytes upon experimental activation of the Gαq-linked receptor PAR1 
by TFLLR, proposed to mimic the endogenous action of neurotransmitters on astrocytic 
GPCRs (Carlsen and Perrier, 2014; Chapter 2). Extracellular ectonucleotidases mediate the 
hydrolysis of ATP to adenosine, which activates neuronal Gi-linked A1 receptors to inhibit 
signalling through Gαs-linked D1-like receptors at the level of adenylyl cyclase. Reduced cAMP 
production by adenylyl cyclase results in reduced activation of PKA. PKA acts on unidentified 
targets, perhaps including ion channels and ionotropic receptors, to reduce neuronal 






Chapter 4: Differential regulation of NMDA receptors by D-
serine and glycine in mammalian spinal locomotor 
networks 
Introduction 
Chapters 2 and 3 considered the importance of gliotransmission in the modulation of spinal 
locomotor networks. However, glial information processing is proposed to be important in 
processes other than the Ca2+-dependent release of modulators. These may include the 
regulation of the N-methyl-D-aspartate (NMDA) receptor (NMDAR) co-agonists D-serine and 
glycine. This chapter will consider the importance of NMDAR co-agonist regulation within 
spinal locomotor networks. Although the availability of D-serine and glycine at excitatory 
synapses in the spinal cord is likely to be determined, at least in part, by astrocytes (Le Bail et 
al., 2015), a direct demonstration of their involvement in NMDAR regulation is beyond the 
scope of this chapter. 
Mammalian locomotion requires the activation of limb and trunk muscles with precise timing. 
During locomotor tasks such as walking, running and swimming, the coordination and pacing 
of muscle activation are determined by central pattern generator (CPG) networks within the 
spinal cord (Kiehn, 2016). Whereas much of the patterning of network output is determined by 
glycine/GABAergic inhibitory transmission, excitatory drive is largely glutamatergic (Kiehn et 
al., 2008, 2010). Changes in the intensity of glutamatergic transmission affect the frequency 
and amplitude of locomotor-related network output (Kiehn et al., 2008; Talpalar and Kiehn, 
2010) and contribute to gait selection (Talpalar et al., 2013; Bellardita and Kiehn, 2015). Thus 
excitatory signalling underlies behavioural modifications that allow mammals to respond to the 
varying demands of their habitat (Orlovsky, Deliagina and Grillner, 1999; Grillner, 2006; 
Bellardita and Kiehn, 2015).  
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In mammalian spinal locomotor networks, endogenous glutamate acts via both NMDARs and 
non-NMDARs, namely α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and 
kainate receptors, with blockade of either resulting in alterations to locomotor-related output 
(Cazalets, Sqalli-Houssaini and Clarac, 1992; Douglas et al., 1993; Beato, Bracci and Nistri, 
1997; Talpalar and Kiehn, 2010). In most studies of isolated rodent spinal cord preparations, 
blockade of NMDARs results in either pronounced reductions in the frequency and amplitude 
of locomotor-related rhythmic activity or its cessation, likely depending on the strength of the 
stimulus used to excite network activity (Beato, Bracci and Nistri, 1997; Bracci, Beato and 
Nistri, 1998; Cowley et al., 2005; Talpalar and Kiehn, 2010). However, blockade of NMDARs 
is also reported to increase the frequency of locomotor network activity in mice (Whelan, 
Bonnot and Donovan, 2000), while at high frequencies of pharmacologically induced network 
activity, NMDAR blockade results in severe disruption to the coordination of rhythmic bursting 
without altering frequency (Talpalar and Kiehn, 2010). It remains to be determined whether 
these disparate findings reflect a fundamental difference in glutamatergic signalling between 
mice and rats or methodological differences between these studies. 
Unlike non-NMDARs, canonical GluN1/GluN2 subunit-containing NMDARs require the 
binding of a co-agonist in addition to the binding of glutamate for their activation (Johnson and 
Ascher, 1987; Kleckner and Dingledine, 1988; Clements and Westbrook, 1991; Paoletti, 
Bellone and Zhou, 2013). In the brain, the endogenous co-agonist may be either glycine or D-
serine, with one or the other dominating at a given synapse(Mothet et al., 2000; Kalbaugh, 
Zhang and Diamond, 2009; Li et al., 2009, 2013, Henneberger et al., 2010, 2013; Papouin et 
al., 2012; Le Bail et al., 2015; Meunier et al., 2016). The identity of the dominant co-agonist is 
proposed to vary during development (Le Bail et al., 2015), with receptor subunit composition 
(Kalbaugh, Zhang and Diamond, 2009; Papouin et al., 2012; Le Bail et al., 2015), between 
synaptic and extrasynaptic receptor populations (Papouin et al., 2012), and in an activity-
dependent manner (Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013). In the spinal 
cord, co-agonist identity has hitherto received little attention. 
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Dynamic regulation of co-agonist binding site occupancy is proposed as a mechanism for the 
modulation of NMDAR activity (Berger, Dieudonné and Ascher, 1998; Li et al., 2009, 2013). 
An unsaturated co-agonist binding site could permit the regulation of glutamatergic signalling 
by adjustments to the availability of the co-agonist (Berger, Dieudonné and Ascher, 1998; Li 
et al., 2009, 2013). The co-agonist binding site is reported to be unsaturated in some 
preparations (Berger, Dieudonné and Ascher, 1998; Kalbaugh, Zhang and Diamond, 2009; Li 
et al., 2009, 2013; Le Bail et al., 2015) but saturated in others (Kemp et al., 1988; Li et al., 
2009; Shigetomi et al., 2013), and activity-dependent changes in co-agonist binding have 
been reported in the brain (Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013). The 
co-agonist binding site is unsaturated in in vitro forelimb locomotor circuit preparations of pre- 
and postnatal rats (Shimomura et al., 2015), in motoneurons in a hemisected spinal cord 
preparation from postnatal rats (Brugger et al., 1990), and in the locomotor network of 
Xenopus tadpoles during swimming; in this latter preparation episodes of swimming are 
prolonged by exogenous D-serine or glycine (Issberner and Sillar, 2007). Thus, either 
increases or decreases in co-agonist availability could modulate excitatory transmission within 
mammalian spinal locomotor networks to modulate behaviour. 
The availability of D-serine is largely determined by the opposing actions of serine racemase, 
the enzyme that synthesises D-serine from L-serine, and D-amino acid oxidase (DAAO), the 
enzyme responsible for degrading D-serine in vivo (Wolosker, Blackshaw and Snyder, 1999; 
Sasabe et al., 2014); however, see Crow et al. (2012) for a review of the complexities of D-
serine metabolism (Crow, Marecki and Thompson, 2012). Concentrations of D-serine in the 
mammalian spinal cord are considerably lower than those of glycine, and considerably lower 
than those detected in the brain (Schell et al., 1997; Sasabe et al., 2007; Miyoshi et al., 2012; 
Thompson et al., 2012). Accordingly, glycine was proposed as the exclusive co-agonist of 
NMDARs in the spinal cord (Schell et al., 1997). However, selective degradation of D-serine 
reduces pain symptoms in rats subjected to nerve ligation (Lefèvre et al., 2015; Moon et al., 
2015), and levels of both D-serine and serine racemase are higher following surgery (Lefèvre 
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et al., 2015; Moon et al., 2015). Furthermore, aberrant D-serine metabolism in the spinal cord 
is implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) (Sasabe et al., 2007; 
Mitchell et al., 2010; Paul and de Belleroche, 2014). Thus the role of D-serine in spinal cord 
physiology in both health and disease merits further investigation. 
Glycine, the other NMDAR co-agonist, is released by exocytosis at glycinergic synapses 
(Bowery and Smart, 2006), by Asc-1 (Rosenberg et al., 2013) and possibly by reverse 
operation of glycine transporter-1 and -2 (GlyT1 and GlyT2) (Attwell, Barbour and Szatkowski, 
1993). Forward operation of GlyT1 and GlyT2 serves to clear glycine from the extracellular 
space and determines concentrations of free glycine (Eulenburg et al., 2005). Both 
transporters are highly expressed in the spinal cord and brainstem, where glycinergic 
transmission is prevalent (Eulenburg et al., 2005). Whereas GlyT2 is preferentially expressed 
at inhibitory synapses (Danglot et al., 2004), GlyT1 is expressed at excitatory synapses (Zafra, 
Aragón, et al., 1995; Cubelos, Giménez and Zafra, 2005) and is capable of holding the 
concentration of glycine within the restricted space of the synaptic cleft below its concentration 
in the surrounding area (Supplisson and Bergman, 1997; Berger, Dieudonné and Ascher, 
1998; Bergeron et al., 1998). Thus, glycine is ineffective at potentiating NMDAR currents in 
brainstem preparations when bath applied at concentrations under 100 µM, orders of 
magnitude above its EC50 (Berger, Dieudonné and Ascher, 1998). By contrast, NMDAR 
currents are potentiated by GlyT1 blockade (Lim, Hoang and Berger, 2004). These findings 
illustrate the GlyT1 exercises very tight regulation of glycine at excitatory terminals. 
In the spinal cord, spillover of synaptically released glycine is reported to facilitate NMDAR 
currents in the dorsal horn of postnatal rats (Ahmadi et al., 2003). In pre- and postnatal rat 
forelimb locomotor circuits, activity is facilitated by blockade of GlyT1 (Shimomura et al., 2015), 
suggesting a role for glycine transport in the regulation of excitatory transmission. Similarly, 
blockade of GlyT1 enhances NMDAR-dependent swimming in Xenopus tadpoles (Issberner 
and Sillar, 2007). However, it is unknown whether GlyT1 regulates glycine concentrations at 
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excitatory synapses in the spinal cord to determine rhythmic locomotor-related activity in 
mammals. 
The gating of NMDARs via the co-agonist binding site may provide a potent mechanism for 
the dynamic regulation of glutamatergic transmission in spinal locomotor networks, and thus 
of behaviour (Issberner and Sillar, 2007). However, the importance of NMDARs during 
locomotor-related activity in mice is currently unclear, and the roles and regulation of glycine 
and D-serine within the mammalian spinal cord are yet to be characterised.  
This chapter assesses the regulation of NMDARs via the co-agonist binding site during 
network activity in spinal cord preparations isolated from postnatal mice. Evidence is provided 
to show that in mice, as in rats, NMDARs contribute to speed control during pharmacologically 
induced locomotor-related activity, and that increasing co-agonist availability enhances 
NMDAR activation and network activity. Furthermore, it is shown that endogenous glycine and 
D-serine regulate NMDARs in a synapse-specific manner, and that occupancy of the co-
agonist binding differs between locomotor-related and disinhibited activity, implying activity-
dependent regulation. Finally, GlyT1 is shown to be a potent regulator of activity at excitatory 
synapses. Together, these findings demonstrate the importance of co-agonist binding site 
regulation during activity of a mammalian network with a behaviourally relevant output. 
Methods 
Ethics Statement  
All procedures performed on animals were conducted in accordance with the UK Animals 
(Scientific Procedures) Act 1986 and were approved by the University of St Andrews Animal 
Welfare and Ethics Committee. 
Tissue preparation 
Spinal cords were isolated from postnatal day (P)1-P4 C57BL/6 mice as previously described 
(Jiang, Carlin and Brownstone, 1999). In summary, animals were killed by cervical dislocation, 
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decapitated and eviscerated, before being transferred to a dissection chamber containing 
artificial cerebrospinal fluid (aCSF; equilibrated with 95% oxygen, 5% carbon dioxide, ~4°C). 
Spinal cords were then isolated between midthoracic and upper sacral segments, and ventral 
and dorsal roots were trimmed.  
Ventral root recordings 
Isolated spinal cords were pinned ventral-side up in a recording chamber perfused with aCSF 
(equilibrated with 95% oxygen, 5% carbon dioxide; RT) at 10 ml min-1. Glass suction 
electrodes were attached to the first or second lumbar ventral roots (L1, L2) on each side of 
the spinal cord to record flexor-related activity. In some experiments a further suction electrode 
was attached to the fifth lumbar ventral root (L5) to record the corresponding extensor-related 
activity. Locomotor-related activity was evoked by bath application of 5-hydroxytryptamine (5-
HT; 15 µM) and dopamine (DA; 50 µM), and was characterised by rhythmic bursting 
alternating contralaterally between upper ventral roots and ipsilaterally between upper ventral 
roots and L5. For disinhibited preparations (Bracci, Ballerini and Nistri, 1996; Witts, Panetta 
and Miles, 2012), strychnine (1 µM) and picrotoxin (60 µM) were applied to evoke rhythmic 
bursting that was synchronous in all roots. In some experiments, D(−)-2-amino-5-
phosphonopentanoic acid (D-APV; 50 µM) or erythro-beta-hydroxy-L-aspartic acid (HOAsp; 
400 µM) were bath-applied at the onset of locomotor-related bursting. Any drugs present 
during the control period were also present during application of further drugs and during 
washout. In all experiments, stable rhythmic bursting was established over a period of ~1 h 
prior to the control period. Rhythmic bursting was considered stable when the frequency, 
amplitude and duration of bursts were unchanged over several minutes. Data were amplified 
and filtered (band-pass filter 30-3,000 Hz, Qjin Design), and acquired at a sampling frequency 
of 6 kHz with a Digidata 1440A analogue-digital converter and Axoscope software (Molecular 
Devices, Sunnyvale, CA). Custom-built amplifiers (Qjin Design) enabled simultaneous online 




Data were analysed offline with DataView software (courtesy of Dr W.J. Heitler, University of 
St Andrews). Ventral-root bursts were identified from rectified/integrated traces and their 
instantaneous frequencies, peak-to-peak amplitudes, and durations were then measured from 
the corresponding raw traces. Amplitude was measured as a non-calibrated unit and is 
presented here in arbitrary units (a.u.). For time-course plots, data were averaged across 1-
min bins and normalised to a 10-min pre-control period to permit comparison between 
preparations. Statistical comparisons were performed on raw data averaged over 5-min 
periods or 10-min periods for disinhibited preparations. Data were analysed with Student’s t-
tests. p values < 0.05 were considered significant. Tests were performed in SPSS Statistics 
for Windows, Version 21.0 (IBM Corp. Armonk, NY) or Excel 2013 (Microsoft Corp. Redmond, 
WA). 
Solution, drug and enzyme preparation 
The aCSF used for dissections and recordings contained (in mM) 127 NaCl, 26 NaHCO3, 10 
glucose, 3 KCl, 2 CaCl, 1.25 NaH2PO4, and 1 MgCl2. 5,7-dichlorokynurenic acid (DCKA) was 
supplied by Abcam (Cambridge, UK); 5-HT, D-amino acid oxidase from porcine kidney 
(DAAO), D-APV, D-serine, glycine, L-serine, NMDA, picrotoxin and strychnine were supplied 
by Sigma-Aldrich (Poole, UK); N-[(3R)-3-([1,1'-Biphenyl]-4-yloxy)-3-(4-fluorophenyl)propyl]-N-
methylglycine hydrochloride (ALX 5407) was supplied by Tocris Bioscience (Bristol, UK); 
HOAsp was supplied by Wako Chemicals USA (Richmond, VA). ALX 5407 and picrotoxin 
were dissolved in DMSO, the concentration of which did not exceed 0.1% (v/v) in working 
solutions; DCKA and HOAsp were dissolved in 1 eq. NaOH; all other drugs and DAAO were 




NMDAR activation enhances the frequency and amplitude of pharmacologically 
induced locomotor-related activity 
The contribution of NMDARs to the production of rhythmic bilaterally alternating locomotor-
related network activity in isolated mouse spinal cord preparations has been subject to 
conflicting reports (Nishimaru, Takizawa and Kudo, 2000; Whelan, Bonnot and Donovan, 2000; 
Talpalar and Kiehn, 2010). To assess the role of NMDARs in this preparation, D-APV (50 µM), 
a selective, competitive NMDAR antagonist that interacts with the glutamate-binding site on 
GluN2 subunits, was bath applied during recordings of pharmacologically induced (5-HT, 15 
µM; DA, 50 µM) locomotor-related output from lumbar ventral roots. D-APV produced a 
marked reduction in the frequency of flexor-related bursting in L2 roots (64.9 ± 4.6%; p < 0.01, 
n = 6), from 0.125 ± 0.016 Hz to 0.043 ± 0.011 Hz (Fig. 1, A and B). The amplitude of 
locomotor-related L2 bursts was also reduced, but to a lesser extent (16.7 ± 4.4%; Fig 1, A 
and C; p < 0.05, n = 6). Alternation of bursts between contralateral L2 roots was maintained 
throughout the drug application and wash periods; however, extensor-related activity recorded 
from L5 roots became indistinct upon application of D-APV (Fig. 1A) and was not assessed 
further. No differences were found between the effects of D-APV at 50 µM and 100 µM (n = 6) 
on either the frequency (p > 0.05) or amplitude (p > 0.05) of bursting in L2 roots, indicating that 
receptors were saturated at the lower concentration, consistent with previous reports (Talpalar 
and Kiehn, 2010). 
To further investigate the contribution of NMDARs to locomotor-related activity, and to confirm 
the requirement for occupation of the co-agonist binding site, DCKA (5 µM), a competitive 
inhibitor acting at the co-agonist binding site on GluN1 subunits (Henderson, Johnson and 
Ascher, 1990), was applied to rhythmically active preparations. Like D-APV, DCKA potently 
reduced the frequency of locomotor-related bursting in L2 roots (63.7 ± 7.2%; Fig. 1, D and E; 
p < 0.01, n = 6) and modestly reduced burst amplitude (14.6 ± 2.6%; Fig. 1, D and F; p < 0.05, 












Fig. 1. NMDARs determine the speed and amplitude of locomotor-related activity in 
spinal cord preparations from postnatal mice. A: raw (top) and rectified/integrated (bottom) 
traces recorded from left (L) and right (R) L2 ventral roots and RL5 showing the effect of the 
competitive glutamate-binding site antagonist D-APV (50 µM) on locomotor-related activity 
induced by 5-HT (15 µM) and DA (50 µM). Bi: locomotor-burst frequency over 5 min during a 
control period, during a 40-min application of D-APV, and during a 30-min washout. Individual 
data points are shown in grey, and means are represented by black lines. n = 6 preparations. 
Bii: time course plot of normalised data aggregated into 1-min bins showing a reduction in 
burst frequency during D-APV application. n = 6. Ci: locomotor-burst amplitude over 5 min 
during a control period, during a 40-min application of D-APV, and during a 30-min washout. 
n = 6. Cii: time course plot of normalised data aggregated into 1-min bins showing a reduction 
in burst amplitude during D-APV application. n = 6. D: raw (top) and rectified/integrated 
(bottom) traces recorded from left (L) and right (R) L2 ventral roots showing the effect of the 
competitive co-agonist binding site antagonist DCKA (5 µM) on locomotor-related activity. Ei: 
locomotor-burst frequency over 5 min during a control period, during a 30-min application of 
DCKA, and during a 30-min washout. n = 6. Eii: time course plot of normalised data 
aggregated into 1-min bins showing a reduction in burst frequency during DCKA application. 
n = 6. Fi: locomotor-burst amplitude over 5 min during a control period, during a 30-min 
application of DCKA, and during a 30-min washout. n = 6. Fii: time course plot of normalised 
data aggregated into 1-min bins showing a reduction in burst amplitude during DCKA 
application. n = 6. Error bars: ± SEM. Statistically significant difference from control: *p < 0.05, 







for NMDARs in controlling the frequency and amplitude of locomotor-related activity in mouse 
spinal cord preparations, consistent with findings from rat preparations (Beato, Bracci and 
Nistri, 1997; Bracci, Beato and Nistri, 1998; Cowley et al., 2005), and contradicting findings 
from an earlier study of the mouse (Whelan, Bonnot and Donovan, 2000). Furthermore, these 
effects are mediated by canonical GluN1/GluN2 subunit-containing NMDARs. 
The NMDAR co-agonist binding site is unsaturated during fictive locomotion 
Occupancy of the co-agonist binding site by D-serine or glycine is a precondition for the 
activation of NMDARs by glutamate (Johnson and Ascher, 1987; Kleckner and Dingledine, 
1988; Clements and Westbrook, 1991); however, the co-agonist binding site may not be fully 
saturated for a given receptor population, and co-agonist availability may be adjusted to 
modulate glutamatergic transmission during network activity (Berger, Dieudonné and Ascher, 
1998; Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013). Therefore, it was next 
investigated whether co-agonist binding sites are saturated during fictive locomotion by bath 
applying D-serine at a range of concentrations (0.01 µM n = 7 preparations; 0.1 µM, n = 5; 1 
µM, n = 7; 3 µM, n = 6; duration 15 min); D-serine, unlike glycine, is not subject to rapid 
clearance from the synapse (Supplisson and Bergman, 1997). D-serine rapidly increased 
burst frequency at concentrations of 0.01-3 µM, with the greatest effect at 1 µM (70.9 ± 13.6%; 
Fig. 2, A, Ci and D; p < 0.01, n = 7). At higher concentrations (Fig. 2, B and Ci), and when 
applied for longer periods (not shown), rhythmic activity became disordered, and a smaller 
effect on burst frequency was recorded. D-serine altered burst amplitude only at 1 µM, 
although the reduction detected at that concentration was modest (8.1 ± 2.1%; Fig. 2, A, Cii 
and E; p < 0.05, n = 7). Alternation of bursts, both between contralateral L2 roots and between 
ipsilateral roots L2 and L5, was maintained throughout the drug application and wash periods 
(Fig 2, A and B). To confirm that the effects of D-serine were mediated exclusively by NMDARs 
(Kakegawa et al., 2011), it was applied during NMDAR blockade. In the presence of saturating 
D-APV (50 µM), D-serine (1-10 µM) failed to modulate either the frequency (Fig. 2, F and G; 








Fig. 2. Exogenous D-serine acts at unsaturated NMDAR co-agonist binding sites to 
modulate locomotor-related activity. A and B: Raw (top) and rectified/integrated (bottom) 
traces recorded from left (L) and right (R) L2 ventral roots and RL5 showing the effect of D-
serine at 1 µM (A) and 3 µM (B) on locomotor-related activity induced by 5-HT (15 µM) and 
DA (50 µM). C: Percentage change in frequency (Ci) and amplitude (Cii) in response to varying 
concentrations of D-serine, calculated by comparing a 5-min window during a control period 
with a 5-min window during a 15-min application of D-serine. n = 5-7 preparations. Di: 
locomotor-burst frequency over 5 min during a control period, during a 15-min application of 
D-serine (1 µM), and during a 20-min washout. Individual data points are shown in grey, and 
means are represented by black lines. n = 7. Dii: time course plot of normalised data 
aggregated into 1-min bins showing an increase in burst frequency during D-serine (1 µM) 
application. n = 7. Ei: locomotor-burst amplitude over 5 min during a control period, during a 
15-min application of D-serine (1 µM), and during a 20-min washout. n = 7. Eii: time course 
plot of normalised data aggregated into 1-min bins showing a reduction in burst amplitude 
during D-serine (1 µM) application. n = 7. F: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots showing the effect of D-serine (10 µM) on 
locomotor-related activity in the presence of D-APV (50 µM). Gi: locomotor-burst frequency 
over 5 min during a control period, during a 30-min application of D-serine (1-10 µM), and 
during a 20-min washout. D-APV was present throughout. n = 6. Gii: time course plot of 
normalised data aggregated into 1-min bins showing no change in burst frequency when D-
serine is applied in the presence of D-APV n = 6. Hi: locomotor-burst amplitude over 5 min 
during a control period, during a 30-min application of D-serine (1-10 µM), and during a 20-
min washout. D-APV was present throughout. n = 6. Hii: time course plot of normalised data 
aggregated into 1-min bins showing no change in burst amplitude when D-serine is applied in 
the presence of the competitive glutamate-binding site antagonist D-APV n = 6. Error bars: ± 




indicate that NMDARs within the spinal motor circuitry are unsaturated during fictive 
locomotion, permitting enhancement of NMDAR activation by increased co-agonist availability. 
Endogenous D-serine acts via NMDARs to reduce the frequency of locomotor-
related activity 
In various brain preparations, the endogenous NMDAR co-agonist is either D-serine or glycine, 
with one or the other gating receptors in a non-redundant manner (Mothet et al., 2000; 
Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013, Henneberger et al., 2010, 2013; 
Papouin et al., 2012; Le Bail et al., 2015; Meunier et al., 2016). Co-agonist identity within spinal 
networks was assessed by selective depletion of endogenous D-serine. Unexpectedly, 
selective degradation of endogenous D-serine by bath application of the enzyme DAAO (0.29 
U ml-1) (Papouin et al., 2012; Sasabe et al., 2014) resulted in a pronounced increase in the 
frequency of locomotor-related bursting (71.6 ± 20.7%; Fig. 3, A and B; p < 0.01, n = 8), but 
did not alter burst amplitude (Fig. 3, A and C; p > 0.05, n = 8). Likewise, application of HOAsp 
(400 µM) (Strísovský et al., 2005; Henneberger et al., 2010) to inhibit endogenous serine 
racemase increased the frequency of rhythmic bursting (77.9 ± 21.3%; Fig. 3, D and E; p < 
0.01, n = 6) without affecting amplitude (Fig. 3, D and F; p > 0.05, n = 6). To confirm that the 
increase in locomotor frequency upon depletion of endogenous D-serine was mediated by 
NMDARs, HOAsp was bath applied in the presence of D-APV (50 µM). In these experiments, 
neither burst frequency (Fig. 3, G and H; p > 0.05, n = 10) nor amplitude (p > 0.05, n = 10) 
were altered, indicating that endogenous D-serine acts at NMDARs. However, it is unlikely 
that endogenous D-serine acts universally at NMDARs since, if this were the case, its 
depletion would result in reduced frequency and amplitude of locomotor-related bursting, 
reproducing the effects of NMDA blockade. The finding that depletion of endogenous D-serine 
instead increases the frequency of network output implies that its action is restricted to a 
subset of NMDARs. Previously, it was shown that selective inhibition of a subset of 
glutamatergic neurons within the spinal cord proposed  to synapse onto inhibitory interneurons  










Fig. 3. Endogenous D-serine acts via NMDARs to modulate the frequency but not the 
amplitude of locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots showing the effect of the D-serine 
scavenger DAAO (0.29 U ml-1) on locomotor-related activity induced by 5-HT (15 µM) and DA 
(50 µM). Bi: locomotor-burst frequency over 5 min during a control period, during a 40-min 
application of DAAO, and during a 40-min washout. Individual data points are shown in grey, 
and means are represented by black lines. n = 8. Bii: time course plot of normalised data 
aggregated into 1-min bins showing an increase in burst frequency during DAAO application. 
n = 8. Ci: locomotor-burst amplitude over 5 min during a control period, during a 40-min 
application of DAAO, and during a 40-min washout. n = 8. Cii: time course plot of normalised 
data aggregated into 1-min bins showing no change in burst amplitude during DAAO 
application. n = 8. D: raw (top) and rectified/integrated (bottom) traces recorded from left (L) 
and right (R) L2 ventral roots showing the effect of the serine racemase inhibitor HOAsp (400 
µM) on locomotor-related activity. Ei: locomotor-burst frequency over 5 min during a control 
period, during a 40-min application of HOAsp, and during a 40-min washout. n = 6. Eii: time 
course plot of normalised data aggregated into 1-min bins showing an increase in burst 
frequency during HOAsp application. n = 6. Fi: locomotor-burst amplitude over 5 min during a 
control period, during a 40-min application of HOAsp, and during a 40-min washout. n = 6. Fii: 
time course plot of normalised data aggregated into 1-min bins showing no change in burst 
amplitude during HOAsp application. n = 6. G: raw (top) and rectified/integrated (bottom) 
traces recorded from left (L) and right (R) L2 ventral roots showing the effect of HOAsp on 
locomotor-related activity in the presence of the competitive glutamate-binding site antagonist 
D-APV (50 µM). H: locomotor-burst frequency over 5 min during a control period, during a 30-
min application of HOAsp, and during a 20-min washout. D-APV was present throughout. n = 






Fig 4: Racemisation of L-serine within the spinal cord results in a decrease in the 
frequency of locomotor-related activity. A: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots showing the effect of the D-serine precursor 
L-serine (50 µM) on locomotor-related activity induced by 5-HT (15 µM) and DA (50 µM). B: 
locomotor-burst frequency over 5 min during a control period, during a 15-min application of 
L-serine (40-100 µM), and during a 30-min washout. Individual data points are shown in grey, 
and means are represented by black lines. n = 9 preparations. C: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of L-serine (50 µM) on locomotor-related activity in the presence of the serine 
racemase inhibitor HOAsp (400 µM). D: locomotor-burst frequency over 5 min during a control 
period, during a 15-min application of L-serine (50 µM), and during a 30-min washout. HOAsp 
was present throughout. n = 6. Error bars: ± SEM. Statistically significant difference from 






To further investigate the activity of endogenous D-serine, experiments were performed in 
which the substrate of serine racemase, L-serine, was applied to preparations. Whereas bath-
applied D-serine is expected to potentiate all NMDARs at which the co-agonist binding site is 
unsaturated, application of L-serine is likely to enhance the availability of D-serine 
preferentially at synapses proximate to its synthesis (Rosenberg et al., 2010). 
Supplementation of L-serine (40-100 µM) consistently reduced the frequency of locomotor-
related bursting (16.2 ± 3.6%; Fig. 4, A and B; p < 0.01, n = 9), without affecting amplitude (p > 
0.05, n = 9). Burst frequency was unchanged when L-serine (50 µM) was applied in the 
presence of HOAsp (400 µM; Fig. 4, C and D; p > 0.05, n = 6), indicating that serine racemase 
is required for its conversion to D-serine, which in turn facilitates NMDAR activation. 
Collectively, these data support a role for endogenous D-serine in the regulation of a restricted 
population of NMDARs in the spinal cord, with the remaining fraction of NMDARs likely being 
gated by glycine. 
D-serine does not modulate excitatory components of locomotor networks 
during disinhibited bursting 
If endogenous D-serine acts as a dominant co-agonist at a subset of NMDARs, it is likely that 
these are expressed by inhibitory interneurons that act to constrain the frequency of 
locomotor-related activity. To test the relative sensitivity of excitatory versus inhibitory 
components of the spinal motor circuitry to D-serine, experiments were performed in which 
inhibitory transmission was blocked by the glycine receptor (GlyR) antagonist strychnine (1 
μM) and the GABAA channel antagonist picrotoxin (60 μM) (Bracci, Ballerini and Nistri, 1996; 
Witts, Panetta and Miles, 2012; Foster et al., 2014). Blockade of inhibitory transmission 
resulted in slow (0.032 ± 0.002 Hz, n = 25), long-duration, high-amplitude bursts that were 
synchronous across ventral roots (Fig. 5 and 6). When D-APV (50 µM) was applied to 
determine the importance of NMDARs for the generation of this pattern of network activity, 
bursting rapidly ceased in all experiments (Fig. 5, A, Bii and Cii; n = 6), as previously reported 












Fig. 5: NMDA receptors are active during disinhibited bursting. A: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of the competitive glutamate-binding site antagonist D-APV (50 µM) applied to 
preparations in which inhibitory transmission was blocked by the GABAA-receptor antagonist 
pictrotoxin (60 μM) and the glycine-receptor antagonist strychnine (1 μM). Bi: Ventral-root 
burst frequency over 10 min during a control period, during a 30-min application of D-APV, 
and during a 40-min washout. Individual data points are shown in grey, and means are 
represented by black lines. n = 6 preparations. Bii: time course plot of normalised data 
aggregated into 1-min bins showing a reduction in burst frequency during D-APV application. 
n = 6. Ci: Ventral-root amplitude over 10 min during a control period, during a 30-min 
application of D-APV, and during a 40-min washout. n = 6. Cii: time course plot of normalised 
data aggregated into 1-min bins showing a reduction in burst amplitude during D-APV 
application. n = 6. D: raw (top) and rectified/integrated (bottom) traces recorded from left (L) 
and right (R) L2 ventral roots showing the effect of NMDA (10 µM) applied to preparations in 
which inhibitory transmission was blocked. Ei: Ventral-root burst frequency over 10 min during 
a control period, during a 20-min application of NMDA, and during a 30-min washout. n = 6. 
Eii: time course plot of normalised data aggregated into 1-min bins showing an increase in 
burst frequency during NMDA application. n = 6. Fi: Ventral-root burst amplitude over 10 min 
during a control period, during a 20-min application of NMDA, and during a 30-min washout. 
n = 6. Fii: time course plot of normalised data aggregated into 1-min bins showing a reduction 
in burst amplitude during NMDA application. n = 6. Error bars: ± SEM. Statistically significant 
















Fig. 6: Neither exogenous nor endogenous D-serine modulates disinhibited activity 
mediated by excitatory components of locomotor networks. A: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of D-serine (10 µM) applied to preparations in which inhibitory transmission was 
blocked by the GABAA-receptor antagonist pictrotoxin (60 μM) and the glycine-receptor 
antagonist strychnine (1 μM). Bi: Ventral-root burst frequency over 10 min during a control 
period, during a 30-min application of D-serine (1-10 µM), and during a 40-min washout. 
Individual data points are shown in grey, and means are represented by black lines. n = 6 
preparations. Bii: time course plot of normalised data aggregated into 1-min bins showing no 
change in burst frequency during D-serine application. n = 6. Ci: Ventral-root burst amplitude 
over 10 min during a control period, during a 30-min application of D-serine (1-10 µM), and 
during a 40-min washout. n = 6. Cii: time course plot of normalised data aggregated into 1-
min bins showing no change in burst amplitude during D-serine application. n = 6. D: raw (top) 
and rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots 
showing the effect of the serine racemase inhibitor HOAsp (400 µM) applied to preparations 
in which inhibitory transmission was blocked. Ei: Ventral-root burst frequency over 10 min 
during a control period, during a 30-min application of HOAsp, and during a 40-min washout. 
n = 7. Eii: time course plot of normalised data aggregated into 1-min bins showing no change 
in burst frequency during HOAsp application. n = 7. Fi: Ventral-root burst amplitude over 10 
min during a control period, during a 30-min application of HOAsp, and during a 40-min 
washout. n = 7. Fii: time course plot of normalised data aggregated into 1-min bins showing 






period  of  D-APV  application  at  a  reduced  frequency  (Fig. 5B)  and  amplitude  (Fig. 5C), 
indicating that NMDARs contribute to network excitation within disinhibited preparations, but 
may not be indispensable. NMDA (10 µM) was also applied during disinhibited bursting to 
determine whether NMDAR activation could be further increased. NMDA consistently 
increased burst frequency (221.2 ± 28.1%; Fig. 5, D and E; p < 0.001, n = 6) while reducing 
burst amplitude (20.1 ± 5.0%; Fig. 5, D and F; p < 0.05, n = 6).  
Next, D-serine (1-10 µM) was applied to assess whether NMDAR currents could be modulated 
via the co-agonist binding site during disinhibited activity. Neither burst frequency (Fig. 6, A 
and B; p > 0.05, n = 6) nor amplitude (Fig. 6, A and C; p > 0.05, n = 6) were altered, indicating 
that NMDARs expressed by excitatory components of the locomotor circuitry have saturated 
co-agonist binding sites under disinhibited conditions. To assess whether endogenous D-
serine acted as an NMDAR co-agonist within excitatory components of the locomotor circuitry, 
HOAsp (400 µM) was applied during disinhibited activity. Bursting was unchanged in both 
frequency (Fig. 6, D and E; p > 0.05, n = 7) and amplitude (Fig. 6, D and F; p > 0.05, n = 7) 
during HOAsp application, indicating that D-serine is not required as a co-agonist by NMDAR 
populations involved in the production of disinhibited bursting. These results support 
differential regulation of spinal cord NMDARs via the co-agonist binding site, whereby 
endogenous D-serine is required by NMDARs expressed by inhibitory components of the 
circuitry only and receptors are saturated under some conditions but not others. 
GlyT1 regulates extracellular glycine concentration and NMDAR activation 
Because the action of endogenous D-serine appears limited to a subpopulation of NMDARs 
within spinal networks, the role of glycine in the gating of NMDARs during bilaterally alternating 
locomotor-related activity was then assessed. Although glycine is the principal inhibitory 
transmitter within the spinal cord (Bowery and Smart, 2006) and has a similar binding affinity 
and potency to D-serine at NMDAR co-agonist binding sites (Brugger et al., 1990; Priestley et 
al., 1995; Chen et al., 2007), application of glycine did not modulate the frequency or amplitude 










Fig. 7. GlyT1 glycine transporters control the availability of glycine at excitatory 
synapses. A: raw (top) and rectified/integrated (bottom) traces recorded from left (L) and right 
(R) L2 ventral roots showing the effect of glycine (100 µM) on locomotor-related activity 
induced by 5-HT (15 µM) and DA (50 µM). Bi: locomotor-burst frequency over 5 min during a 
control period, during a 15-min application of glycine, and during a 40-min washout. Individual 
data points are shown in grey, and means are represented by black lines. n = 6. Bii: time 
course plot of normalised data aggregated into 1-min bins showing no change in burst 
frequency during glycine application. n = 6. Ci: locomotor-burst amplitude over 5 min during a 
control period, during a 15-min application of glycine, and during a 40-min washout. n = 6. Cii: 
time course plot of normalised data aggregated into 1-min bins showing no change in burst 
amplitude during glycine application. n = 6. D: raw (top) and rectified/integrated (bottom) traces 
recorded from left (L) and right (R) L2 ventral roots showing the effect of the GlyT1 inhibitor 
ALX 5407 (30 µM) on locomotor-related activity. Ei: locomotor-burst frequency over 5 min 
during a control period, during a 30-min application of ALX 5407, and during a 30-min washout. 
n = 6. Eii: time course plot of normalised data aggregated into 1-min bins showing an increase 
in burst frequency during ALX 5407 application. n = 6. Fi: locomotor-burst amplitude over 5 
min during a control period, during a 30-min application of ALX 5407, and during a 30-min 
washout. n = 6. Fii: time course plot of normalised data aggregated into 1-min bins showing 
no change in burst amplitude during ALX 5407 application. n = 6. G: raw (top) and 
rectified/integrated (bottom) traces recorded from left (L) and right (R) L2 ventral roots showing 
the effect of ALX 5407 on locomotor-related activity in the presence of the competitive 
glutamate-binding site antagonist D-APV (50 µM). H: locomotor-burst frequency over 5 min 
during a control period, during a 30-min application of HOAsp, and during a 30-min washout. 
D-APV was present throughout. n = 6. Error bars: ± SEM. Statistically significant difference 





(frequency: p > 0.05, n = 6; amplitude: p > 0.05, n = 6) or 100 µM (frequency: p > 0.05, n = 6; 
amplitude: p > 0.05, n = 6; Fig. 7, A-C), nor was left-right alternation of bursting altered (Fig 7. 
A). 
The glycine transporter GlyT1 is highly expressed at excitatory synapses in both the spinal 
cord and brainstem (Zafra, Gomeza, et al., 1995; Cubelos, Giménez and Zafra, 2005) and has 
been  proposed  to  maintain  sub-saturating  concentrations  of  glycine  in  the  latter (Berger, 
Dieudonné and Ascher, 1998; Lim, Hoang and Berger, 2004). The selective GlyT1 antagonist 
ALX 5407 (30 µM) (Atkinson et al., 2001) was applied to rhythmically active preparations to 
determine the influence of GlyT1 on extracellular glycine and locomotor-related network 
activity. GlyT1 antagonism resulted in a gradual increase in burst frequency (52.0 ± 13.9%; 
Fig. 7, D and E; p < 0.01, n = 6) but had no effect on amplitude (Fig. 7, D and F; p > 0.05, n = 
6). By contrast, no changes in locomotor frequency (Fig. 7, G and H; p > 0.05, n = 6) or 
amplitude (p > 0.05, n = 6) were observed when ALX 5407 (30 µM) was applied in the 
presence of D-APV (50 µM). Together, these results indicate that GlyT1 governs occupation 
of NMDAR co-agonist binding sites by exercising tight control over the concentration of glycine 
at excitatory synapses. 
Discussion 
This chapter provides evidence that both endogenous D-serine and glycine gate NMDARs 
within mammalian spinal networks to regulate the frequency of locomotor-related activity, that 
the NMDAR co-agonist binding site at which they act is unsaturated during locomotor-related 
but saturated during disinhibited activity, and that the glycine transporter GlyT1 is a potent 
regulator of glycine concentration at excitatory synapses. These findings suggest that dynamic 
regulation of NMDARs via the co-agonist binding site contributes to flexibility in the output 
repertoire of mammalian spinal motor circuits.  
Glutamatergic transmission operates both within spinal locomotor networks, where it 
determines the frequency, amplitude and robustness of rhythmic activity (Talpalar and Kiehn, 
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2010), and between spinal networks and descending pathways, which transmit commands for 
both the initiation (Jordan et al., 2008; Hägglund et al., 2010) and, paradoxically, the cessation 
(Bouvier et al., 2015) of locomotion. Glutamatergic signalling within spinal networks is 
mediated by both NMDARs and non-NMDARs (Cazalets, Sqalli-Houssaini and Clarac, 1992; 
Beato, Bracci and Nistri, 1997; Nishimaru, Takizawa and Kudo, 2000; Whelan, Bonnot and 
Donovan, 2000; Talpalar and Kiehn, 2010). Previously, it was proposed that the contribution 
of NMDARs to network output differed between isolated spinal cord preparations from 
postnatal rats and mice (Nishimaru, Takizawa and Kudo, 2000). In rats, application of NMDAR 
agonists alone is reported to induce sustained fictive locomotion (Kudo and Yamada, 1987; 
Smith, Feldman and Schmidt, 1988), whereas in mice, sustained activity is reported to require 
5-HT in addition to NMDAR agonists (Jiang, Carlin and Brownstone, 1999). In addition, 
NMDAR blockade consistently inhibits rhythmic activity in rats (Smith, Feldman and Schmidt, 
1988; Cazalets, Sqalli-Houssaini and Clarac, 1992; Beato, Bracci and Nistri, 1997; Bracci, 
Beato and Nistri, 1998; Gabbay, 2004; Cowley et al., 2005), whereas in mice, it has been 
reported to enhance burst frequency during pharmacologically induced (5-HT, 15 µM; DA, 75 
µM) fictive locomotion (Whelan, Bonnot and Donovan, 2000). In the present study, it is shown 
that NMDAR blockade reduces the frequency of pharmacologically induced locomotor-related 
activity in mouse spinal cord preparations, as previously reported in rat preparations (Beato, 
Bracci and Nistri, 1997; Gabbay, 2004; Cowley et al., 2005). It is also shown that NMDAR 
blockade reduces burst amplitude, an observation previously reported in the mouse (Whelan, 
Bonnot and Donovan, 2000) and rat (Beato, Bracci and Nistri, 1997). As in rat preparations 
(Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Cowley et al., 2005), left-right 
rhythmic alternation of bursts is maintained during NMDAR blockade. This study does not 
consider the effects of NMDAR blockade during high frequency (>0.4 Hz) fictive locomotion, 
during which it is reported to affect the robustness of rhythmic activity by disrupting patterned 
output by increasing non-resetting deletions – interruptions to patterned bursting lasting an 
integer of the cycle period – rather than altering frequency per se (Talpalar and Kiehn, 2010). 
The data presented here are consistent with previous reports that NMDARs are not essential 
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for the operation of the rodent locomotor CPG, but instead function to modulate pacing, at 
least at lower frequencies (< 0.4 Hz) of network activity (Beato, Bracci and Nistri, 1997; Bracci, 
Beato and Nistri, 1998; Cowley et al., 2005; Talpalar and Kiehn, 2010). D-APV, a competitive 
inhibitor of the glutamate-binding site, and DCKA, a competitive inhibitor of the co-agonist 
binding site, have similar effects on burst frequency and amplitude, revealing a requirement 
for binding of both glutamate and a co-agonist, and implying that canonical GluN1/GluN2 
subunit-containing NMDARs dominate in the spinal motor circuitry. 
The finding that extensor-related bursting recorded from root L5 becomes indistinct upon 
NMDAR blockade likely reflects relatively weak locomotor drive to the lower lumbar segments 
according to the rostrocaudal gradient of excitability within the locomotor circuitry (Bonnot et 
al., 2002), rather than a greater contribution of NMDARs to the generation of activity in that 
root, since bursting in L5 is reported to continue during NMDAR blockade when a strong 
pharmacological stimulus is applied (Talpalar and Kiehn, 2010). 
Blockade of NMDARs is shown to result in sustained abolition of disinhibited bursting in most 
but not all preparations. Similarly, it is reported that NMDAR blockade abolishes disinhibited 
bursting in rat preparations, except when AMPAR currents are enhanced (Bracci, Ballerini and 
Nistri, 1996). Thus, NMDARs make a substantial contribution to disinhibited activity in both 
rats and mice, but are not essential for it. As in bilaterally alternating locomotor-related activity 
(Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; Nishimaru, Takizawa and Kudo, 
2000; Whelan, Bonnot and Donovan, 2000; Gabbay, 2004; Cowley et al., 2005; Talpalar and 
Kiehn, 2010), disinhibited activity can be sustained during NMDAR blockade when an 
alternative stimulus of sufficient intensity is provided. 
Together these results confirm the importance of NMDARs during both locomotor-related and 
disinhibited activity in the mouse, suggesting that NMDARs function in a similar manner in 
both mice and rats, by contrast with previous reports (Nishimaru, Takizawa and Kudo, 2000; 
Whelan, Bonnot and Donovan, 2000). Furthermore, these data demonstrate the necessity for 
a co-agonist to be bound to receptors in addition to glutamate.  
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It is shown that the NMDAR co-agonist binding site is unsaturated during locomotor-related 
activity and may be subject to cell type-specific and activity-dependent regulation. An 
unsaturated co-agonist binding site could permit the regulation of glutamatergic signalling and 
locomotor frequency by adjustments to co-agonist availability (Berger, Dieudonné and Ascher, 
1998; Li et al., 2009, 2013). Exogenous D-serine acts at NMDARs to increase the frequency 
of locomotor-related activity in a dose-dependent manner. The effective concentrations of 
exogenous D-serine are consistent with the binding affinities and potencies reported for D-
serine and glycine, with EC50 values in the range of ~0.1-1.3 µM (Brugger et al., 1990; Priestley 
et al., 1995; Chen et al., 2007). However, bursting becomes disrupted at higher concentrations 
of D-serine, as previously reported for NMDA itself (Talpalar and Kiehn, 2010), illustrating a 
requirement for regulation of NMDAR activation to ensure correct network activity. Excessive 
NMDAR activity resulting from aberrant regulation at the co-agonist binding site is a cause of 
excitotoxicity (Shleper, Kartvelishvily and Wolosker, 2005) and is proposed as a mechanism 
in the pathogenesis of amyotrophic lateral sclerosis (ALS) (Sasabe et al., 2007; Paul et al., 
2014).  
The effect of exogenous D-serine varies with the mode of network activity. Exogenous D-
serine does not modulate disinhibited bursting generated and coordinated exclusively by 
excitatory components of the motor circuitry, despite strong activation of NMDARs during this 
mode of activity. By contrast, exogenous D-serine increases the burst frequency of bilaterally 
alternating locomotor-related activity. Given that excitatory interneurons provide rhythmic drive 
and speed control within locomotor networks (Kiehn et al., 2008; Kiehn, 2016), modulation of 
their activity is likely to underlie increases in the frequency of rhythmic bursting during both 
modes of activity The finding that burst frequency increases upon NMDA but not D-serine 
application during disinhibited bursting indicates that the co-agonist binding sites of NMDARs 
expressed by excitatory interneurons are saturated. This may relate to presumably stronger 
activation of glutamate receptors during disinhibited bursting, which is characterised by 
seizure-like, high-amplitude, long-duration bursts. Thus, although it is uncertain whether 
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populations of rhythmogenic interneurons are identical between disinhibited and locomotor-
related preparations, these data indicate differential availability of the co-agonist depending 
on network activity. Similarly, it is reported that co-agonist availability scales with glutamate 
release in brain preparations (Li et al., 2009, 2013). 
Whereas NMDA and glutamate enhance burst amplitude during locomotor-related activity at 
lower concentrations and reduce it at higher concentrations (Talpalar and Kiehn, 2010), 
exogenous D-serine only modestly reduces burst amplitude. Since this effect occurs only at 
the concentration of D-serine that most potently increases burst frequency, it may be an 
indirect effect of rapid network activity. The failure of D-serine to enhance burst amplitude at 
lower doses implies that motoneuronal NMDARs are saturated during locomotor-related 
activity. Consistent with this possibility, burst amplitude is also unchanged when glycine 
availability is enhanced by blockade of GlyT1. Amplitude is also unaffected by D-serine 
application during disinhibited bursting, although this may be a function of more intense 
glutamate release (see above). By contrast, the co-agonist binding site of motoneuronal 
NMDARs is unsaturated when network activity is silenced by TTX (Brugger et al., 1990). Thus, 
the co-agonist site may be subject to cell-type specific as well as activity-dependent regulation, 
implying flexibility in the regulation of co-agonist availability to extend the range of possible 
network outputs.  
This study provides evidence that endogenous D-serine, as well as glycine, regulates the 
frequency of locomotor-related activity. If D-serine were the exclusive co-agonist in spinal 
locomotor networks, or if it acted in conjunction with glycine at all NMDARs, its depletion would 
mimic the effect of NMDAR inhibition by D-APV of DCKA; that is, it would reduce the frequency 
and amplitude of locomotor-related. Instead, depletion of endogenous D-serine, either with an 
enzymatic scavenger or by inhibition of its synthesising enzyme, results in a pronounced 
increase in burst frequency with no change in burst amplitude. Conversely, supplementation 
of the d-serine precursor L-serine results in a decrease in burst frequency that is dependent 
on D-serine synthesis. Exogenous L-serine presumably enhances D-serine production at 
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synapses where serine racemase is concentrated and D-serine is utilised, whereas 
exogenous D-serine potentiates NMDARs at all synapses where the co-agonist binding site is 
unsaturated. The finding that endogenous D-serine inhibits locomotor-related activity suggests 
that it is primarily required at excitatory synapses onto inhibitory interneurons. Consistent with 
this possibility, serine racemase inhibition has no effect when excitatory components of the 
network are examined in isolation. As a similar example of excitatory signalling acting to 
reduce network activity, excitation of spinal cord networks by descending glutamatergic V2a 
interneurons mediates inhibition of locomotor-related activity, likely through excitation of 
inhibitory interneurons (Bouvier et al., 2015)..Together, the findings of this study suggest a 
model in which D-serine acts via a subpopulation of NMDARs expressed by inhibitory 
interneurons to constrain locomotor speed, with the remaining moiety of co-agonist binding 
sites presumably regulated by glycine.  
Despite having two possible targets in the spinal cord (strychnine-sensitive inhibitory GlyR and 
the strychnine-insensitive NMDAR co-agonist binding site), and binding NMDARs with a 
similar affinity to D-serine (Brugger et al., 1990; Priestley et al., 1995; Chen et al., 2007) which 
potently modulates locomotor-related activity via NMDARs at 1 µM, exogenous glycine does 
not perturb locomotor-related activity at concentrations up to 100 µM. Although it cannot be 
ruled out that the actions of glycine at inhibitory receptors mask opposing activity at NMDARs, 
it is unlikely that GlyRs were activated in these experiments, as they have a considerably lower 
affinity for glycine than NMDARs, with EC50 values 2-3 orders of magnitude higher (Young and 
Snyder, 1974; Engblom and Akerman, 1991; Blednov, Bleck and Harris, 1996; Lewis et al., 
1998; Tapia and Aguayo, 1998; Graham et al., 2011). Furthermore, increasing extracellular 
glycine concentration by GlyT1 blockade in the presence of D-APV does not reveal inhibitory 
effects of glycine. The lack of effect of exogenous glycine in spinal cord preparations parallels 
observations in the brainstem, where D-serine facilitates NMDAR currents in the low-
micromolar range, but glycine is ineffective at concentrations below 100 µM until GlyT1 is 
inhibited (Berger, Dieudonné and Ascher, 1998). The lack of effect of exogenous glycine is 
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thus attributable to powerful glycine clearance by GlyT1, which is highly expressed in both 
regions (Cubelos, Giménez and Zafra, 2005). GlyT1 is a potent regulator of glycine availability 
at excitatory synapses, and is capable of holding glycine at subsaturating concentrations 
within the restricted space of the synaptic cleft below those of both the cerebrospinal fluid and 
a perfusate with a glycine concentration an order of magnitude greater (Supplisson and 
Bergman, 1997; Bergeron et al., 1998). Consistent with tight regulation of glycine 
concentration by GlyT1 at excitatory synapses within locomotor circuitry, it is shown that GlyT1 
antagonism results in an NMDAR-dependent increase in locomotor-burst frequency but not 
amplitude, similar to the effect of global facilitation of NMDARs with unsaturated co-agonist 
binding sites by exogenous D-serine. Similarly, inhibition of GlyT1 potentiates NMDAR 
currents in the brainstem (Lim, Hoang and Berger, 2004) and enhances swimming in Xenopus 
tadpoles in a manner resembling glycine or D-serine application (Issberner and Sillar, 2007). 
The regulation of glycine concentration at inhibitory synapses by GlyT2 is not considered here 
(Danglot et al., 2004; Eulenburg et al., 2005); however, these results reveal an important role 
for GlyT1 in the gating of NMDARs and the regulation of rhythmic activity in the mouse spinal 
cord, a role that is conserved between amphibians and mammals (Issberner and Sillar, 2007). 
Modulation of GlyT1 activity to adjust the availability of glycine at excitatory synapses could 
provide a mechanism for the regulation of motor behaviour (Issberner and Sillar, 2007). GlyT1 
is modulated, for instance, by protein kinase C (PKC) (Sato et al., 1995), which is activated by 
endogenous modulators of locomotor networks released during network activity, including 5-
HT (Anji et al., 2001) and acetylcholine (Sculptoreanu et al., 2001). GlyT1 is also modulated 
by brain derived neurotrophic factor (BDNF) (Aroeira, Sebastião and Valente, 2015), which is 
released in an activity-dependent manner (Goodman et al., 1996; Marini et al., 1998). Thus, 
GlyT1 is equipped to mediate the dynamic regulation of glycine availability at excitatory 
synapses and may extend the repertoire of adaptive behaviours produced by spinal networks.  
The regulation of NMDARs is essential to the proper functioning of spinal locomotor networks 
in health and disease. Tuning of NMDAR activation by adjustments to the availability of the 
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co-agonist would enhance the flexibility of glutamatergic signalling in healthy animals, 
providing a mechanism for speed control and perhaps contributing to the determination of gait 
(Talpalar and Kiehn, 2010; Talpalar et al., 2013; Bellardita and Kiehn, 2015). By contrast, 
dysregulation of NMDARs results in excitotoxicity (Shleper, Kartvelishvily and Wolosker, 2005), 
and may be implicated in the pathogenesis of ALS (Sasabe et al., 2007; Paul et al., 2014). 
Dichotomous regulation of NMDARs by glycine and D-serine is described in the brain 
(Kalbaugh, Zhang and Diamond, 2009; Papouin et al., 2012; Li et al., 2013; Le Bail et al., 
2015), although the rationale for regulation of NMDARs by two different co-agonists remains 
to be elucidated. This study provides the first evidence that NMDARs in the spinal cord are 
also regulated by both D-serine and glycine acting at distinct populations of NMDARs, and 
that co-agonist availability varies with neuronal activity. Furthermore, GlyT1 is shown to control 
the availability of glycine at excitatory synapses. Together, these findings reveal previously 














Chapter 5: General discussion 
Introduction 
Many studies indicate that glia release of modulators in response to neuronal activity, yet the 
importance of gliotransmission in regulating network activity and in shaping behaviour remains 
controversial (Araque et al., 2014; Bazargani and Attwell, 2016). This study provides evidence 
that glia release ATP-adenosine in an activity-dependent manner to modulate hindlimb 
locomotor networks in spinal cord preparations from postnatal mice. The activity of adenosine 
produced in this way is shown to be mediated by an antagonistic interaction between A1 
adenosine receptors and D1-like dopamine receptors. This study also demonstrates that 
locomotor-related activity in murine spinal networks entails activation of N-methyl-D-aspartate 
receptors (NMDARs). NMDARs are shown to be gated in a synapse-specific manner by 
glycine and D-serine, co-agonists of glutamate that are regulated by astrocytes. Since spinal 
locomotor networks direct the activation of muscles in intact animals, it is proposed that the 
modulation of network activity by glia described in this study is important in locomotion and 
adds to evidence that glial information processing is relevant to behaviour. 
Adenosine derived from glia reduces the frequency of ongoing 
locomotor related activity 
According to the tripartite synapse model, Gαq-coupled G-protein coupled receptors (GPCRs) 
expressed by astrocytes detect local release of neurotransmitters, stimulating inositol 
trisphosphate (IP3) receptor-dependent release of intracellular Ca2+; in turn, astrocytic Ca2+ 
elevations stimulate vesicular release of gliotransmitters such as glutamate, D-serine and 
adenosine triphosphate (ATP), which activate neuronal receptors to modify neuronal 
excitability or synaptic transmission (Araque et al., 1999, 2014; Bazargani and Attwell, 2016). 
This model is supported by evidence that astrocytic Ca2+ elevations are closely related to 
activity in neighbouring neurons, that Ca2+ elevations are related to activation of Gαq-coupled 
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GPCRs, and that experimental stimulation of astrocytic Ca2+ elevations results in modulation 
of neuronal activity (Araque et al., 1999, 2014; Bazargani and Attwell, 2016). In the present 
study, the endogenous Gαq-coupled G-protein protease-activated receptor-1 (PAR1) is 
exploited to stimulate Gαq-dependent release of gliotransmitters during ongoing locomotor-
related activity in spinal cord preparations. PAR1 has previously been shown to be 
preferentially expressed by astrocytes in the brain (Weinstein et al., 1995; Junge et al., 2004), 
and has been used to stimulate Ca2+ elevations and gliotransmitter release (Lee et al., 2007; 
Shigetomi et al., 2008; Carlsen and Perrier, 2014; Lalo et al., 2014). In Chapter 2, it is shown 
that the Gαq-coupled GPCR PAR1 is also preferentially expressed by glia within the spinal 
cord. Brief activation of PAR1 during ongoing locomotor-related activity is shown to result in a 
reversible reduction in the frequency but not the amplitude of locomotor-related bursting. 
Because this effect can be prevented by the gliotoxins methionine sulfoximine and 
fluoroacetate, inhibition of neuronal A1 but not A2A adenosine receptors, or inhibition of 
extracellular ectonucleotidases, it is proposed that PAR1 activation triggers the release of ATP 
from glia, rapid hydrolysis of ATP to adenosine catalysed by extracellular ectonucleotidases, 
and activation of neuronal A1 but not A2A receptors.  
The finding that PAR1 activation results in the release of ATP from glia in isolated spinal cords, 
followed by the rapid conversion of ATP to adenosine, is consistent with a previous study 
showing that PAR1 activation in slice preparations reduces amplitude of evoked excitatory 
postsynaptic potentials (EPSCs) by a presynaptic mechanism sensitive to inhibition of A1 
receptors and ectonucleotidases (Carlsen and Perrier, 2014). In addition, adenosinergic 
modulation of locomotor-related activity is prevented following pharmacological ablation of glia, 
indicating that glia are the primary source of modulatory adenosine in spinal locomotor 
networks (Witts, Panetta and Miles, 2012). Consistent with these observations, production of 
adenosine from ATP released following stimulation of glial Ca2+ signalling has previously been 
reported in the brain (Pascual et al., 2005; Serrano et al., 2006; Panatier et al., 2011). 
Importantly, GPCRs that stimulate astrocytic Ca2+ signalling differ in their capacity to elicit 
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gliotransmitter release (Shigetomi et al., 2008). Future studies should seek to corroborate the 
effects of PAR1 stimulation by using other techniques for stimulating astrocytes during network 
activity, such as activation of genetically encoded GPCRs (Agulhon et al., 2013; Bonder and 
McCarthy, 2014; Scofield et al., 2015; Yang, Qi and Yang, 2015) or channelrhodopsins 
(Gourine et al., 2010; Li et al., 2012; Beppu et al., 2014). Alternative approaches may reveal 
that spinal cord glia are competent to release modulators other than adenosine. 
The present study does not consider the effects of suppressing glial Ca2+ signalling during 
ongoing activity in locomotor networks. In acute spinal cord slices, introduction of a Ca2+ 
chelator into astrocytes via a patch pipette increases the amplitude of evoked EPSCs in 
neighbouring neurons, perhaps because by reducing astrocytic release of ATP-adenosine 
(Carlsen and Perrier, 2014); however, the mechanism by which this occurs was not tested 
directly. Techniques that would permit the acute and selective inhibition of Ca2+ elevations in 
all astrocytes within spinal locomotor networks are lacking. However, comparison of 
locomotor-related activity in isolated spinal cords from wild-type mice and from mice lacking 
IP3 receptor type 2 (IP3R2), which is preferentially expressed by astrocytes, may be 
informative (Petravicz, Fiacco and McCarthy, 2008; Takata et al., 2011; Navarrete et al., 2012; 
Haustein et al., 2014; Petravicz, Boyt and McCarthy, 2014; Martin et al., 2015). Although 
locomotor behaviour was reported to be unaltered in IP3R2-knockout mice (Agulhon et al., 
2013; Petravicz, Boyt and McCarthy, 2014), in these studies IP3R2 knockout was not acute 
and affected all regions of the nervous system, raising the possibility that neuronal 
compensatory mechanisms masked astrocytic deficits. Network-specific effects may therefore 
be revealed in isolated spinal cord preparations. 
IP3R2-knockout mice could also be used to confirm that PAR1 activation results in adenosine 
production via Gαq-mediated release of intracellular Ca2+ in spinal cord astrocytes. Interestingly, 
activation of a Gαq-coupled DREADD (designer receptor exclusively activated by designer 
drugs) expressed by glia in IP3R2-knockout results in inhibition of locomotion by an unknown 
mechanism (Agulhon et al., 2013). The rapid production of adenosine reported here is 
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consistent with Ca2+-dependent release of gliotransmitters (Lalo et al., 2014), but direct 
demonstration that PAR1 activation triggered Ca2+ elevations and that these directed release 
of ATP-adenosine was beyond the scope of this study. Use of Ca2+ imaging to show that PAR1 
activation stimulates Ca2+ transients in spinal cord astrocytes was also not possible here, but 
would further support a Gαq- and Ca2+-dependent mechanism of ATP-adenosine release. 
The effects of adenosine secreted from glia following PAR1 activation are consistent with 
studies showing that bath-applied adenosine reduces the frequency but not the amplitude of 
locomotor-related bursting in postnatal mice in an A1 but not A2A-dependent manner (Witts, 
Panetta and Miles, 2012; Acevedo et al., 2016). In addition, modulation of network activity by 
bath-applied ATP or endogenous adenosine requires ectonucleotidase activity, indicating that 
adenosine within mammalian spinal cords derives from ATP and that ATP alone does not 
modulate network activity (Witts, Panetta and Miles, 2012). Although adenosine acting at A1 
receptors has a similar depressive effect on locomotion in Xenopus tadpoles, ATP is also an 
effective modulator of spinal networks in tadpoles (Dale and Gilday, 1996). Thus, some but 
not all features of purinergic signalling are common to tadpoles and mice.  
Adenosine modulates the frequency of synaptic inputs to 
heterogeneous ventral horn interneurons 
The cell population that mediates the effect of adenosine on the frequency of network activity 
remains to be determined. Synchronous bursting produced by blockade of inhibitory 
transmission is shown here to be unaltered by adenosine produced upon PAR1 activation or 
by adenosine released during network activity, as revealed by inhibition of A1 receptors; 
similarly, it is unaltered by bath-applied adenosine (Witts, Panetta and Miles, 2012). These 
findings imply that both endogenous and exogenous adenosine act via inhibitory interneurons, 
perhaps by disynaptic inhibition (Witts, Panetta and Miles, 2012). However, bath-applied 
adenosine and adenosine produced upon PAR1 activation are shown in Chapter 2 to increase 
the interval between postsynaptic currents (PSCs) recorded from a mixed population of 
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rhythmically active ventral-horn interneurons during network activity in hemicords, whereas 
PSC interval is increased by blockade of A1 receptors. These changes in PSC interval may 
simply reflect changes in network activity; however, bath-applied adenosine also increases 
the interval between PSCs in heterogeneous interneurons in slice preparations, and this effect 
persists in the presence of tetrodotoxin (TTX), suggesting adenosine acts broadly within the 
ventral horn via a presynaptic mechanism (Witts, Nascimento and Miles, 2015). Adenosine 
also acts by a presynaptic mechanism to reduce the amplitude of evoked EPSCs in mixed 
ventral horn interneurons in slice preparations (Carlsen and Perrier, 2014). It is possible that 
adenosine acts via multiple mechanisms, not all of which may be relevant to network output. 
The observation that adenosine induces a hyperpolarising current in interneurons in slices 
(Witts, Nascimento and Miles, 2015) but not in rhythmically active hemicords indicates that 
the effects of adenosine are state-dependent. Furthermore, the studies showing modulation 
of PSCs by adenosine in slices were conducted in the absence of dopamine, yet it is shown 
in Chapter 3 that adenosine does not modulate network activity in the absence of either 
dopamine or a D1-like receptor agonist (see below). Since activation of D1-like dopamine 
receptors is prerequisite for the modulation of network activity by adenosine, future studies to 
determine the actions of adenosine at the cellular level, as well as the cell population 
responsible for its network effects, will also need to consider the activities and distribution of 
D1-like receptors in addition to the effects of network activity. 
Glia detect neuronal activity within spinal locomotor networks 
The observation in Chapter 2 that modulation of locomotor-related activity by endogenous 
adenosine scales with the frequency of network activity is consistent with activity-dependent 
release of ATP-adenosine by glia. Glia are therefore proposed to mediate a negative feedback 
loop, whereby activity-dependent release of adenosine depresses and perhaps stabilises 
network output, resulting in even, controlled movement. This model implies that ventral horn 
glia detect neuronal activity, for instance by detection of neurotransmitter release, as predicted 
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by the tripartite synapse model. Ca2+ imaging of astrocytes could be used in future studies to 
confirm astrocytic responsiveness to neuronal activity, as has been demonstrated in the brain 
(Araque et al., 2014; Bazargani and Attwell, 2016). Preliminary reports have indicated that 
ventral horn astrocytes display rhythmic Ca2+ elevations during network activity, and that these 
are blocked by inhibition of metabotropic glutamate receptor 1 (mGluR1) (Chub, Liu and 
O’Donovan, 2012; Chub and O’Donovan, 2011). The relationship between mGluR1 signalling 
in astrocytes and release of ATP-adenosine has not been assessed.  
Release of adenosine in proportion to neuronal activity could be demonstrated directly by 
measurement of adenosine within the spinal cord at different frequencies of network activity. 
It was not possible to achieve this with three-enzyme molecular biosensors for adenosine 
(Llaudet et al., 2003). In Chapter 2 adenosine biosensors are shown to lose sensitivity when 
placed in contact with spinal cord tissue, perhaps because of the presence in spinal cord tissue 
of a reversible inhibitor of one of their constituent enzymes. An alternative method for detecting 
substances released during locomotor-related activity, such as an analysis of the extracellular 
medium by high performance liquid chromatography (HPLC) (Huxtable et al., 2010), could be 
used instead in future studies.  
Adenosine is a second-order modulator of dopamine within 
locomotor networks 
Endogenous adenosine fails to modulate locomotor-related activity in the absence of 
dopamine or following inhibition of D1-like receptors or their downstream effector protein 
kinase A (PKA), suggesting that endogenous adenosine modulates network activity via an 
interaction between A1 and D1-like receptors (Acevedo et al., 2016). In Chapter 3, these 
observations are corroborated by data showing that bath-applied adenosine, adenosine 
produced upon PAR1 activation, and A1-receptor blockade fail to modulate locomotor-related 
activity when dopamine or an agonist of D1-like receptors is absent, but that the effects of 
adenosine reported in the presence of dopamine are restored when a D1-receptor agonist is 
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present. Adenosine therefore appears to function as a metamodulator of dopamine during 
locomotor-related activity. Previously, it was shown that nitric oxide (NO) modulates the 
release of noradrenaline in the spinal locomotor networks of Xenopus tadpoles (McLean and 
Sillar, 2004) and the activity of endocannabinoids in the spinal locomotor networks of lampreys 
(Song, Kyriakatos and El Manira, 2012). Metamodulation of this kind could serve to diversify 
the effects of first-order modulators, extending the repertoire of behavioural outputs of spinal 
networks (Katz, 1999). 
Previously, D1-like receptors were proposed not to modulate the frequency of rhythmic 
bursting in postnatal mice (Humphreys and Whelan, 2012; Sharples et al., 2015). In the 
present study, D1-like receptors are shown to have an excitatory effect, increasing the 
frequency of locomotor-related bursting. The reason for this discrepancy is uncertain and 
could be investigated in future studies; however, the agonist used in the earlier studies was 
applied at a concentration that may have activated inhibitory D2-like receptors in addition to 
D1-like receptors, masking their frequency effect (Neumeyer et al., 2003). The data presented 
here supporting an excitatory effect of D1-like receptors are consistent with findings that 
selective activation of D1-like receptors initiates locomotor-related activity in intact adult mice 
(Lapointe et al., 2009) and in isolated spinal cords from postnatal rats (Barrière, Mellen and 
Cazalets, 2004). Furthermore, an excitatory role is implied by the proposed interaction 
between A1 and D1-like receptors, whereby the former inhibit the activity of the latter to depress 
the frequency of network activity. 
The mechanisms by which D1-like receptors modulate ventral horn interneurons, including the 
molecular targets of PKA, remain to be determined. D1-like receptors are broadly expressed 
in the ventral horn (Dubois et al., 1986; Zhu et al., 2007, 2008), likely by multiple populations 
of physiologically distinct interneurons in which signalling by D1-like receptors could have 
different effects (Sharples et al., 2014). It remains to be determined whether adenosine 
modulates all or a fraction of those cell types. The failure of adenosine to modulate disinhibited 
activity suggests that its activity is restricted to inhibitory interneurons expressing D1-like 
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receptors. It was not possible by the pharmacological approach taken in the present study to 
distinguish between D1, D5, both members of the D1-like receptor subfamily; in future studies, 
this could be assessed using mice in which either D1 or D5 receptors are knocked out . 
D-serine and glycine regulate excitatory transmission in spinal 
locomotor networks 
Activation of NMDARs by glutamate requires the binding of a co-agonist, either D-serine of 
glycine, and the availability of both substances at excitatory synapses is regulated by glia (Le 
Bail et al., 2015). This study provides evidence that D-serine and glycine gate NMDARs during 
network activity in the spinal cord in a synapse-specific and activity dependent manner, as 
occurs in the brain (Mothet et al., 2000; Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 
2013; Henneberger et al., 2013; Le Bail et al., 2015; Meunier et al., 2016). 
Selective blockade of NMDARs within murine spinal locomotor networks is shown in Chapter 
4 to consistently reduce the frequency and amplitude of pharmacologically induced network 
activity. Although this contradicts previous studies using spinal cords from postnatal mice 
(Nishimaru, Takizawa and Kudo, 2000; Whelan, Bonnot and Donovan, 2000), it is consistent 
with findings from postnatal rats (Beato, Bracci and Nistri, 1997; Bracci, Beato and Nistri, 1998; 
Cowley et al., 2005). The reason for this conflict is unclear, since this study used similar 
methods to the previous mouse studies, and it seems unlikely that the different mouse strains 
used in these studies would differ very greatly in properties of a fundamental mechanism of 
excitatory transmission. 
Both D-serine and glycine regulate NMDARs in the spinal cord. Selective depletion of D-serine 
increases the frequency of locomotor-activity, but does not alter disinhibited bursting, 
suggesting that it regulates NMDARs expressed by a population of inhibitory interneurons that 
mediates disynaptic inhibition, such as V1 interneurons (Gosgnach et al., 2006). By deduction, 
glycine is proposed to gate the remaining fraction of NMDARs. It was beyond the scope of this 
study to assess NMDAR currents in individual neurons; however, whole-cell patch-clamp 
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recordings could be used in future to confirm that co-agonist identity is synapse-specific, as 
suggested by the data presented here. Although enzymatic depletion of glycine would 
presumably abolish locomotor-related bursting during network activity, as blockade of glycine 
and GABAA receptors produces synchronous bursting (Bracci, Ballerini and Nistri, 1996), 
scavenging both glycine and D-serine could be performed in slice preparations to characterise 
co-agonist identity in a cell-type specific manner (Papouin et al., 2012; Li et al., 2013; Le Bail 
et al., 2015). 
The extent to which the co-agonist binding site is occupied differs between locomotor-related 
activity and disinhibited activity, in which glutamate release is likely to be greater. It is therefore 
proposed that co-agonist availability is regulated in an activity-dependent manner, as reported 
in the brain (Kalbaugh, Zhang and Diamond, 2009; Li et al., 2009, 2013). Activity-dependent 
release has been detected in brain slices by assessing the degree to which the co-agonist 
binding site is occupied while varying the intensity of an electrical or pharmacological stimulus 
(Li et al., 2009, 2013). A similar approach could be used in spinal cord slices in future studies 
to corroborate the effects at the level of network output presented here. 
Finally, glycine applied at concentrations sufficient to facilitate NMDARs is shown not to alter 
network activity, whereas blockade of the glycine transporter-1 (GlyT1) enhances the 
frequency of locomotor-related bursting, implying that GlyT1 has a key role in regulating 
glycine availability in hindlimb locomotor networks, as previously reported in rat forelimb 
networks (Shimomura et al., 2015), in the spinal cord of Xenopus tadpoles (Issberner and 
Sillar, 2007) and in the brain (Berger, Dieudonné and Ascher, 1998; Bergeron et al., 1998). 
Dynamic regulation of GlyT1 activity is implied by activity-dependent regulation of co-agonist 
availability, but it was not possible to demonstrate this directly here. Future studies could 
assess the roles of regulators of GlyT1 in spinal locomotor networks; these may include protein 
kinase C (PKC) (Sato et al., 1995) and brain derived neurotrophic factor (BDNF) (Aroeira, 
Sebastião and Valente, 2015). 
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Although it was not possible in this study to directly characterise the role of astrocytes in 
regulating glycine and D-serine, the results presented here provide a basis for future 
investigations into the role of astrocytes in excitatory transmission in the spinal cord. GlyT1 is 
preferentially expressed by astrocytes and is highly expressed in the spinal cord and 
brainstem (Zafra, Gomeza, et al., 1995; Cubelos, Giménez and Zafra, 2005), although 
relatively modest expression of GlyT1 is also reported in neurons (Cubelos, Giménez and 
Zafra, 2005). D-serine biosynthesis requires 3-phosphoglycerate dehydrogenase, which is 
exclusively expressed by astrocytes (Ehmsen et al., 2013), and D-serine may be released by 
astrocytes in addition to neurons (Yang et al., 2003; Mothet et al., 2005; Henneberger et al., 
2010; Verrall et al., 2010; Rosenberg et al., 2013). Regulation of co-agonist availability has 
been shown to entail functional interactions between neurons and glia in the brain (Yang et 
al., 2003; Mothet et al., 2005; Henneberger et al., 2010; Li et al., 2013; Shigetomi et al., 2013; 
Le Bail et al., 2015). It may be possible in future to demonstrate a similar interaction between 
neurons and glia in the spinal cord by comparing experiments to assess occupancy of the co-
agonist binding site and co-agonist identity in intact preparations, as here, with similar 
experiments performed in preparations in which glia have been pharmacologically ablated, an 
approach that has been taken in the brain (Li et al., 2013; Le Bail et al., 2015). However, 
further characterisation of functional interactions between neurons and glia will require 
recordings from individual neurons in conjunction with acute pharmacological or genetic 
manipulations. The finding presented in Chapter 2 that the effects of PAR1 activation can be 
abolished by inhibition of A1 receptors suggests that spinal cord astrocytes do not release D-
serine in response to Gαq signalling, but this should be confirmed using alternative techniques 
to stimulate glia (Shigetomi et al., 2008). Nevertheless, astrocytic participation in activity-
dependent regulation of NMDARs would implie a degree of information processing and may 




Stimulation of glia is shown in this study to result in release of ATP-adenosine and the 
modulation of hindlimb locomotor networks in spinal cord preparations from postnatal mice, 
the output of which is directly relevant to a defined behaviour. This study adds to evidence 
that neuromodulators released by glia contribute to the production of behaviour (Gourine et 
al., 2010; Halassa and Haydon, 2010; Angelova et al., 2015; Morquette et al., 2015), 
supporting studies at the cellular level demonstrating that astrocytic information processing 
results in release of neuromodulators (Araque et al., 2014; Bazargani and Attwell, 2016). The 
use of isolated networks may in future help to determine why these studies are contradicted 
by others reporting no effect of glial Ca2+ signalling in behaving animals (Agulhon et al., 2013; 
Petravicz, Boyt and McCarthy, 2014).  
Spinal locomotor networks are also shown to be modulated by D-serine and glycine, co-
agonists of glutamate at NMDARs. The proposed role of astrocytes in regulating these 
substances is not directly demonstrated here, but this finding indicates a further important role 
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